<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?DTDIdentifier.IdentifierValue article.dtd?><?DTDIdentifier.IdentifierType system?><?SourceDTD.DTDName article.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName bmc2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Genome Biol</journal-id><journal-title-group><journal-title>Genome Biology</journal-title></journal-title-group><issn pub-type="ppub">1465-6906</issn><issn pub-type="epub">1465-6914</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">gb-2009-10-10-r104</article-id><article-id pub-id-type="pmid">19799774</article-id><article-id pub-id-type="doi">10.1186/gb-2009-10-10-r104</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Molecular networks involved in mouse cerebral corticogenesis and spatio-temporal regulation of <italic>Sox4 </italic>and <italic>Sox11 </italic>novel antisense transcripts revealed by transcriptome profiling</article-title></title-group><contrib-group><contrib contrib-type="author" id="A1"><name><surname>Ling</surname><given-names>King-Hwa</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><xref ref-type="aff" rid="I3">3</xref><xref ref-type="aff" rid="I7">7</xref><email>michael.ling@imvs.sa.gov.au</email></contrib><contrib contrib-type="author" id="A2"><name><surname>Hewitt</surname><given-names>Chelsee A</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I9">9</xref><email>chelsee.hewitt@petermac.org</email></contrib><contrib contrib-type="author" id="A3"><name><surname>Beissbarth</surname><given-names>Tim</given-names></name><xref ref-type="aff" rid="I4">4</xref><xref ref-type="aff" rid="I10">10</xref><email>tim.beissbarth@ams.med.uni-goettingen.de</email></contrib><contrib contrib-type="author" id="A4"><name><surname>Hyde</surname><given-names>Lavinia</given-names></name><xref ref-type="aff" rid="I4">4</xref><xref ref-type="aff" rid="I11">11</xref><email>lavinia.gordon@mcri.edu.au</email></contrib><contrib contrib-type="author" id="A5"><name><surname>Banerjee</surname><given-names>Kakoli</given-names></name><xref ref-type="aff" rid="I5">5</xref><email>kakolib@yahoo.com</email></contrib><contrib contrib-type="author" id="A6"><name><surname>Cheah</surname><given-names>Pike-See</given-names></name><xref ref-type="aff" rid="I5">5</xref><xref ref-type="aff" rid="I6">6</xref><email>pikesee.cheah@adelaide.edu.au</email></contrib><contrib contrib-type="author" id="A7"><name><surname>Cannon</surname><given-names>Ping Z</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>cannon@wehi.edu.au</email></contrib><contrib contrib-type="author" id="A8"><name><surname>Hahn</surname><given-names>Christopher N</given-names></name><xref ref-type="aff" rid="I7">7</xref><email>chris.hahn@imvs.sa.gov.au</email></contrib><contrib contrib-type="author" id="A9"><name><surname>Thomas</surname><given-names>Paul Q</given-names></name><xref ref-type="aff" rid="I5">5</xref><email>paul.thomas@adelaide.edu.au</email></contrib><contrib contrib-type="author" id="A10"><name><surname>Smyth</surname><given-names>Gordon K</given-names></name><xref ref-type="aff" rid="I4">4</xref><email>smyth@wehi.edu.au</email></contrib><contrib contrib-type="author" id="A11"><name><surname>Tan</surname><given-names>Seong-Seng</given-names></name><xref ref-type="aff" rid="I8">8</xref><email>stan@florey.edu.au</email></contrib><contrib contrib-type="author" id="A12"><name><surname>Thomas</surname><given-names>Tim</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>tthomas@wehi.edu.au</email></contrib><contrib contrib-type="author" corresp="yes" id="A13"><name><surname>Scott</surname><given-names>Hamish S</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><xref ref-type="aff" rid="I7">7</xref><email>hamish.scott@imvs.sa.gov.au</email></contrib></contrib-group><aff id="I1"><label>1</label>Molecular Medicine Division, The Walter and Eliza Hall Institute of Medical Research, Royal Parade, Parkville, Victoria 3052, Australia</aff><aff id="I2"><label>2</label>The School of Medicine, The University of Adelaide, SA, 5005, Australia</aff><aff id="I3"><label>3</label>Department of Obstetrics and Gynaecology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor DE, Malaysia</aff><aff id="I4"><label>4</label>Bioinformatics Division, The Walter and Eliza Hall Institute of Medical Research, Royal Parade, Parkville, Victoria 3052, Australia</aff><aff id="I5"><label>5</label>School of Molecular and Biomedical Science, Faculty of Sciences, University of Adelaide, Adelaide, SA 5005, Australia</aff><aff id="I6"><label>6</label>Department of Human Anatomy, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor DE, Malaysia</aff><aff id="I7"><label>7</label>Department of Molecular Pathology, The Institute of Medical and Veterinary Science and The Hanson Institute, Adelaide, SA 5000, Australia</aff><aff id="I8"><label>8</label>Howard Florey Institute, The University of Melbourne, Parkville, Victoria 3010, Australia</aff><aff id="I9"><label>9</label>Current address: Pathology Department, The Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, Victoria 3002, Australia</aff><aff id="I10"><label>10</label>Current address: Department of Medical Statistics (Biostatistics), University of G&#x000f6;ttingen, Humboldtalle 32, 37073 G&#x000f6;ttingen, Germany</aff><aff id="I11"><label>11</label>Current address: The Bioinformatics Unit, Murdoch Childrens Research Institute, Royal Children's Hospital, Melbourne, Victoria 3052, Australia</aff><pub-date pub-type="ppub"><year>2009</year></pub-date><pub-date pub-type="epub"><day>2</day><month>10</month><year>2009</year></pub-date><volume>10</volume><issue>10</issue><fpage>R104</fpage><lpage>R104</lpage><history><date date-type="received"><day>6</day><month>6</month><year>2009</year></date><date date-type="rev-recd"><day>20</day><month>7</month><year>2009</year></date><date date-type="accepted"><day>2</day><month>10</month><year>2009</year></date></history><permissions><copyright-statement>Copyright &#x000a9;2009 Ling et al.; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2009</copyright-year><copyright-holder>Ling et al.; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href="http://genomebiology.com/2009/10/10/R104"/><abstract abstract-type="short"><p>SAGE analysis reveals spatiotemporally regulated transcripts and overlapping sense and antisense transcripts that are important for mouse cerebral cortex development</p></abstract><abstract><sec><title>Background</title><p>Development of the cerebral cortex requires highly specific spatio-temporal regulation of gene expression. It is proposed that transcriptome profiling of the cerebral cortex at various developmental time points or regions will reveal candidate genes and associated molecular pathways involved in cerebral corticogenesis.</p></sec><sec><title>Results</title><p>Serial analysis of gene expression (SAGE) libraries were constructed from C57BL/6 mouse cerebral cortices of age embryonic day (E) 15.5, E17.5, postnatal day (P) 1.5 and 4 to 6 months. Hierarchical clustering analysis of 561 differentially expressed transcripts showed regionalized, stage-specific and co-regulated expression profiles. SAGE expression profiles of 70 differentially expressed transcripts were validated using quantitative RT-PCR assays. Ingenuity pathway analyses of validated differentially expressed transcripts demonstrated that these transcripts possess distinctive functional properties related to various stages of cerebral corticogenesis and human neurological disorders. Genomic clustering analysis of the differentially expressed transcripts identified two highly transcribed genomic loci, <italic>Sox4 </italic>and <italic>Sox11</italic>, during embryonic cerebral corticogenesis. These loci feature unusual overlapping sense and antisense transcripts with alternative polyadenylation sites and differential expression. The <italic>Sox4 </italic>and <italic>Sox11 </italic>antisense transcripts were highly expressed in the brain compared to other mouse organs and are differentially expressed in both the proliferating and differentiating neural stem/progenitor cells and P19 (embryonal carcinoma) cells.</p></sec><sec><title>Conclusions</title><p>We report validated gene expression profiles that have implications for understanding the associations between differentially expressed transcripts, novel targets and related disorders pertaining to cerebral corticogenesis. The study reports, for the first time, spatio-temporally regulated <italic>Sox4 </italic>and <italic>Sox11 </italic>antisense transcripts in the brain, neural stem/progenitor cells and P19 cells, suggesting they have an important role in cerebral corticogenesis and neuronal/glial cell differentiation.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>Complex behavioral tasks, from perception of sensory input and the control of motor output to cognitive functions such as learning and memory, are dependent on the precise development of innumerable interconnections of neuronal networks in the cerebral cortex. The development of the cerebral cortex (also known as cerebral corticogenesis) involves the specific influence of intrinsic and extrinsic mechanisms, which are triggered spatio-temporally [<xref ref-type="bibr" rid="B1">1</xref>-<xref ref-type="bibr" rid="B4">4</xref>]. Between embryonic day 11 (E11) and 18 (E18), the mouse cerebral cortex develops from a relatively homogenous band of mitotic multipotent progenitor cells into a complex laminated structure containing various classes of neuronal cells [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B4">4</xref>-<xref ref-type="bibr" rid="B6">6</xref>]. Cerebral corticogenesis involves: proliferation of multipotent progenitors (E11 to E16.5); migration of postmitotic cells (E11 to E17); cell morphogenesis (E13 to E18); gliogenesis and synaptogenesis (E16 until early postnatal period); and reorganization, elimination and stabilization of neuronal networks (up to adulthood).</p><p>The mouse cerebral cortex develops in the latero-medial and rostro-caudal axes [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B8">8</xref>]. At E11, the primordial plexiform layer begins to form in the most lateral part of the neural wall. Its growth continues in the latero-medial axis to the medial part of the telencephalon by E13. The primordial plexiform layer is also expanded in the rostro-caudal axis. The growth in this axis is always less than the growth in the latero-medial axis. The first wave of migratory neuronal cells form the cortical plate 2 days later after the development of the primordial plexiform layer. These events are followed by the development of the cortical plate into an organization of six distinct layers that forms the adult cerebral cortex. Generally, the rostral-most regions of the adult cerebral cortex consist of areas involved in executive functions and motor coordination, whilst the caudal-most regions consist of areas involved in sensory perception such as visual function. Although distinct functional arealization of the cerebral cortex do not fully apply to rodents, mounting evidence suggesting that regulated arealization exists has been shown in mice involving transcription factors such as empty spiracles homolog 2 (<italic>Emx2</italic>; <italic>Drosophila</italic>) [<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B10">10</xref>], paired box gene 6 (<italic>Pax6</italic>) [<xref ref-type="bibr" rid="B9">9</xref>], COUP transcription factor 1 (<italic>Coup-tf1</italic>) [<xref ref-type="bibr" rid="B11">11</xref>], Sp8 transcription factor (<italic>Sp8</italic>) [<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B13">13</xref>], distal-less homeobox 1/2 (<italic>Dlx1/2</italic>) and gastrulation brain homeobox 2 (<italic>Gbx2</italic>) [<xref ref-type="bibr" rid="B14">14</xref>]. The extensive cyto-architectural and anatomical changes occurring in a spatio-temporal manner during the peak (E15) and at the end (E17) of embryonic cerebral neurogenesis as well as during early postnatal (P1) corticogenesis through to adulthood involves complex underlying molecular regulatory networks.</p><p>Complex molecular regulatory elements are important determinants in both spatial and temporal cerebral corticogenesis. These elements regulate gene expression at the chromatin, DNA or RNA, and protein levels through chromatin packaging or remodeling, histone acetylation and deacetylation, chromatin insulation, DNA methylation, post-transcriptional regulation and post-translational protein modification or degradation signaling pathways [<xref ref-type="bibr" rid="B15">15</xref>-<xref ref-type="bibr" rid="B17">17</xref>]. Other processes involved in such regulation include pre-mRNA processing and nuclear mRNA retention by nuclear-specific paraspeckle complexes [<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B19">19</xref>], microRNAs (miRNAs) that interfere with mRNA translation [<xref ref-type="bibr" rid="B20">20</xref>-<xref ref-type="bibr" rid="B22">22</xref>], and a new class of under-characterized non-coding RNA transcripts known as natural antisense transcripts (NATs) [<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B24">24</xref>]. These regulatory networks play a pivotal role in establishing when, where and how a multipotent progenitor cell should proliferate, migrate and settle at a designated position in the cortex. The information regarding regulatory networks during cerebral corticogenesis, however, remains incomplete and does not provide a comprehensive view of the underlying regulatory elements throughout this complex event.</p><p>In this study, we employed both short and long 3' serial analysis of gene expression (SAGE) technologies [<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B26">26</xref>] to identify differentially expressed regulatory elements by comparing transcriptomes of cerebral cortices generated from four selected developmental stages: E15.5, E17.5, P1.5 and 4 to 6 months old. We also compared rostral to caudal regions of E15.5 and left to right regions of adult cerebral cortices. We report temporally co-regulated gene clusters, novel molecular networks and associated pathways, novel candidates in regionalized development and genomic clustering of SRY-box containing gene 4 (<italic>Sox4</italic>) and SRY-box containing gene 11 (<italic>Sox11</italic>) sense and antisense transcripts. The genomic clustering analysis led us to the discovery of spatio-temporal regulation of novel <italic>Sox4 </italic>and <italic>Sox11 </italic>antisense transcripts as well as differential regulation of these transcripts in proliferating and differentiating neural stem/progenitor cells (NSPCs) and P19 (embryonal carcinoma) cells.</p></sec><sec><title>Results</title><sec><title>Generation and analysis of SAGE tags</title><p>We constructed 10 SAGE libraries from the cerebral cortex of E15.5, E17.5 and 4- to 6-month-old adult C57BL/6 mice (N = 10; Table <xref ref-type="table" rid="T1">1</xref>). The data from two additional SAGE libraries generated from E15.5 and P1.5 cerebral cortices from Gunnersen <italic>et al. </italic>[<xref ref-type="bibr" rid="B27">27</xref>] were also incorporated into our analysis. These SAGE libraries represent key stages of cerebral corticogenesis and are accessible from the Gene Expression Omnibus (GEO) website [GEO: <underline>GSE15031</underline>] [<xref ref-type="bibr" rid="B28">28</xref>]. The libraries contain a total of 531,266 SAGE tags (approximately 44,000 tags per SAGE library), 223,471 of which are unique (non-redundant) after screening for artifacts and mapping of short SAGE tags to long SAGE tags (Table <xref ref-type="table" rid="T1">1</xref>). The number of unique tags in each library ranges from approximately 7,200 to 32,000 due to the variation in library size (approximately 13,500 to 70,000). The distribution of tag abundance, however, is similar in all libraries (Figures S1 and S2 in Additional data file 1), in which the majority of tags were detected only once (58 to 76% or approximately 5,500 to approximately 24,000 tags), representing a trend comparable with previously reported SAGE analyses of mouse neocortices [<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B29">29</xref>]. Of all unique tags, only 5,199 (approximately 2.4%) are common to all developmental stages. The low number of common unique tags is most probably due to the high abundance of tags that occur only once.</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>SAGE library information</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">SAGE library*</th><th align="center">Sex</th><th align="left">Age</th><th align="left">Tissue</th><th align="center">Generated sequences</th><th align="center">Generated SAGE tag (library)</th><th align="center">Unique tags</th><th align="center">Unique tags (after scaling to 100,000 tags/library)</th><th align="center">GEO accession number</th></tr></thead><tbody><tr><td align="left">E15_1<sup>&#x02020;</sup></td><td align="center">U</td><td align="left">E15.5</td><td align="left">Rostral cerebral cortex</td><td align="center">2,044</td><td align="center">43,327</td><td align="center">15,664</td><td align="center">36,153</td><td align="center"><underline>GSM375449</underline></td></tr><tr><td align="left">E15_2<sup>&#x02020;</sup></td><td align="center">U</td><td align="left">E15.5</td><td align="left">Caudal cerebral cortex</td><td align="center">2,925</td><td align="center">39,314</td><td align="center">19,929</td><td align="center">50,692</td><td align="center"><underline>GSM375450</underline></td></tr><tr><td align="left">E15_3<sup>&#x02020;&#x02021;</sup></td><td align="center">U</td><td align="left">E15.5</td><td align="left">Cerebral cortex</td><td align="center">1,920</td><td align="center">44,332</td><td align="center">15,787</td><td align="center">35,611</td><td align="center"><underline>GSM375451</underline></td></tr><tr><td align="left">E17_1<sup>&#x02020;</sup></td><td align="center">U</td><td align="left">E17.5</td><td align="left">Cerebral cortex</td><td align="center">384</td><td align="center">13,573</td><td align="center">7,214</td><td align="center">53,150</td><td align="center"><underline>GSM375638</underline></td></tr><tr><td align="left">E17_2<sup>&#x02020;</sup></td><td align="center">U</td><td align="left">E17.5</td><td align="left">Cerebral cortex</td><td align="center">1,053</td><td align="center">47,733</td><td align="center">19,508</td><td align="center">40,869</td><td align="center"><underline>GSM375639</underline></td></tr><tr><td align="left">P1_1<sup>&#x02020;&#x02021;</sup></td><td align="center">U</td><td align="left">P1.5</td><td align="left">Cerebral cortex</td><td align="center">4,194</td><td align="center">42,869</td><td align="center">20,465</td><td align="center">47,738</td><td align="center"><underline>GSM375640</underline></td></tr><tr><td align="left">Ad_1</td><td align="center">M</td><td align="left">4 months</td><td align="left">Left cerebral cortex</td><td align="center">2,016</td><td align="center">50,760</td><td align="center">19,032</td><td align="center">37,494</td><td align="center"><underline>GSM375458</underline></td></tr><tr><td align="left">Ad_2</td><td align="center">M</td><td align="left">4 months</td><td align="left">Left cerebral cortex</td><td align="center">1,536</td><td align="center">52,476</td><td align="center">19,157</td><td align="center">36,506</td><td align="center"><underline>GSM375459</underline></td></tr><tr><td align="left">Ad_3</td><td align="center">F</td><td align="left">5-6 months</td><td align="left">Left cerebral cortex</td><td align="center">2,688</td><td align="center">30,914</td><td align="center">15,998</td><td align="center">51,750</td><td align="center"><underline>GSM375460</underline></td></tr><tr><td align="left">Ad_4</td><td align="center">F</td><td align="left">5 months</td><td align="left">Left cerebral cortex</td><td align="center">1,728</td><td align="center">43,592</td><td align="center">17,262</td><td align="center">39,599</td><td align="center"><underline>GSM375461</underline></td></tr><tr><td align="left">Ad_5</td><td align="center">F</td><td align="left">5-6 months</td><td align="left">Right cerebral cortex</td><td align="center">2,684</td><td align="center">53,292</td><td align="center">21,693</td><td align="center">40,706</td><td align="center"><underline>GSM375462</underline></td></tr><tr><td align="left">Ad_6</td><td align="center">F</td><td align="left">6 months</td><td align="left">Right cerebral cortex</td><td align="center">3,264</td><td align="center">69,084</td><td align="center">31,762</td><td align="center">45,976</td><td align="center"><underline>GSM375463</underline></td></tr></tbody></table><table-wrap-foot><p>*Each library was constructed by using an independent mouse cerebral cortex. <sup>&#x02020;</sup>Short tags were generated from these libraries. <sup>&#x02021;</sup>These libraries were obtained from [<xref ref-type="bibr" rid="B27">27</xref>]. F: female; M: male; U: undetermined sex.</p></table-wrap-foot></table-wrap></sec><sec><title>Analysis of differentially expressed transcripts/tags</title><p>To identify differentially expressed tags/transcripts (DETs), we considered only those 25,165 unique tags with a count &#x0003e;2 across all libraries. Under stringent analyses (Table S1 in Additional data file 1), we identified a total of 561 DETs in various comparisons between developmental stages (Table <xref ref-type="table" rid="T2">2</xref>; Figure S3 in Additional data file 1). A full list of DETs with assigned IDs is provided in Additional data file 2. Greater numbers of DETs are observed when the interval of two comparative developmental stages becomes wider. We find the largest number of DETs (approximately 59% or 328 DETs) in the embryonic versus adult stages (E versus Ad) followed by P1.5 versus Ad (approximately 34% or 192 DETs), E15.5 versus P1.5 (approximately 6% or 36 DETs) and E15.5 versus E17.5 (approximately 7% or 38 DETs) comparisons. These indicate distinctive transcript signatures during cerebral cortex development. Comparisons between rostral and caudal E15.5 (R versus C), and left and right adult cerebral cortices (L versus Ri) are described in a different section below.</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Summary of tag classification into various categories and comparisons</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th/><th align="center" colspan="7">DETs in various comparisons*</th></tr><tr><th/><th/><th colspan="7"><hr/></th></tr><tr><th align="left">Category</th><th align="center">Number of DETs<sup>&#x02020;</sup></th><th align="center">E15.5 R versus C</th><th align="center">Adult L versus Ri</th><th align="center">E15.5 versus E17.5</th><th align="center">E15.5 versus P1.5</th><th align="center">P1.5 versus Ad</th><th align="center">E versus Ad</th><th align="center">Total</th></tr></thead><tbody><tr><td align="left">Gene</td><td align="center">386 (68.8)</td><td align="center">25 (56.8)</td><td align="center">10 (58.8)</td><td align="center">24 (63.2)</td><td align="center">16 (44.4)</td><td align="center">114 (59.4)</td><td align="center">253 (77.1)</td><td align="center">442</td></tr><tr><td align="left">EST</td><td align="center">33 (5.9)</td><td align="center">2 (4.5)</td><td align="center">2 (11.8)</td><td align="center">1 (2.6)</td><td align="center">1 (2.8)</td><td align="center">9 (4.7)</td><td align="center">24 (7.3)</td><td align="center">39</td></tr><tr><td align="left">Multiple matches</td><td align="center">55 (9.8)</td><td align="center">9 (20.5)</td><td align="center">3 (17.6)</td><td align="center">5 (13.2)</td><td align="center">4 (11.1)</td><td align="center">21(10.9)</td><td align="center">23 (7.0)</td><td align="center">65</td></tr><tr><td align="left">Ambiguous</td><td align="center">44 (7.8)</td><td align="center">4 (9.1)</td><td align="center">2 (11.8)</td><td align="center">6 (15.8)</td><td align="center">4 (11.1)</td><td align="center">14 (7.3)</td><td align="center">20 (6.1)</td><td align="center">50</td></tr><tr><td align="left">No match</td><td align="center">43 (7.7)</td><td align="center">4 (9.1)</td><td align="center">0 (0)</td><td align="center">2 (5.3)</td><td align="center">11 (30.6)</td><td align="center">34 (17.7)</td><td align="center">8 (2.4)</td><td align="center">59</td></tr><tr><td align="left">Total</td><td align="center">561</td><td align="center">44</td><td align="center">17</td><td align="center">38</td><td align="center">36</td><td align="center">192</td><td align="center">328</td><td align="center">655</td></tr></tbody></table><table-wrap-foot><p>Tag classification into various categories and comparisons was based on the mouse genome assembly released in July 2007. Values in parentheses represent the 'percentage' across a column. *Total number of tags for various comparisons is 655 (rather than 561) due to the same tag being statistically significant in more than one comparison. <sup>&#x02020;</sup>Differentially expressed tags. Ad: adult stage; C: caudal region; E: embryonic day/stage; L: adult left hemisphere; P: postnatal days; R: rostral region; Ri: adult right hemisphere.</p></table-wrap-foot></table-wrap><p>Approximately 69% of DETs have been assigned to known genes and 6% to expressed sequence tags (ESTs), while 10% of DETs have multiple matches (tag matching multiple gene identifiers) and 8% having ambiguous matches (tag matching the same gene identifier at multiple chromosome loci). Approximately 8% of DETs have no matches and it is most likely that these DETs belong to transcripts from less defined regions, such as centromeric and telomeric areas of a chromosome or assembly gaps of the mouse genome.</p></sec><sec><title>Hierarchical clustering of DETs</title><p>To identify co-regulated genes, all 561 DETs were hierarchically grouped into 12 clusters based on the calculation of the Euclidean distance of logged normalized counts (Figure <xref ref-type="fig" rid="F1">1</xref>). Clusters 1, 5 and 6 consist of embryonic-specific DETs that exhibit the highest expression during embryonic development of the cerebral cortex. DETs in cluster 1 are expressed throughout all stages of development but exhibit the lowest expression in the adult cortex. Expression of DETs in cluster 5 ceases prior to birth, whereas DETs in cluster 6 are expressed up to early postnatal stage. On the other hand, clusters 4, 8 and 10 consist of adult specific DETs, showing very similar temporal expression profiles, but with different magnitudes (for example, highest expression in cluster 10). Clusters 2 and 7 are termed 'gene-switching' clusters as they show interesting expression-switching profiles. Cluster 2 shows an expression switch between P1.5 and adult stages whilst cluster 7 shows an expression switch between embryonic and adult stages. Clusters 3 and 9 consist of DETs showing region- (caudal region of E15.5 cerebral cortex) and stage-specific (P1.5 only) expression. Clusters 11 and 12 were excluded from subsequent analyses because they contained very few annotated tags. DETs within the same cluster may be co-regulated and/or involved in similar biological functions during cerebral corticogenesis.</p><fig id="F1" position="float"><label>Figure 1</label><caption><p><bold>Hierarchical clustering of 561 differentially expressed transcripts/tags</bold>. Log2 of normalized counts of DETs from cerebral cortices of various developmental stages were clustered. Dark green clusters denote high levels of expression whereas light green to white clusters denote low levels of expression. The x-axis represents the SAGE libraries whereas the y-axis represents the SAGE tags. The panel on the right shows the 12 different clusters.</p></caption><graphic xlink:href="gb-2009-10-10-r104-1"/></fig><p>We performed a systematic gene ontology functional clustering using the standardized Gene Ontology term analysis tool DAVID (Database for Annotation, Visualization and Integrated Discovery) [<xref ref-type="bibr" rid="B30">30</xref>] (Additional data file 3). Functional analysis of these gene clusters reveals that they have distinctive roles during cerebral corticogenesis. Embryonic-specific gene clusters (1, 5 and 6) are dominated by genes associated with cellular protein and macromolecule metabolic processes or biosynthesis, and nervous system and neuron development. These results match with the expected functional ontologies during embryonic cerebral cortex development in which neuronal migration, differentiation and axonogenesis events are at their peak. In contrast, adult-specific gene clusters (4, 8 and 10) consist of genes related to biological processes in the mature cerebral cortex, such as ion homeostasis, synaptic transmission and regulation of neurotransmitter level. In addition, these gene clusters are also enriched for ribonucleotide/nucleotide binding activity and components of cytoplasmic membrane-bound vesicles. These functional ontologies are in accordance with adult cerebral cortex function, which features synaptogenesis and nerve impulse transmission at synapses. Gene-switching clusters 2 and 7 are enriched with gene ontologies that are similar to both the embryonic- and adult-specific gene clusters. In addition, these gene clusters are also enriched for microtubule cytoskeleton organization and biogenesis, nucleotide biosynthesis and regulation of mRNA translation processes.</p></sec><sec><title>Quantitative RT-PCR validation of DETs and gene clusters</title><p>To ascertain the robustness of the SAGE datasets, we selected 136 candidate DETs and two additional genes of interests (ATPase, Cu++ transporting, alpha polypeptide, <italic>Atp7a</italic>, and cullin-associated and neddylation-dissociated 2, <italic>Cand2</italic>) for validation after considering both stage-to-stage and hierarchical based analyses (Table S2 in Additional data file 1). The selected DETs are transcription regulators, chromatin modifiers or post-translational regulators, such as ubiquitination pathway related molecules. Seventeen DETs are ESTs, which have been identified in brain-related mouse cDNA libraries or transcriptomes. Independent quantitative RT-PCR (RT-qPCR) validation was carried out using three biological replicates of unpooled cerebral cortex total RNA for each developmental stage. We validated 70 DETs (including 10 ESTs) from SAGE profiles of comparisons between two developmental stages (Additional data file 3) after considering various stringent criteria and cutoffs. The RT-qPCR results for all the 70 validated DETs, <italic>Atp7a </italic>and <italic>Cand2 </italic>are presented in Tables <xref ref-type="table" rid="T3">3</xref>, <xref ref-type="table" rid="T4">4</xref>, <xref ref-type="table" rid="T5">5</xref> and <xref ref-type="table" rid="T6">6</xref> (Additional data file 4). To validate the expression profiles of gene clusters from the hierarchical clustering analysis, we performed additional RT-qPCR analyses on 65 validated DETs (based on the analysis of two developmental stages), <italic>Atp7a </italic>and <italic>Cand2 </italic>by including other developmental stages (Additional data file 5). The analysis validated 62 out of 65 DETs (Figure <xref ref-type="fig" rid="F2">2</xref>). Of these, 22 are from embryonic gene clusters, 26 from adult gene clusters, and 14 from gene-switching clusters. We assigned <italic>Atp7a </italic>and <italic>Cand2 </italic>to clusters 2 and 5, respectively, based on their RT-qPCR expression profiles across all the developmental stages. See Tables <xref ref-type="table" rid="T3">3</xref>, <xref ref-type="table" rid="T4">4</xref>, <xref ref-type="table" rid="T5">5</xref> and <xref ref-type="table" rid="T6">6</xref> for complete list of DETs and their full gene names.</p><fig id="F2" position="float"><label>Figure 2</label><caption><p><bold>High-throughput RT-qPCR validation of gene clusters</bold>. All validations were based on DETs for canonical mRNA. Failed validation of DETs according to hierarchical clustering expression profiles is indicated by arrows. N = 3 and data are presented as mean &#x000b1; standard error of the mean.</p></caption><graphic xlink:href="gb-2009-10-10-r104-2"/></fig><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>RT-qPCR validation of SAGE profile for E versus adult comparison</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th/><th/><th align="center" colspan="4">Fold change</th></tr><tr><th/><th/><th/><th colspan="4"><hr/></th></tr><tr><th align="left">SAGE tag</th><th align="left">RefSeq accession</th><th align="left">Gene ID</th><th align="center">Ad/E15.5 (SAGE)</th><th align="center">Ad/E17.5 (SAGE)</th><th align="center">Ad/E15.5 (RT-qPCR)</th><th align="center">Ad/E17.5 (RT-qPCR)</th></tr></thead><tbody><tr><td align="left">gcttccccacccccctt</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_177407">NM_177407</ext-link></td><td align="left">calcium/calmodulin-dependent protein kinase II alpha, <italic>Camk2a</italic></td><td align="center"><italic>As</italic></td><td align="center"><italic>As</italic></td><td align="center">111.59</td><td align="center">54.74</td></tr><tr><td align="left">ggatatgtggtgtgtac</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_007913">NM_007913</ext-link></td><td align="left">early growth response 1, <italic>Egr1</italic></td><td align="center"><italic>As</italic></td><td align="center"><italic>As</italic></td><td align="center">108.47</td><td align="center">38.93</td></tr><tr><td align="left">aaattattgggaaatcc</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_011123">NM_011123</ext-link></td><td align="left">proteolipid protein (myelin) 1, <italic>Plp1</italic></td><td align="center">28.77</td><td align="center"><italic>As</italic></td><td align="center">103.15</td><td align="center">89.13</td></tr><tr><td align="left">gtatttgcaaaaaaaaa</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_025451">NM_025451</ext-link></td><td align="left">calcium/calmodulin-dependent protein kinase II inhibitor 1, <italic>Camk2n1</italic></td><td align="center">69.59</td><td align="center">59.76</td><td align="center">40.08</td><td align="center">21.46</td></tr><tr><td align="left">gcttcatctccagggag</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_009964">NM_009964</ext-link></td><td align="left">crystallin, alpha B, <italic>Cryab</italic></td><td align="center"><italic>As</italic></td><td align="center">11.59</td><td align="center">30.47</td><td align="center">20.58</td></tr><tr><td align="left">ttaccatactgggttgg</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_022029">NM_022029</ext-link></td><td align="left">neurogranin, <italic>Nrgn</italic></td><td align="center">24.67</td><td align="center">8.47</td><td align="center">43.67</td><td align="center">17.00</td></tr><tr><td align="left">cctcatttcccctgttc</td><td align="left"><ext-link ext-link-type="gen" xlink:href="BQ176089">BQ176089</ext-link></td><td align="left">EST from adult C57BL/6 subfornical organ and postrema tissues</td><td align="center"><italic>As</italic></td><td align="center"><italic>As</italic></td><td align="center">23.01</td><td align="center">8.91</td></tr><tr><td align="left">acccggctagtagtgaa</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_011129">NM_011129</ext-link></td><td align="left">septin 4, <italic>Sept4</italic></td><td align="center">18.97</td><td align="center">16.29</td><td align="center">22.38</td><td align="center">12.96</td></tr><tr><td align="left">ctcattataatcaagaa</td><td align="left"><ext-link ext-link-type="gen" xlink:href="CD802535">CD802535</ext-link></td><td align="left">EST from 27-32 days C57BL/6 hippocampus tissue</td><td align="center"><italic>As</italic></td><td align="center">9.05</td><td align="center">22.03</td><td align="center">13.25</td></tr><tr><td align="left">aataaagccaatctgac</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_033610">NM_033610</ext-link></td><td align="left">synuclein, beta, <italic>Sncb</italic></td><td align="center">20.89</td><td align="center">7.66</td><td align="center">18.20</td><td align="center">15.83</td></tr><tr><td align="left">gcttttgttaccatctc</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_030689">NM_030689</ext-link></td><td align="left">neuronal pentraxin receptor, <italic>Nptxr</italic></td><td align="center">17.88</td><td align="center">12.24</td><td align="center">15.02</td><td align="center">10.93</td></tr><tr><td align="left">tccctcccttagtatcc</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_144828">NM_144828</ext-link></td><td align="left">protein phosphatase 1, regulatory (inhibitor) subunit 1B, <italic>Ppp1r1b</italic></td><td align="center"><italic>As</italic></td><td align="center"><italic>As</italic></td><td align="center">10.47</td><td align="center">6.88</td></tr><tr><td align="left">gccccttcttcattggc</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_010358">NM_010358</ext-link></td><td align="left">glutathione S-transferase, mu 1, <italic>Gstm1</italic></td><td align="center"><italic>As</italic></td><td align="center"><italic>As</italic></td><td align="center">9.87</td><td align="center">5.58</td></tr><tr><td align="left">tgactagcgtgacctgt</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_007694">NM_007694</ext-link></td><td align="left">chromogranin B, <italic>Chgb</italic></td><td align="center">6.13</td><td align="center">6.30</td><td align="center">9.43</td><td align="center">7.22</td></tr><tr><td align="left">atttcttttctggatgg</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_010585">NM_010585</ext-link></td><td align="left">inositol 1,4,5-triphosphate receptor 1, <italic>Itpr1</italic></td><td align="center">14.34</td><td align="center">6.16</td><td align="center">9.29</td><td align="center">6.12</td></tr><tr><td align="left">actttgagattgtacct</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_009062">NM_009062</ext-link></td><td align="left">regulator of G-protein signaling 4, <italic>Rgs4</italic></td><td align="center">12.23</td><td align="center">21.01</td><td align="center">8.84</td><td align="center">5.32</td></tr><tr><td align="left">aataattagccttaggt</td><td align="left"><ext-link ext-link-type="gen" xlink:href="AK139402">AK139402</ext-link></td><td align="left">Mus musculus 10 days neonate cortex cDNA</td><td align="center"><italic>As</italic></td><td align="center"><italic>As</italic></td><td align="center">8.28</td><td align="center">7.55</td></tr><tr><td align="left">ctagacagaggcattat</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_019634">NM_019634</ext-link></td><td align="left">tetraspanin 7, <italic>Tspan7</italic></td><td align="center">13.08</td><td align="center">5.61</td><td align="center">7.99</td><td align="center">5.38</td></tr><tr><td align="left">tgtatacacacacgggt</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_007547">NM_007547</ext-link></td><td align="left">signal-regulatory protein alpha, <italic>Sirpa</italic></td><td align="center"><italic>As</italic></td><td align="center"><italic>As</italic></td><td align="center">7.18</td><td align="center">4.63</td></tr><tr><td align="left">tgacaagacactgtggc</td><td align="left"><ext-link ext-link-type="gen" xlink:href="AU258168">AU258168</ext-link></td><td align="left">EST from mouse brain</td><td align="center"><italic>As</italic></td><td align="center"><italic>As</italic></td><td align="center">6.49</td><td align="center">4.58</td></tr><tr><td align="left">cttacctcaggtttcct</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_008913">NM_008913</ext-link></td><td align="left">protein phosphatase 3, catalytic subunit, alpha isoform, <italic>Ppp3ca</italic></td><td align="center"><italic>As</italic></td><td align="center">5.43</td><td align="center">5.48</td><td align="center">3.45</td></tr><tr><td align="left">atagctttctacacact</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_007471">NM_007471</ext-link></td><td align="left">amyloid beta (A4) precursor protein, <italic>App</italic></td><td align="center">3.98</td><td align="center">2.74</td><td align="center">4.56</td><td align="center">3.49</td></tr><tr><td align="left">tttcagcagtgttggct</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_013556">NM_013556</ext-link></td><td align="left">hypoxanthine guanine phosphoribosyl transferase 1, <italic>Hprt1</italic></td><td align="center">6.90</td><td align="center">8.87</td><td align="center">3.45</td><td align="center">2.85</td></tr><tr><td align="left">aggtatgtacaaagttt</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_016886">NM_016886</ext-link></td><td align="left">glutamate receptor, ionotropic, AMPA3 (alpha 3), <italic>Gria3</italic></td><td align="center">4.97</td><td align="center">8.51</td><td align="center">3.40</td><td align="center">1.81*</td></tr><tr><td align="left">tccaacttgtaactata</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_009790">NM_009790</ext-link></td><td align="left">calmodulin 1, <italic>Calm1</italic></td><td align="center">4.23</td><td align="center">3.17</td><td align="center">3.24</td><td align="center">2.27</td></tr><tr><td align="left">cctcagcctggggtaga</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_009983">NM_009983</ext-link></td><td align="left">cathepsin D, <italic>Ctsd</italic></td><td align="center">3.46</td><td align="center">2.04</td><td align="center">3.22</td><td align="center">3.84</td></tr><tr><td align="left">gcttcgtccacacagcg</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_010777">NM_010777</ext-link></td><td align="left">myelin basic protein, <italic>Mbp</italic></td><td align="center">202.46</td><td align="center">173.85</td><td align="center">3.19</td><td align="center">2.05</td></tr><tr><td align="left">tattaaatgtgcttttt</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_080555">NM_080555</ext-link></td><td align="left">phosphatidic acid phosphatase type 2B, <italic>Ppap2b</italic></td><td align="center">5.71</td><td align="center">2.44</td><td align="center">3.02</td><td align="center">2.76</td></tr><tr><td align="left">cttatcctcacctcagc</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NC_005089">NC_005089</ext-link></td><td align="left">NADH dehydrogenase 6, mitochondrial, <italic>mt-ND6</italic></td><td align="center"><italic>As</italic></td><td align="center"><italic>As</italic></td><td align="center">2.65</td><td align="center">2.13</td></tr><tr><td align="left">caaacctccaaaaacca</td><td align="left"><ext-link ext-link-type="gen" xlink:href="AK140219">AK140219</ext-link></td><td align="left">Mus musculus adult male corpora quadrigemina cDNA</td><td align="center">29.22</td><td align="center">18.62</td><td align="center">2.63</td><td align="center">2.03</td></tr><tr><td align="left">agtggctaattaggtgt</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_009900">NM_009900</ext-link></td><td align="left">chloride channel 2, <italic>Clcn2</italic></td><td align="center">14.55</td><td align="center">4.16</td><td align="center">2.23</td><td align="center">2.18</td></tr><tr><td align="left">accaatgaacaaaaaaa</td><td align="left"><ext-link ext-link-type="gen" xlink:href="AK154943">AK154943</ext-link></td><td align="left">Mus musculus NOD-derived CD11c +ve dendritic cells cDNA</td><td align="center">109.40</td><td align="center">51.13</td><td align="center">1.76*</td><td align="center">1.35 (NS)</td></tr><tr><td align="left">ccagtacctgaaaaaaa</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_008453">NM_008453</ext-link></td><td align="left">Kruppel-like factor 3 (basic), <italic>Klf3</italic></td><td align="center"><italic>As</italic></td><td align="center">-52.97</td><td align="center">-1.47<sup>&#x02020;&#x02021;</sup></td><td align="center">-1.27 (NS)</td></tr><tr><td align="left">aagaaaacatttaaata</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_012010">NM_012010</ext-link></td><td align="left">eukaryotic translation initiation factor 2, subunit 3, structural gene X-linked, <italic>Eif2s3x</italic></td><td align="center">-7.70</td><td align="center">-10.38</td><td align="center">-1.72*</td><td align="center">-1.74*</td></tr><tr><td align="left">caccctgtgggagctca</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_172656">NM_172656</ext-link></td><td align="left">amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 2 (human), <italic>Als2cr2</italic></td><td align="center">-11.03</td><td align="center">-12.88</td><td align="center">-1.75*</td><td align="center">-2.48</td></tr><tr><td align="left">cctccatcctttatact</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_009536">NM_009536</ext-link></td><td align="left">tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide, <italic>Ywhae</italic></td><td align="center">-3.19</td><td align="center">-2.52</td><td align="center">-1.82*</td><td align="center">-2.66</td></tr><tr><td align="left">tgtgcttccctgtctta</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_008683">NM_008683</ext-link></td><td align="left">neural precursor cell expressed, developmentally down-regulated gene 8, <italic>Nedd8</italic></td><td align="center">-4.73</td><td align="center">-8.41</td><td align="center">-1.83</td><td align="center">-1.86</td></tr><tr><td align="left">ctcctgaaggcatagtt</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_009454">NM_009454</ext-link></td><td align="left">ubiquitin-conjugating enzyme E2E 3, UBC4/5 homolog (yeast), <italic>Ube2e3</italic></td><td align="center">-4.14</td><td align="center">-5.52</td><td align="center">-2.51</td><td align="center">-3.22</td></tr><tr><td align="left">gtgaaactaaaaaaaaa</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_009094">NM_009094</ext-link></td><td align="left">ribosomal protein S4, X-linked, <italic>Rps4x</italic></td><td align="center">-10.46</td><td align="center">-19.19</td><td align="center">-2.76</td><td align="center">-3.35</td></tr><tr><td align="left">aatgtttctgctttaca</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_011045">NM_011045</ext-link></td><td align="left">proliferating cell nuclear antigen, <italic>Pcna</italic></td><td align="center">-14.21</td><td align="center">-8.30</td><td align="center">-3.09</td><td align="center">-2.62</td></tr><tr><td align="left">cgtggatccctctgtca</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_009876">NM_009876</ext-link></td><td align="left">cyclin-dependent kinase inhibitor 1C (P57), <italic>Cdkn1c</italic></td><td align="center">-13.68</td><td align="center">-7.16</td><td align="center">-3.39*</td><td align="center">-3.30*</td></tr><tr><td align="left">cctttgtgacagtggcc</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_025635">NM_025635</ext-link></td><td align="left">ZW10 interactor, <italic>Zwint</italic></td><td align="center">7.29</td><td align="center">8.84</td><td align="center">-3.47<sup>&#x02021;</sup></td><td align="center">-4.80<sup>&#x02021;</sup></td></tr><tr><td align="left">gaagccagtgggccatc</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_001033273">NM_001033273</ext-link></td><td align="left">RIKEN cDNA 5031439G07 gene, <italic>5031439G07Rik</italic></td><td align="center">-9.10</td><td align="center">-10.00</td><td align="center">-4.13</td><td align="center">-3.65</td></tr><tr><td align="left">gctgtgggtcgctgtgg</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_010561">NM_010561</ext-link></td><td align="left">interleukin enhancer binding factor 3, <italic>Ilf3</italic></td><td align="center"><italic>As</italic></td><td align="center"><italic>As</italic></td><td align="center">-4.15<sup>&#x02021;</sup></td><td align="center">-2.97<sup>&#x02021;</sup></td></tr><tr><td align="left">acccctgaccccttgtt</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_016707">NM_016707</ext-link></td><td align="left">B-cell CLL/lymphoma 11A (zinc finger protein), <italic>Bcl11a</italic></td><td align="center">-7.88</td><td align="center">-5.52</td><td align="center">-4.42</td><td align="center">-4.78</td></tr><tr><td align="left">cggtgtcccccacctcc</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_012015">NM_012015</ext-link></td><td align="left">H2A histone family, member Y, <italic>H2afy</italic></td><td align="center">-21.48</td><td align="center">-27.88</td><td align="center">-4.62</td><td align="center">-3.70</td></tr><tr><td align="left">cagttgcaataaaaata</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_010894">NM_010894</ext-link></td><td align="left">neurogenic differentiation 1, <italic>Neurod1</italic></td><td align="center">-7.54</td><td align="center">-4.96</td><td align="center">-5.62</td><td align="center">-5.10</td></tr><tr><td align="left">aagtttgcaagtctcca</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_008538">NM_008538</ext-link></td><td align="left">myristoylated alanine rich protein kinase C substrate, <italic>Marcks</italic></td><td align="center">-24.87</td><td align="center">-11.76</td><td align="center">-5.72</td><td align="center">-5.56</td></tr><tr><td align="left">ttgctggcttttataaa</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_053104">NM_053104</ext-link></td><td align="left">RNA binding motif protein 9, <italic>Rbm9</italic></td><td align="center">-6.10</td><td align="center">-7.82</td><td align="center">-6.50</td><td align="center">-5.97</td></tr><tr><td align="left">ggttttgtttgtttgac</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_019653">NM_019653</ext-link></td><td align="left">WD repeat and SOCS box-containing 1, <italic>Wsb1</italic></td><td align="center">-7.88</td><td align="center">-11.96</td><td align="center">-6.54</td><td align="center">-7.00</td></tr><tr><td align="left">tatattgattgtggcaa</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_007569">NM_007569</ext-link></td><td align="left">B-cell translocation gene 1, anti-proliferative, <italic>Btg1</italic></td><td align="center">-15.28</td><td align="center">-16.48</td><td align="center">-6.93</td><td align="center">-5.58</td></tr><tr><td align="left">taagaaacct</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_019413">NM_019413</ext-link></td><td align="left">roundabout homolog 1 (Drosophila), <italic>Robo1</italic></td><td align="center">-28.64</td><td align="center">-16.73</td><td align="center">-8.23</td><td align="center">-11.35</td></tr><tr><td align="left">gctttgactgttctctt</td><td align="left"><ext-link ext-link-type="gen" xlink:href="AA122503">AA122503</ext-link></td><td align="left">EST from M2 cells of skin melanoma</td><td align="center">-17.17</td><td align="center">-18.68</td><td align="center">-9.88</td><td align="center">-10.15</td></tr><tr><td align="left">tggagcgttggctgtat</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_009870">NM_009870</ext-link></td><td align="left">cyclin-dependent kinase 4, <italic>Cdk4</italic></td><td align="center">-114.55</td><td align="center">-80.88</td><td align="center">-14.77</td><td align="center">-10.00</td></tr><tr><td align="left">ctttccctgccaatgta</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_013834">NM_013834</ext-link></td><td align="left">secreted frizzled-related protein 1, <italic>Sfrp1</italic></td><td align="center"><italic>Es</italic></td><td align="center"><italic>Es</italic></td><td align="center">-16.48</td><td align="center">-16.37</td></tr><tr><td align="left">tgcagctttctgttcaa</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_007971">NM_007971</ext-link></td><td align="left">enhancer of zeste homolog 2 (Drosophila), <italic>Ezh2</italic></td><td align="center">-10.63</td><td align="center">-5.52</td><td align="center">-21.36</td><td align="center">-17.59</td></tr><tr><td align="left">cacgacaccccccaccc</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_009559">NM_009559</ext-link></td><td align="left">zinc finger protein 57, <italic>Zfp57</italic></td><td align="center">-30.72</td><td align="center">-42.33</td><td align="center">-29.13</td><td align="center">-44.46</td></tr><tr><td align="left">tgtgtgaggtgttgtga</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_010025">NM_010025</ext-link></td><td align="left">doublecortin, <italic>Dcx</italic></td><td align="center">-44.41</td><td align="center">-58.81</td><td align="center">-73.76</td><td align="center">-91.10</td></tr><tr><td align="left">cagagtgtagtgtgttg</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_009234">NM_009234</ext-link></td><td align="left">SRY-box containing gene 11, <italic>Sox11</italic></td><td align="center"><italic>Es</italic></td><td align="center"><italic>Es</italic></td><td align="center">-140.05</td><td align="center">-120.35</td></tr></tbody></table><table-wrap-foot><p>All RT-qPCR data are statistically significant at <italic>P </italic>&#x0003c; 0.001 unless specified: * <italic>P </italic>&#x0003c; 0.01; <sup>&#x02020;</sup><italic>P </italic>&#x0003c; 0.05. <sup>&#x02021;</sup>A disagreement between RT-qPCR and SAGE data. <italic>As</italic>, adult-specific expression; <italic>Es</italic>, embryonic-specific expression; NS, no statistically significant difference between two developmental stages. Fold change values of &#x0003c;1.0 are presented in a negative fold change format.</p></table-wrap-foot></table-wrap><table-wrap id="T4" position="float"><label>Table 4</label><caption><p>RT-qPCR validation of SAGE profile for P1.5 versus adult stages</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th/><th/><th align="center" colspan="2">Fold change</th></tr><tr><th/><th/><th/><th colspan="2"><hr/></th></tr><tr><th align="left">SAGE tag</th><th align="left">RefSeq accession</th><th align="left">Gene ID</th><th align="center">Adult/P1.5 (SAGE)</th><th align="center">Adult/P1.5 (RT-qPCR)</th></tr></thead><tbody><tr><td align="left">aaattattgggaaatcc</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_011123">NM_011123</ext-link></td><td align="left">proteolipid protein (myelin) 1, <italic>Plp1</italic></td><td align="center">38.9</td><td align="center">43.33</td></tr><tr><td align="left">tttcagcagtgttggct</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_013556">NM_013556</ext-link></td><td align="left">hypoxanthine guanine phosphoribosyl transferase 1, <italic>Hprt1</italic></td><td align="center">6.99</td><td align="center">2.26</td></tr><tr><td align="left">actcggagccaccagac</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_009790">NM_009790</ext-link></td><td align="left">calmodulin 1, <italic>Calm1</italic></td><td align="center">4.57</td><td align="center">1.83</td></tr><tr><td align="left">gcttcgtccacacagcg</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_010777">NM_010777</ext-link></td><td align="left">myelin basic protein, <italic>Mbp</italic></td><td align="center"><italic>As</italic></td><td align="center">1.79</td></tr><tr><td align="left">tccccgtcat</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_026106">NM_026106</ext-link></td><td align="left">down-regulator of transcription 1, <italic>Dr1</italic></td><td align="center"><italic>Ps</italic></td><td align="center">-1.46</td></tr><tr><td align="left">gggaaactaagggagag</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_172503">NM_172503</ext-link></td><td align="left">zinc finger, SWIM domain containing 4, <italic>Zswim4</italic></td><td align="center">-42.42</td><td align="center">-1.96*</td></tr><tr><td align="left">gaacgcaagttcagccc</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_031404">NM_031404</ext-link></td><td align="left">actin-like 6B, <italic>Actl6b</italic></td><td align="center">-5.51</td><td align="center">-2.26</td></tr><tr><td align="left">gtgaaactaaaaaaaaa</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_009094">NM_009094</ext-link></td><td align="left">ribosomal protein S4, X-linked, <italic>Rps4x</italic></td><td align="center">-4.72</td><td align="center">-2.27</td></tr><tr><td align="left"><italic>Nil</italic></td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_009726">NM_009726</ext-link></td><td align="left">ATPase, Cu++ transporting, alpha polypeptide, <italic>Atp7a</italic></td><td align="center"><italic>Nil</italic></td><td align="center">-2.91</td></tr><tr><td align="left">agaagtgtttggagttt</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_008253">NM_008253</ext-link></td><td align="left">high mobility group box 3, <italic>Hmgb3</italic></td><td align="center">-20.99</td><td align="center">-3.53</td></tr><tr><td align="left">cctttgtgacagtggcc</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_025635">NM_025635</ext-link></td><td align="left">ZW10 interactor, <italic>Zwint</italic></td><td align="center">4.65</td><td align="center">-4.04<sup>&#x02020;</sup></td></tr><tr><td align="left">acagtctatgttggagg</td><td align="left"><ext-link ext-link-type="gen" xlink:href="BQ177886">BQ177886</ext-link>/<ext-link ext-link-type="gen" xlink:href="NM_010487">NM_010487</ext-link></td><td align="left">C57BL/6 whole brain E15.5 (or known as embryonic lethal, abnormal vision, Drosophila-like 3 (Hu antigen C), <italic>Elavl3</italic>)</td><td align="center">-41.99</td><td align="center">-4.06</td></tr><tr><td align="left">gatacttggaatgacta</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_007393">NM_007393</ext-link></td><td align="left">actin, beta, cytoplasmic, <italic>Actb</italic></td><td align="center">-18.49</td><td align="center">-4.35</td></tr><tr><td align="left">ctggcttctt</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_008538">NM_008538</ext-link></td><td align="left">myristoylated alanine rich protein kinase C substrate, <italic>Marcks</italic></td><td align="center"><italic>Ps</italic></td><td align="center">-4.76</td></tr><tr><td align="left"><italic>Nil</italic></td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_025958">NM_025958</ext-link></td><td align="left">cullin-associated and neddylation-dissociated 2 (putative), <italic>Cand2</italic></td><td align="center"><italic>Nil</italic></td><td align="center">-5.62</td></tr><tr><td align="left">gctttgactgttctctt</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_009870">NM_009870</ext-link></td><td align="left">cyclin-dependent kinase 4, <italic>Cdk4</italic></td><td align="center">-56.55</td><td align="center">-5.77</td></tr><tr><td align="left">ctcagtaatg</td><td align="left"><ext-link ext-link-type="gen" xlink:href="AA122503">AA122503</ext-link></td><td align="left">EST from M2 cells of skin melanoma</td><td align="center">-12.28</td><td align="center">-11.12</td></tr><tr><td align="left">tggagcgttggctgtat</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_009238">NM_009238</ext-link></td><td align="left">SRY-box containing gene 4, <italic>Sox4</italic></td><td align="center">-31.51</td><td align="center">-11.74</td></tr><tr><td align="left">cacgacaccccccaccc</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_007792">NM_007792</ext-link></td><td align="left">cysteine and glycine-rich protein 2, <italic>Csrp2</italic></td><td align="center"><italic>Ps</italic></td><td align="center">-26.10</td></tr><tr><td align="left">tgtgtgaggtgttgtga</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_009559">NM_009559</ext-link></td><td align="left">zinc finger protein 57, <italic>Zfp57</italic></td><td align="center">-16.33</td><td align="center">-32.74</td></tr><tr><td align="left">gggacctcgtggaagcc</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_010025">NM_010025</ext-link></td><td align="left">doublecortin, <italic>Dcx</italic></td><td align="center">-24.56</td><td align="center">-82.11</td></tr></tbody></table><table-wrap-foot><p>All RT-qPCR data are statistically significant at <italic>P </italic>&#x0003c; 0.001 unless specified: * <italic>P </italic>&#x0003c; 0.01. <sup>&#x02020;</sup>A disagreement between RT-qPCR and SAGE data. <italic>As:</italic> adult-specific expression; <italic>Nil</italic>: SAGE data not available; <italic>Ps</italic>: P1.5-specific expression. Fold change values of &#x0003c;1.0 are presented in a negative fold change format.</p></table-wrap-foot></table-wrap><table-wrap id="T5" position="float"><label>Table 5</label><caption><p>RT-qPCR validation of SAGE profile for E15.5 versus P1.5 stages</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th/><th/><th align="center" colspan="2">Fold change</th></tr><tr><th/><th/><th/><th colspan="2"><hr/></th></tr><tr><th align="left">SAGE tag</th><th align="left">RefSeq accession</th><th align="left">Gene ID</th><th align="center">P1.5/E15.5 (SAGE)</th><th align="center">P1.5/E15.5 (RT-qPCR)</th></tr></thead><tbody><tr><td align="left">Atttctttggtgatttt</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_010838">NM_010838</ext-link></td><td align="left">microtubule-associated protein tau, <italic>Mapt</italic></td><td align="center">5.51</td><td align="center">1.53*</td></tr><tr><td align="left">Gcactgttaacaagtgt</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_009234">NM_009234</ext-link></td><td align="left">SRY-box containing gene 11, <italic>Sox11</italic></td><td align="center">-2.17</td><td align="center">-3.32</td></tr></tbody></table><table-wrap-foot><p>All RT-qPCR data are statistically significant at <italic>P </italic>&#x0003c; 0.001 unless specified: * <italic>P </italic>&#x0003c; 0.05. Fold change values of &#x0003c;1.0 are presented in a negative fold change format.</p></table-wrap-foot></table-wrap><table-wrap id="T6" position="float"><label>Table 6</label><caption><p>RT-qPCR validation of SAGE profile for rostral E15.5 and caudal E15.5 regions</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th/><th/><th align="center" colspan="2">Fold change</th></tr><tr><th/><th/><th/><th colspan="2"><hr/></th></tr><tr><th align="left">SAGE tag</th><th align="left">RefSeq accession</th><th align="left">Gene ID</th><th align="center">Caudal/rostral (SAGE)</th><th align="center">Caudal/rostral (RT-qPCR)</th></tr></thead><tbody><tr><td align="left">gttgttcttccagtcgg</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_016916">NM_016916</ext-link></td><td align="left">bladder cancer associated protein homolog (human), <italic>Blcap</italic></td><td align="center">2.68</td><td align="center">1.43</td></tr><tr><td align="left">gtcatagctgttctgtg</td><td align="left"><ext-link ext-link-type="gen" xlink:href="BC025816">BC025816</ext-link></td><td align="left">EST sequence <ext-link ext-link-type="gen" xlink:href="BC025816">BC025816</ext-link></td><td align="center"><italic>Cs</italic></td><td align="center">1.31 (NS)</td></tr><tr><td align="left">aagcttgacatttggaa</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_026187">NM_026187</ext-link></td><td align="left">ankyrin repeat and zinc finger domain containing 1, <italic>Ankzf1</italic></td><td align="center"><italic>Rs</italic></td><td align="center">1.17<sup>&#x02020; </sup>(NS)</td></tr><tr><td align="left">gatacttggaatgacta</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_007393">NM_007393</ext-link></td><td align="left">actin, beta, cytoplasmic, <italic>Actb</italic></td><td align="center">-2.63</td><td align="center">-1.32</td></tr><tr><td align="left">ttggtgaaggaaaaaac</td><td align="left"><ext-link ext-link-type="gen" xlink:href="NM_021278">NM_021278</ext-link></td><td align="left">thymosin, beta 4, X chromosome, <italic>Tmsb4x</italic></td><td align="center">-2.33</td><td align="center">-2.13 (NS)</td></tr></tbody></table><table-wrap-foot><p>All RT-qPCR data are statistically significant at <italic>P </italic>&#x0003c; 0.05 unless specified. <sup>&#x02020;</sup>A disagreement between RT-qPCR and SAGE data. <italic>Cs:</italic> caudal region-specific expression; NS: no statistically significant difference between two developmental stages; <italic>Rs:</italic> rostral region-specific expression. Fold change values of &#x0003c;1.0 are presented in a negative fold change format.</p></table-wrap-foot></table-wrap><p>According to the comparison between two developmental stages, the most abundantly expressed and validated DETs in the E versus Ad analysis are <italic>Camk2a</italic>, <italic>Egr1 </italic>and <italic>Plp1 </italic>(Table <xref ref-type="table" rid="T3">3</xref>). In the adult cerebral cortex, the expression of these DETs is more than 100-fold greater than that at E15.5. Other validated adult-specific DETs with expression levels of approximately tenfold or greater than those in the embryonic brain are <italic>Camk2n1</italic>, <italic>Cryab</italic>, <italic>Nrgn</italic>, <ext-link ext-link-type="gen" xlink:href="BQ176089">BQ176089</ext-link>, <ext-link ext-link-type="gen" xlink:href="CD802535">CD802535</ext-link>, <italic>Sncb </italic>and <italic>Nptxr</italic>. Conversely, <italic>Sox11</italic>, an embryonic specific DET, is expressed in the E15.5 and E17.5 cerebral cortices with an expression level of at least 100-fold greater than that in the adult. Other validated embryonic specific DETs are <italic>Dcx</italic>, <italic>Zfp57</italic>, <italic>Ezh2</italic>, <italic>Sfrp1 </italic>and <italic>Cdk4</italic>, which have expression levels approximately tenfold or greater than those in the adult.</p><p>In the P1.5 versus Ad analysis, <italic>Dcx </italic>is expressed at a level approximately 80-fold greater in P1.5 compared to the adult cerebral cortex (Table <xref ref-type="table" rid="T4">4</xref>). Other P1.5 enriched and validated DETs are (in descending order of enrichment) <italic>Zfp57</italic>, <italic>Csrp2</italic>, AA122503, <italic>Cdk4</italic>, <italic>Sox4</italic>, <italic>Marcks</italic>, <italic>Actb</italic>, <ext-link ext-link-type="gen" xlink:href="BQ177889">BQ177889</ext-link>, <italic>Hmgb3</italic>, <italic>Rps4x</italic>, <italic>Actl6b</italic>, <italic>Zswim4 </italic>and <italic>Dr1</italic>, whose expression ranges from 33- to 1.4-fold greater than in the adult. On the other hand, the <italic>Plp1 </italic>is expressed at a level 40 times greater in the adult cerebral cortex compared to P1.5. Other validated genes that are enriched in the adult cerebral cortex include (in descending order) <italic>Hprt1</italic>, <italic>Calm1 </italic>and <italic>Mbp</italic>, with a 2.3- to 1.8-fold greater expression than the P1.5 cerebral cortex. Comparison between E15.5 and P1.5 shows that <italic>Mapt </italic>has a 1.5-fold greater expression level in the P1.5 cerebral cortex while <italic>Sox11 </italic>expression is 3.3-fold lower (Table <xref ref-type="table" rid="T5">5</xref>).</p><p>We were unable to validate all 17 DETs from L versus Ri regions, suggesting the left and right hemispheres of the adult mouse cerebral cortex are highly similar and indistinguishable at the molecular level. SAGE and RT-qPCR analyses for R versus C regions of E15.5 are discussed in a separate section below.</p></sec><sec><title>Functional analysis of validated gene clusters using Ingenuity Pathway Analysis</title><p>The validated DETs of embryonic, adult and gene-switching clusters were functionally characterized using proprietary software, Ingenuity Pathway Analysis (IPA) from Ingenuity Systems<sup>&#x000ae;</sup>, to identify enriched molecular networks and canonical pathways. Given a list of input genes (known as focus genes), IPA mapped these genes to a global molecular network developed from information contained in the Ingenuity knowledge base (a manually curated database of experimentally proven molecular interactions from published literature). Networks of these focus genes were then algorithmically generated based on their connectivity. IPA determined the most significantly enriched biological functions and/or related diseases by calculating the <italic>P</italic>-value using Fisher's exact test. Using similar methods, significantly represented canonical pathways in a set of focus genes were also determined using IPA (Section C in Additional data file 1).</p><p>From the embryonic-specific gene clusters, we identified two statistically significant molecular networks (made up of 19 focus genes and 47 associated nodes; networks 1 and 2 in Figure <xref ref-type="fig" rid="F3">3</xref>; Figures S4 and S5 in Additional data file 1). The networks are interconnected through two genes, <italic>Marcks </italic>and <italic>Neurod1</italic>. In general, these networks are associated with cell cycle and DNA replication, recombination and repair processes. Three statistically significant (using <italic>P </italic>&#x0003c; 0.05 as a cutoff) canonical pathways are enriched in these networks (Figure <xref ref-type="fig" rid="F3">3</xref>); Wnt/&#x003b2;-catenin signaling (<italic>Sox4</italic>, <italic>Sox11 </italic>and <italic>Sfrp1</italic>), P53 signaling (<italic>Cdk4 </italic>and <italic>Pcna</italic>) and tight junction signaling (<italic>Cdk4 </italic>and <italic>Actb</italic>) pathways. Validated DETs such as <italic>Btg1</italic>, <italic>Cdk4</italic>, <italic>Cdkn1c</italic>, <italic>Csrp2</italic>, <italic>Ezh2</italic>, <italic>Neurod1</italic>, <italic>Pcna</italic>, and <italic>Rps4x </italic>are associated with cell cycle control whereas <italic>Actb</italic>, <italic>Ezh2</italic>, <italic>Als2cr2</italic>, <italic>Marcks</italic>, <italic>Robo1 </italic>and <italic>Dcx </italic>are associated with cellular assembly and organization. These processes are important in the formation of filopodia, membrane blebs and growth cones during neuronal growth, migration and axonogenesis. Known human neurological disorders associated with the networks, particularly network 2, include X-linked lissencephaly (Online Mendelian Inheritance in Man [OMIM:300067]; DCX), juvenile onset dystonia ([OMIM:607371]; ACTB) and Beckwith-Wiedemann syndrome ([OMIM:130600]; CDKN1C). All the DETs implicated in these networks are expressed in the cortical plate with the exception of <italic>Pcna </italic>(Table S5 in Additional data file 1) [<xref ref-type="bibr" rid="B31">31</xref>-<xref ref-type="bibr" rid="B42">42</xref>].</p><fig id="F3" position="float"><label>Figure 3</label><caption><p><bold>Novel molecular networks involved in cerebral corticogenesis</bold>. The figure shows novel molecular networks, related biological functions/diseases, canonical pathways and known human neurological disorders based on Ingenuity Pathway Analysis and OMIM database. Detailed molecular interactions for all networks (indicated by asterisks) are illustrated in Figures S4, S5, S6, S7, S8 and S9 in Additional data file 1. Gene names next to arrow lines refer to common genes shared by two networks. Bold gene name refers to a focus gene. AN: associated nodes; FG: focused genes.</p></caption><graphic xlink:href="gb-2009-10-10-r104-3"/></fig><p>In adult-specific gene clusters, two molecular networks (18 focus genes and 50 associated nodes; networks 3 and 4 in Figure <xref ref-type="fig" rid="F3">3</xref>) were identified and interconnected via a single gene, <italic>Mbp </italic>(Figures S6 and S7 in Additional data file 1). These molecular networks enrich for nine statistically significant canonical pathways (<italic>P </italic>&#x0003c; 0.05) such as synaptic long-term potentiation and depression, calcium signaling, B cell receptor signaling, cAMP-mediated signaling, GM-CSF signaling, amyotrophic lateral sclerosis signaling, G-protein-coupled receptor signaling and xenobiotic metabolism signaling pathways. Validated DETs such as <italic>Camk2a</italic>, <italic>Gria3</italic>, <italic>Itpr1</italic>, <italic>Egr1</italic>, <italic>Rgs4</italic>, <italic>Gstm1 </italic>and <italic>Ppp3ca </italic>are associated with cell-to-cell communication in the adult cerebral cortex. Biological functions such as cell proliferation, movement and death processes are also linked to these networks through the genes <italic>Camk2a</italic>, <italic>Cryab</italic>, <italic>Egr1</italic>, <italic>Gstm1</italic>, <italic>Itpr1</italic>, <italic>Mbp</italic>, <italic>Nrgn</italic>, <italic>Ppp1r1b</italic>, <italic>Ppp3ca</italic>, <italic>Rgs4</italic>, <italic>Sept4</italic>, <italic>Sirpa </italic>and <italic>Sncb</italic>. Known human neurological disorders associated with Network 3 include Pelizaeus-Merzbacher disease ([OMIM:312080]; PLP1) and dementia with Lewy bodies ([OMIM:127750]; SNCB), whereas X-linked mental retardation ([OMIM:300210]; TSPAN7 or TM4SF2) is associated with network 4. MBP, found in both network 3 and 4, is associated with genetic susceptibility to multiple sclerosis [OMIM:126200]. All the DETs implicated in these networks are expressed in layers I to VI of the cerebral cortex, with the exception of <italic>Gstm1 </italic>(layers II to V), <italic>Sirpa </italic>and <italic>Ppp3ca </italic>(layers II to VI), and <italic>Nptxr </italic>(no expression data available) (Table S5 in Additional data file 1) [<xref ref-type="bibr" rid="B32">32</xref>-<xref ref-type="bibr" rid="B34">34</xref>,<xref ref-type="bibr" rid="B43">43</xref>-<xref ref-type="bibr" rid="B52">52</xref>].</p><p>Both networks 5 and 6 (Figure <xref ref-type="fig" rid="F3">3</xref>) are linked to gene-switching clusters. These two molecular networks (14 focus genes and 52 associated nodes) are associated with cellular morphogenesis, amino acid metabolism, cell death processes and developmental disorders (Figures S8 and S9 in Additional data file 1). These networks are connected by <italic>Ctsd </italic>and <italic>Ywhae </italic>and are implicated in amyloid processing (<italic>App </italic>and <italic>Mapt</italic>), aryl hydrocarbon receptor signaling (<italic>Ctsd </italic>and <italic>Nedd8</italic>) and cell cycle G2/M DNA damage checkpoint regulation pathways (<italic>Ywhae</italic>). <italic>App</italic>, <italic>Atp7a</italic>, <italic>Hprt1</italic>, <italic>Mapt</italic>, <italic>Ctsd </italic>and <italic>Clcn2 </italic>are involved in cell morphogenesis, assembly and organization. Among all the networks in the study, network 5 has the greatest number of DETs associated with known human neurological disorders with six out of ten focus genes being associated with known neurological disorders such as neuronal ceroid lipofuscinosis ([OMIM:610127]; CTSD), Alzheimer's disease ([OMIM:104300]; APP), Menkes disease ([OMIM:309400]; ATP7A), X-linked cutis laxa ([OMIM:304150]; ATP7A), epilepsy ([OMIM:606904, 607628 and 607631]; CLCN2), Lesch-Nyhan syndrome ([OMIM:300322]; HPRT1), frontotemporal dementia ([OMIM:600274]; MAPT), progressive supranuclear palsy ([OMIM:601104]; MAPT) and Pick disease of the brain ([OMIM:172700]; MAPT). All the DETs implicated in these networks are expressed in the cortical plate during embryonic development with the exception of <italic>Ube2e3</italic>. In the adult, all DETs are expressed in layers I to VI of the cerebral cortex except for <italic>Bcl11a</italic>, <italic>Clcn2</italic>, <italic>Hprt1 </italic>(layers II to VI), <italic>Atp7a </italic>and <italic>Ube2e3 </italic>(no expression was detected in the adult cerebral cortex) (Table S5 in Additional data file 1) [<xref ref-type="bibr" rid="B32">32</xref>-<xref ref-type="bibr" rid="B35">35</xref>,<xref ref-type="bibr" rid="B46">46</xref>,<xref ref-type="bibr" rid="B53">53</xref>-<xref ref-type="bibr" rid="B61">61</xref>].</p><p>To refine the functional analysis to a cellular level, we grouped all 40 RT-qPCR validated DETs from networks 3, 4, 5 and 6 (adult specific and gene-switching gene clusters) into three groups according to where they are expressed: only in cortical neurons (N group); only in cortical glia (G group); and in both cortical neurons and glia (B group). None of the DETs from networks 1 and 2 (embryonic-specific gene clusters) were analyzed because most of the cells within the cerebral cortex are committed to the neuronal lineage at E15.5. The methods used to tabulate and group validated DETs are detailed in Section D in Additional data file 1. DETs classified as part of the N group are <italic>Bcl11a</italic>, <italic>Calm1</italic>, <italic>Camk2a</italic>, <italic>Camk2n1</italic>, <italic>Hprt1</italic>, <italic>Itpr1</italic>, <italic>Mapt</italic>, <italic>Nedd8</italic>, <italic>Nrgn</italic>, <italic>Ppp1r1b</italic>, <italic>Ppp3ca</italic>, <italic>Rbm9</italic>, <italic>Rgs4</italic>, <italic>Sncb </italic>and <italic>Ywhae</italic>, whereas those in the G group include <italic>Cryab</italic>, <italic>Mbp</italic>, <italic>Nptxr</italic>, <italic>Plp1</italic>, <italic>Ppap2b</italic>, <italic>Sept4 </italic>and <italic>Tspan7</italic>. The B group consists of <italic>App</italic>, <italic>Atp7a</italic>, <italic>Chgb</italic>, <italic>Ctsd</italic>, <italic>Egr1</italic>, <italic>Gria3</italic>, <italic>Gstm1 </italic>and <italic>Sirpa</italic>. DETs without any cellular expression information, such as <italic>Actl6b</italic>, <italic>Clcn2</italic>, <italic>Hmgb3</italic>, <italic>Ube2e3</italic>, <ext-link ext-link-type="gen" xlink:href="AK138272">AK138272</ext-link>, <ext-link ext-link-type="gen" xlink:href="AK139402">AK139402</ext-link>, <ext-link ext-link-type="gen" xlink:href="AK140219">AK140219</ext-link>, <ext-link ext-link-type="gen" xlink:href="AK154943">AK154943</ext-link>, <ext-link ext-link-type="gen" xlink:href="AU258168">AU258168</ext-link> and <ext-link ext-link-type="gen" xlink:href="BQ176089">BQ176089</ext-link>, were placed into group B to facilitate downstream analysis. Of the 40 DETs, only 35 were mapped to the IPA knowledgebase and subjected to further analysis. Functional analysis of these 35 DETs show that the neuron-based DETs (N and B groups) are enriched for various human neurological disorders, such as schizophrenia (9 DETs; <italic>P </italic>= 4.36E-8), Huntington's disease (8 DETs; <italic>P </italic>= 1.03E-5), X-linked mental retardation (4 DETs; <italic>P </italic>= 3.78E-7), Parkinson's disease (3 DETs; <italic>P </italic>= 6.99E-3) and Alzheimer's disease (3 DETs; <italic>P </italic>= 1.52E-2) (Figure S10 in Additional data file 1). Thirteen DETs associated with these neurological disorders are also implicated in processes related to cell death. Of these, eight DETs are expressed in neurons only, two in glia only and three in both neurons and glia.</p><p>From the above IPA analysis, <italic>Cand2 </italic>(embryonic gene clusters), <italic>Camk2n1 </italic>(adult gene clusters), <italic>Hmgb3 </italic>(gene-switching clusters) and 10 ESTs (<ext-link ext-link-type="gen" xlink:href="BQ176089">BQ176089</ext-link>, <ext-link ext-link-type="gen" xlink:href="CD802535">CD802535</ext-link>, <ext-link ext-link-type="gen" xlink:href="AK139402">AK139402</ext-link>, <ext-link ext-link-type="gen" xlink:href="AU258168">AU258168</ext-link>, <ext-link ext-link-type="gen" xlink:href="AK138272">AK138272</ext-link>, <ext-link ext-link-type="gen" xlink:href="AK140219">AK140219</ext-link>, <ext-link ext-link-type="gen" xlink:href="AK154943">AK154943</ext-link>, <ext-link ext-link-type="gen" xlink:href="AA122503">AA122503</ext-link>, <ext-link ext-link-type="gen" xlink:href="NM_001033273">NM_001033273</ext-link> and <ext-link ext-link-type="gen" xlink:href="BQ177886">BQ177886</ext-link>) are not currently connected to any networks.</p></sec><sec><title>Regionalized expression of DETs in the E15.5 cerebral cortex</title><p>Early regionalized development is an important event that could lay the foundations for adult arealization of cerebral functions. To identify genes with regionalized expression profiles, we compared SAGE libraries generated from rostral and caudal regions (equivalent to anterior and posterior regions of the human cerebral cortex) of the E15.5 cerebral cortex. We identified 44 DETs and selected 25 DETs (22 known genes, 1 EST and 2 ambiguous genes; Additional data file 2) and 2 genes of interest (bladder cancer associated protein, <italic>Blcap</italic>, and ankyrin repeat and zinc finger domain containing 1, <italic>Ankzf1</italic>) for RT-qPCR validation and further detailed region-based analysis. This was done using independent biological triplicates of clearly defined regions/quadrants, such as rostro-lateral (RL), rostro-medial (RM), caudo-lateral (CL) and caudo-medial (CM) of the E15.5 cerebral cortex (see Materials and methods). Two positive controls with known regionalised expression were included in the RT-qPCR: RAR-related orphan receptor beta (<italic>Rorb</italic>) and nuclear receptor subfamily 2, group F, member 1 (<italic>Nr2f1</italic>). <italic>Rorb </italic>is highly expressed in the rostral region whereas <italic>Nr2f1 </italic>is highly expressed in the caudal region of the cerebral cortex [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B62">62</xref>].</p><p>An initial RT-qPCR analysis of combined RL and RM (rostral) as well as CL and CM (caudal) regions shows upregulation of <italic>Rorb </italic>and <italic>Nr2f1 </italic>in rostral and caudal regions, respectively (based on fold change direction and magnitude of 1.3 times). The same analysis also confirmed the SAGE data for 3 out of 25 DETs (<italic>Actb</italic>, <italic>Tmsb4x </italic>and BC025816) and <italic>Blcap </italic>(Table <xref ref-type="table" rid="T6">6</xref>; Additional data file 6). Both <italic>Actb </italic>and <italic>Tmsb4x </italic>have greater expression in the rostral region whereas <italic>Blcap </italic>and BC025816 are greater in the caudal region. To identify expression profiles in a more refined area and prevent regional compensation due to combined quadrant analysis, we performed a quadrant versus quadrant multiple regions comparison. The largest number of DETs were found in the RL versus CM comparison, as they are the two developmentally most distinct regions within the cerebral cortex at E15.5 compared to others; RL versus CL &#x0003e; RM versus CL &#x0003e; RL versus RM = RM versus CM &#x0003e; CL versus CM. The region-specific expression profiles were plotted for each of the DETs (Figure <xref ref-type="fig" rid="F4">4</xref>) and grouped into two categories: RL-specific DETs, such as <italic>Actb</italic>, <italic>Tmsb4x </italic>and cytochrome b-245, beta polypeptide (<italic>Cybb</italic>); and CM-specific DETs, including <italic>Blcap</italic>, EST BC025816, <italic>Ankzf1 </italic>and cytochrome c oxidase I, mitochondrial (<italic>Cox1</italic>) (Additional data file 6).</p><fig id="F4" position="float"><label>Figure 4</label><caption><p><bold>RT-qPCR analysis of all R versus C DETs based on quadrant versus quadrant analysis</bold>. RL, RM, CL and CM denote rostro-lateral, rostro-medial, caudo-lateral and caudo-medial regions of the cerebral cortex, respectively. OB denotes olfactory bulb. N = 3 per quadrant and data are presented as mean &#x000b1; standard error of the mean. Fold change values (normalized to RL) are presented above the comparative bar and any values &#x0003c;1 are presented in the negative fold change format. Only the most significant fold change value is presented for each target gene. * P &#x0003c; 0.05; ** P &#x0003c; 0.01; *** P &#x0003c; 0.001.</p></caption><graphic xlink:href="gb-2009-10-10-r104-4"/></fig><p>To visualize the regionalized expression profiles, we performed <italic>in situ </italic>RNA hybridization (ISH) on all DETs validated by quadrant versus quadrant RT-qPCR analysis, <italic>Blcap</italic>, <italic>Ankzf1 </italic>as well as the positive controls <italic>Rorb </italic>and <italic>Nr2f1</italic>. We performed ISH on sagittal and coronal sections (from rostral to caudal regions) of the E15.5 mouse brain (Figure <xref ref-type="fig" rid="F5">5</xref>). Under dark-field microscopic examination, we confirmed the regionalized expression of <italic>Rorb </italic>(at the rostral cortical plate; Figure <xref ref-type="fig" rid="F5">5a</xref>) and <italic>Nr2f1 </italic>(at the caudal ventricular zone; Figure <xref ref-type="fig" rid="F5">5f</xref>). From the analysis, <italic>Actb </italic>is highly expressed at the cortical plate and the subplate (Figure <xref ref-type="fig" rid="F5">5b</xref>). <italic>Tmsb4x </italic>is highly expressed at the cortical plate and the intermediate zone (Figure <xref ref-type="fig" rid="F5">5c-e</xref>).</p><fig id="F5" position="float"><label>Figure 5</label><caption><p><bold><italic>In situ </italic>RNA hybridization of selected R versus C regions of E15.5 DETs</bold>. ISH was performed on <bold>(a-m) </bold>E15.5 and <bold>(n-t) </bold>E11.5 to P150 brains. (g-m) Coronal sections that are generated from the rostral to caudal axis; (a-f, s-t) sagittal sections. Micrographs of higher magnification are presented directly after any micrographs with an inset box (d-e, m, t). All micrographs are in dark-field except for (e, m), which are bright-field micrographs. C: caudal; CB: cerebellum; CP: cortical plate; DG: dentate gyrus; HPf: hippocampal formation; IZ: intermediate zone; OB: olfactory bulb; R: rostral; VZ: ventricular zone. Arrows show the region with expression or silver grains.</p></caption><graphic xlink:href="gb-2009-10-10-r104-5"/></fig><p>ISH analysis showed that both <italic>Blcap </italic>and <italic>Ankzf1 </italic>are caudal specific. Serial coronal sections from rostral to caudal regions of the brain (Figure <xref ref-type="fig" rid="F5">5g-i</xref>) show <italic>Blcap </italic>is weakly expressed in the rostral cerebral cortex, particularly at the intermediate zone, subplate and the cortical plate, but is highly expressed in the hippocampus and thalamus (Figure <xref ref-type="fig" rid="F5">5i</xref>). <italic>Ankzf1 </italic>is expressed specifically in the ventricular zone as well as the cortical plate towards the caudal region of the cerebral cortex (Figure <xref ref-type="fig" rid="F5">5j-m</xref>). The distinctive expression of <italic>Ankzf1 </italic>in both the ventricular zone and cerebral cortex prompted us to extend our ISH analysis to various developmental stages starting from E11.5 to adulthood (Figure <xref ref-type="fig" rid="F5">5n-t</xref>). <italic>Ankzf1 </italic>is expressed in the primordial plexiform and the ventricular zone layers of the telencephalon at E11.5 (Figure <xref ref-type="fig" rid="F5">5n</xref>). By E13.5, <italic>Ankzf1 </italic>is weakly expressed in the ventricular zone, but is highly expressed in the cortical plate (Figure <xref ref-type="fig" rid="F5">5o</xref>). From E17.5 to P1.5, the expression of <italic>Ankzf1 </italic>is maintained in the cerebral cortex (Figure <xref ref-type="fig" rid="F5">5p, q</xref>). In the adult, <italic>Ankzf1 </italic>expression is obvious in the piriform cortex, hippocampus and cerebellum (Figure <xref ref-type="fig" rid="F5">5r-t</xref>).</p></sec><sec><title>Genomic clustering of sense-antisense SAGE tags at the <italic>Sox4 </italic>and <italic>Sox11 </italic>loci</title><p>We performed genomic clustering analysis of the SAGE tags to determine any actively transcribed chromosomal loci throughout cerebral corticogenesis. Probabilities for chance occurrences of two, three, four, and five DETs being clustered within a window of ten adjacent tags present within each chromosomal location, irrespective of genetic distance, were calculated. This analysis was based on the DET lists described above (Additional data file 2). The analysis showed two overrepresented chromosome loci at <italic>Sox4 </italic>and <italic>Sox11</italic>, which derive from embryonic-specific gene clusters.</p><p>At both loci, we observed multiple SAGE tags with both sense and antisense orientations, which signify alternative polyadenylation sites, differential splicing and overlapping antisense transcription. As an initial validation of the antisense messages, we performed strand-specific RT-PCR (Figure <xref ref-type="fig" rid="F6">6</xref>) using cDNA synthesized from equally pooled total RNAs (three mice from each of E15.5, E17.5, P1.5 and adult stages). Three primer sets were used for each locus (designed at the middle, 5'- and 3'-ends of the canonical transcripts). For both <italic>Sox4 </italic>and <italic>Sox11 </italic>loci, the analysis showed positive signals from all primer sets used that were complementary to the antisense strand, therefore confirming the presence of one or more antisense transcript(s) that span the canonical transcript. Hydroxymethylbilane synthase gene (<italic>Hmbs</italic>) served as a negative control and there were no positive bands in the antisense strand RT-PCR, confirming the absence of antisense transcripts.</p><fig id="F6" position="float"><label>Figure 6</label><caption><p><bold>Strand-specific RT-PCR</bold>. Lanes 1 to 6 represent the amplification of the <italic>Sox4 </italic>and <italic>Sox11 </italic>transcripts using more than one probe. Lane 7 shows the amplification of the <italic>Hmbs </italic>housekeeping gene whereas lane 8 represents the amplification of water as non-template control (NTC) using the primer set for <italic>Hmbs</italic>. The first panel consists of amplicons generated from the reverse-transcribed sense strand cDNA whereas the second panel consists of amplicons generated from the reverse-transcribed antisense strand cDNA. The third panel represents amplicons generated from oligo-d [T]<sub>15 </sub>primed reverse-transcribed cDNA, which serves as a positive control. The last panel represents amplicons generated from primer-free reverse-transcription reactions. The numbers on the left indicate the size of the generated bands.</p></caption><graphic xlink:href="gb-2009-10-10-r104-6"/></fig></sec><sec><title>Genomic cluster at the <italic>Sox4 </italic>gene locus</title><p>We mapped SAGE tags from the genomic cluster to the <italic>Sox4 </italic>gene locus using the University of California Santa Cruz (UCSC) genome browser (Figure <xref ref-type="fig" rid="F7">7a</xref>; Additional data file 7) [<xref ref-type="bibr" rid="B63">63</xref>]. Only tags within and around the <italic>Sox4 </italic>canonical transcript are shown. Evidence of mapped mouse mRNAs within this locus further justifies the existence of multiple SAGE tags in addition to the canonical <italic>Sox4 </italic>transcript. Subsequent validation of the genomic clusters was solely based on the SAGE tags situated within the canonical transcript. Based on the SAGE tag information, 6 out of 12 tags are DETs. These include four DETs within the canonical transcript (Figure <xref ref-type="fig" rid="F7">7b</xref>), with sox4_tag10 and sox4_tag15 having greater expression in P1.5 compared to P150 (adult stage), whereas sox4_tag12 and sox4_tag16 are both abundantly expressed in the caudal region of the E15.5 cerebral cortex. Based on the RT-qPCR analysis (Figure <xref ref-type="fig" rid="F7">7c</xref>), sox4_tag10 has greater expression in E15.5 compared to E17.5 (1.76-fold change), P1.5 (3.72-fold change) and Ad (43.67-fold change). For sox4_tag12, sox4_tag15 and sox4_tag16, differences are seen only in P1.5 (-2.00-fold, -1.57-fold and -1.84-fold changes, respectively) and Ad (-82.08-fold, -68.92-fold and -69.41-fold changes, respectively) when compared to E15.5. RT-qPCR analysis on the same tags did not find any differences between rostral and caudal cerebral cortices of E15.5. The differences in fold change between DETs suggest irregular overlapping of various transcript variants at different <italic>Sox4 </italic>gene loci.</p><fig id="F7" position="float"><label>Figure 7</label><caption><p><bold>Genomic cluster at the <italic>Sox4 </italic>locus</bold>. <bold>(a) </bold>The UCSC genome browser of the over-represented <italic>Sox4 </italic>genomic locus. SAGE tags were found in both directions within the <italic>Sox4 </italic>reference gene. <bold>(b) </bold>The SAGE expression profiles for each tag in the <italic>Sox4 </italic>locus. <bold>(c) </bold>The RT-qPCR validations of selected DETs at various loci within the <italic>Sox4 </italic>canonical gene. <bold>(d) </bold>The 3' RACE-Southern blotting analysis. The left panel of the figure shows the sizes of the bands and their corresponding tags. (d1-d3) Amplification of <italic>Sox4 </italic>sense transcripts (ASP); (d4) amplification of <italic>Sox4 </italic>antisense transcripts (SP). Tags with asterisks are DETs. Both (d5) and (d7) are positive controls exclusively generated from the sense strand of <italic>Psmb2 </italic>and <italic>Hmbs </italic>housekeeping genes (ASP), respectively. The corresponding (d6) and (d8) are the antisense expression (negative control) of <italic>Psmb2 </italic>and <italic>Hmbs </italic>(SP), respectively. <bold>(e) </bold>Northern analysis of total RNA isolated from pooled mouse cerebral cortices (N = 7). <bold>(f) </bold>The regionalized expression of <italic>Sox4 </italic>sense transcripts determined by ISH. The table consists of SAGE information for related <italic>Sox4 </italic>sense tags at rostral and caudal regions of the E15.5 cerebral cortex. (f1) and (f2) are sagittal sections obtained from E15.5 and E17.5 mouse brains, respectively. The figures show the expression of the <italic>Sox4 </italic>sense transcript variants. Arrows show brain regions with greater <italic>Sox4 </italic>sense expression. C: caudal region of the cerebral cortex; R: rostral region of the cerebral cortex.</p></caption><graphic xlink:href="gb-2009-10-10-r104-7"/></fig><p>To further validate the expression profiles of the multiple <italic>Sox4 </italic>DETs, we performed 3' rapid amplification of cDNA ends (RACE)-Southern analysis using pooled adaptor-oligo-d [T]<sub>15 </sub>synthesized cDNAs from three mice at each developmental stage. Based on this method, we were able to semi-quantitatively and accurately measure the expression levels of individual SAGE tags at the locus. To show that the amplification was cDNA specific, we performed PCR by using the same primer sets on mouse genomic DNA under the same conditions. In all cases, no amplification was observed (data not shown). This analysis confirmed the presence of four out of seven alternative transcripts for <italic>Sox4 </italic>(Figure <xref ref-type="fig" rid="F7">7d</xref>). Corresponding tags were determined by estimating the amplicon sizes between the strand-specific primers used, the next downstream AAUAAA/AUUAAA polyadenylation signal (if any) and succeeding CATG sequence or SAGE tags. Figure <xref ref-type="fig" rid="F7">7d(1)-d(3)</xref> confirms the existence of sox4_tag10, sox4_tag12 and sox4_tag15. Of these tags, SAGE expression profiles of sox4_tag10 and sox4_tag15 were validated (embryonic-specific and reduced expression after P1.5) but not sox4_tag12 (E15.5 caudal region-specific). 3' RACE-Southern analysis using a sense probe detected bands in the rostral and caudal regions of E15.5, E15.5 and E17.5 cerebral cortices and, therefore, confirmed the existence of the <italic>Sox4 </italic>antisense transcripts (Figure <xref ref-type="fig" rid="F7">7d(4)</xref>). Even though none of these tags were differentially expressed in between these regions based on the SAGE analysis, our findings show distinctive regionalization for sox4_tag14 expression at the E15.5 rostral cerebral cortex. Proteasome (prosome, macropain) subunit, beta type 2 gene (<italic>Psmb2</italic>) and <italic>Hmbs </italic>were used as controls and no antisense or alternative transcripts were identified at these gene loci (Figure <xref ref-type="fig" rid="F7">7d(5)-d(8)</xref>).</p><p>Since 3' RACE-Southern analysis was dependent on oligo- [dT]<sub>15 </sub>priming, we could not rule out the possibility of amplicons that were generated by false priming on homopolymer-A stretches. Therefore, Northern analyses were performed on equally pooled total RNA extracted from the cerebral cortices of seven mice at E15.5, E17.5 and P150 (negative control). By using a double-stranded DNA probe at the 3' untranslated region (UTR) of <italic>Sox4 </italic>(Additional data file 8), we identified six bands ranging from approximately 2 kb to approximately 4.7 kb (Figure <xref ref-type="fig" rid="F7">7e</xref>). <italic>Sox4 </italic>sense transcripts are weakly expressed in the adult, but highly expressed in the embryonic cerebral cortex. The number of bands observed is similar and corresponds to overlapping mouse mRNAs as well as publicly available paired-end diTag (PET) sequences downloaded from Ensembl (Figure <xref ref-type="fig" rid="F7">7a</xref>; Table S6 in Additional data file 1) [<xref ref-type="bibr" rid="B64">64</xref>]. Taken together, the analysis confirmed the existence of multiple overlapping variants of <italic>Sox4 </italic>sense and antisense transcripts at this gene locus.</p><p>To confirm the rostro-caudal expression of <italic>Sox4 </italic>sense transcripts, we performed ISH on sagittal sections of mouse brains using a <italic>Sox4 </italic>antisense riboprobe that spanned across the sox4_tag10, sox4_tag12, sox4_tag15 and sox4_tag16 SAGE tags. <italic>Sox4 </italic>showed regionalized expression at E15.5 and E17.5 (Figure <xref ref-type="fig" rid="F7">7f</xref>). At E15.5, <italic>Sox4 </italic>sense transcripts are expressed more in both the rostral- and caudal-end regions of the cortical plate compared to the intermediate region between them (Figure <xref ref-type="fig" rid="F7">7f(1)</xref>). By E17.5, expression of <italic>Sox4 </italic>sense transcripts is obvious in the rostral cortical plate (Figure <xref ref-type="fig" rid="F7">7f(2)</xref>). At both stages of development, <italic>Sox4 </italic>sense transcripts are uniformly expressed in the intermediate zone of the cerebral cortex. These findings correspond to the SAGE tag counts for E15.5 rostro-caudal regions of the cerebral cortex (Figure <xref ref-type="fig" rid="F7">7f</xref>). These observations explain the averaged total tag count per 100,000 tags for different <italic>Sox4 </italic>sense transcripts, which are predominantly expressed in both rostral and caudal regions of the cerebral cortex. The regionalized expression of <italic>Sox4 </italic>in the cortical plate is obvious only at E15.5 and E17.5, but not at other stages of development (Figure S11 in Additional data file 1).</p></sec><sec><title><italic>In situ </italic>RNA hybridization of <italic>Sox4 </italic>sense and antisense transcripts</title><p>To further ascertain the antisense expression of <italic>Sox4 </italic>in a spatio-temporal manner, we performed ISH on coronal sections obtained from E11.5, E13.5, E15.5, E17.5, P1.5 and P150 mouse brains. Sense and antisense RNA probes were generated from the same clone used in the Northern analysis. At E11.5, <italic>Sox4 </italic>sense transcripts are confined to the primordial plexiform layer (Figure <xref ref-type="fig" rid="F8">8a</xref>). From E13.5 to P1.5, the sense transcripts are expressed throughout the cortical plate (Figure <xref ref-type="fig" rid="F8">8b-e</xref>). Expression of sense transcripts in the subventricular zones is observed at E17.5 and P1.5 only (Figure <xref ref-type="fig" rid="F8">8d, e</xref>). There is no observable sense expression in the adult stage (Figure <xref ref-type="fig" rid="F8">8f</xref>). <italic>Sox4 </italic>antisense transcripts are expressed throughout the telencephalon at E11.5 (Figure <xref ref-type="fig" rid="F8">8g</xref>). From E13.5 to P1.5, <italic>Sox4 </italic>antisense expression is confined to the cortical plate only (Figure <xref ref-type="fig" rid="F8">8h-k</xref>). There is no obvious antisense expression in the cerebral cortex in the adult stage (Figure <xref ref-type="fig" rid="F8">8l</xref>). A microscopic examination at high magnification showed that <italic>Sox4 </italic>antisense transcripts are predominantly localized in the nucleus whereas <italic>Sox4 </italic>sense transcripts are found in both the nucleus and cytoplasm (Figures S12, S13 and S14 in Additional data file 1). We used hemoglobin alpha, adult chain 1 (<italic>Hba-a1</italic>) of the corresponding brain region and time-point as a control in the analysis (Figure <xref ref-type="fig" rid="F8">8m-r</xref>).</p><fig id="F8" position="float"><label>Figure 8</label><caption><p><bold>ISH analysis of <italic>Sox4 </italic>transcripts in E11.5 to P150 mouse brains</bold>. <bold>(a-f) </bold>Expression of the sense transcript for <italic>Sox4</italic>. <bold>(g-l) </bold>The expression of the antisense transcript for <italic>Sox4</italic>. <bold>(m-r) </bold><italic>Hba-a1 </italic>antisense expression (negative control). All micrographs were taken from coronal sections. CP: cortical plate; IZ: intermediate zone; MZ: marginal zone; PP: primordial plexiform layer; SVZ: subventricular zone; VZ: ventricular zone.</p></caption><graphic xlink:href="gb-2009-10-10-r104-8"/></fig><p>Furthermore, <italic>Sox4 </italic>antisense expression occurs in the piriform cortex layer II (Figure <xref ref-type="fig" rid="F9">9a-c</xref>) and dentate gyrus (Figure <xref ref-type="fig" rid="F9">9g-i</xref>) in the adult brain; however, no sense expression is observed in these regions. At P1.5, we identified complementary expression between <italic>Sox4 </italic>sense and antisense transcripts in the olfactory bulb (Figure <xref ref-type="fig" rid="F9">9d-f</xref>). <italic>Sox4 </italic>sense expression was confined to the granular and glomerular layers of the olfactory bulb whereas antisense expression was found only in the outer plexiform layer. We used either <italic>Sox11 </italic>or <italic>Hba-a1 </italic>of the corresponding brain region and time-point as a control in the analysis (Figure <xref ref-type="fig" rid="F9">9c, f, i</xref>).</p><fig id="F9" position="float"><label>Figure 9</label><caption><p><bold><italic>Sox4 </italic>antisense expression in other brain regions</bold>. <bold>(a-i) </bold><italic>Sox4 </italic>antisense expression is also observed in other regions such as the piriform cortex (a-c; arrows), olfactory bulb (d-f) and dentate gyrus (g-i). (a, d, g) <italic>Sox4 </italic>sense expression; (b, e, h) <italic>Sox4 </italic>antisense expression. (c, f, i) <italic>Hba-a1 </italic>or <italic>Sox11 </italic>antisense expression (negative controls). All micrographs were taken from sagittal sections except (a-c), which were taken from coronal sections. gl: glomerular layer; gr: granule layer; Opl: outer plexiform layer; PIR2: piriform cortex layer II.</p></caption><graphic xlink:href="gb-2009-10-10-r104-9"/></fig></sec><sec><title>Analysis of the <italic>Sox11 </italic>genomic cluster</title><p>SAGE tags, which represent multiple overlapping sense and antisense transcript variants at the <italic>Sox11 </italic>genomic cluster, were validated using 3' RACE-Southern analysis as described above. See Section F in Additional data file 1 for a full description of the <italic>Sox11 </italic>results. ISH analysis did not confirm the expression of antisense transcripts of <italic>Sox11</italic>, but the presence of PETs spanning three out of five antisense tags confirmed the existence of <italic>Sox11 </italic>antisense transcripts (Table S8 and Figures S16, S17 and S18 in Additional data file 1). The discrepancy between ISH and RT-qPCR or 3' RACE-Southern analysis suggests that <italic>Sox11 </italic>antisense transcripts might be expressed at low levels or at specific locations of the cerebral cortex, and hence can be detectable only by using serial sections or whole mount ISH.</p></sec><sec><title>Screening of <italic>Sox4 </italic>and <italic>Sox11 </italic>antisense transcripts in the adult mouse brain, organs, P19 cell line and neurospheres</title><p>We screened various adult brain regions (olfactory bulb, cerebellum, medulla, hippocampus, thalamus and cerebral cortex) and selected mouse organs (E15.5 whole brain, heart, kidney, liver, skeletal muscle, skin, spleen, stomach, testis and thymus) for the expression of <italic>Sox4 </italic>and <italic>Sox11 </italic>antisense transcripts by strand-specific RT-qPCR. Within the adult brain, <italic>Sox4 </italic>sense and antisense transcripts are expressed in all regions, with the highest level found in the olfactory bulb, which is approximately four- to nine-fold greater than those in other brain regions (Figure <xref ref-type="fig" rid="F10">10a</xref>). Expression of <italic>Sox4 </italic>antisense transcripts occurs in all mouse organs, with the highest level in the thymus followed by E15.5 whole brain, testis and skin (Figure <xref ref-type="fig" rid="F10">10b</xref>). <italic>Sox4 </italic>sense and antisense expression profiles are similar throughout the entire series of samples screened, with the sense transcripts being consistently expressed at a greater level than the antisense transcripts (approximately 1.7-fold in various brain regions and approximately 2- to 14-fold in various organ comparisons).</p><fig id="F10" position="float"><label>Figure 10</label><caption><p><bold>Expression of <italic>Sox4 </italic>and <italic>Sox11 </italic>transcripts in various mouse organs</bold>. <bold>(a) </bold>Strand-specific RT-qPCR screening of <italic>Sox4 </italic>and <italic>Sox11 </italic>sense and antisense transcript expression in various adult mouse brain regions. N = 2 and data are presented as mean &#x000b1; standard error of the mean (SEM). <bold>(b) </bold>Strand-specific RT-qPCR screening of <italic>Sox4 </italic>and <italic>Sox11 </italic>sense and antisense transcripts in various adult mouse organs. N = 3 and data are presented as mean &#x000b1; SEM.</p></caption><graphic xlink:href="gb-2009-10-10-r104-10"/></fig><p><italic>Sox11 </italic>sense transcripts are expressed at the highest level in the olfactory bulb, approximately two- to seven-fold greater than those in other brain regions (Figure <xref ref-type="fig" rid="F10">10a</xref>). <italic>Sox11 </italic>antisense transcripts, on the other hand, are expressed in all brain regions screened and at a comparable level in the olfactory bulb, hippocampus, thalamus and cerebral cortex. In comparison to other adult mouse organs, <italic>Sox11 </italic>sense and antisense transcripts are highly expressed in the E15.5 whole brain, with <italic>Sox11 </italic>sense transcript levels at least 100-fold greater than those in other mouse organs (Figure <xref ref-type="fig" rid="F10">10b</xref>). On the other hand, <italic>Sox11 </italic>antisense expression is observed only in the E15.5 whole brain, skin and stomach. Notably, <italic>Sox11 </italic>sense transcripts are expressed more highly than antisense transcripts in the E15.5 whole brain and skin (23- and 4-fold, respectively).</p><p>Since both Sox4 and Sox11 are implicated in neuronal differentiation and glial maturation processes [<xref ref-type="bibr" rid="B65">65</xref>,<xref ref-type="bibr" rid="B66">66</xref>], we examined both <italic>Sox4 </italic>and <italic>Sox11 </italic>sense and antisense transcript expression in proliferating and differentiating P19 (embryonal carcinoma cells) and in embryonic NSPCs grown as neurospheres. Both <italic>Sox4 </italic>sense and antisense transcripts are upregulated during P19 cell differentiation (approximately 5.7- and 1.6-fold upregulation, respectively; Figure <xref ref-type="fig" rid="F11">11a</xref>) and neurosphere differentiation (approximately 1.9- and 1.8-fold upregulation, respectively; Figure <xref ref-type="fig" rid="F11">11b</xref>). For <italic>Sox11</italic>, both sense and antisense transcripts are upregulated in the differentiating compared to the proliferating P19 cells by approximately 2.3- and 4.2-fold, respectively (Figure <xref ref-type="fig" rid="F11">11c</xref>). Both the <italic>Sox11 </italic>sense and antisense transcripts are, however, downregulated in the differentiating neurospheres (approximately 2.6- and 1.5-fold, respectively; Figure <xref ref-type="fig" rid="F11">11d</xref>).</p><fig id="F11" position="float"><label>Figure 11</label><caption><p><bold>Expression of <italic>Sox4 </italic>and <italic>Sox11 </italic>transcripts in neuropsheres and P19 cells</bold>. <bold>(a-d) </bold>The figure shows strand-specific RT-qPCR screening of <italic>Sox4 </italic>(a, b) and <italic>Sox11 </italic>(c, d) sense and antisense transcripts expression in proliferating and differentiating P19 cells (a, c) and neuropsheres (b, d). N = 3 for P19 cells and N = 2 for neuropsheres. All data are presented as mean &#x000b1; standard error of the mean. Fold change values (normalization to proliferating cells) are presented above the comparative bar and any values &#x0003c;1 are presented in the negative fold change format. * P &#x0003c; 0.05; ** P &#x0003c; 0.01; *** P &#x0003c; 0.001.</p></caption><graphic xlink:href="gb-2009-10-10-r104-11"/></fig></sec></sec><sec><title>Discussion</title><p>In this study, SAGE was used to analyze global gene expression in the normal mouse cerebral cortex at various developmental stages. We report validated spatio-temporal regulation of genes involved in mouse cerebral cortex development from embryo to adulthood. The study highlights four main findings: association of DETs from different gene clusters with known functional processes or signaling pathways and disease-causative genes that are involved in cerebral corticogenesis; <italic>Ankzf1 </italic>and <italic>Sox4 </italic>sense transcripts are regionally expressed in the E15.5 cerebral cortex; multiple overlapping <italic>Sox4 </italic>and <italic>Sox11 </italic>sense and antisense transcripts are spatio-temporally regulated during cerebral corticogenesis; and <italic>Sox4 </italic>and <italic>Sox11 </italic>antisense transcripts are differentially regulated in both proliferating and differentiating embryonic-derived neurospheres and P19 cells.</p><p>We have shown that most tags generated in all libraries were singletons. The number of singletons could be reduced by increasing the number of tags sequenced. In mammalian cells, the number of additional unique transcripts identified approached zero when the number of SAGE tags sequenced reached approximately 600,000 [<xref ref-type="bibr" rid="B67">67</xref>]. Increasing the number of tags sequenced could improve the sensitivity of the technique to identify weakly expressed or novel transcripts, and the application of massively parallel signature sequencing [<xref ref-type="bibr" rid="B68">68</xref>] using a next-generation sequencer would be an ideal solution to accomplish this. In addition, one of the benefits of SAGE is that datasets generated from different groups or in public repositories such as SAGE Genie [<xref ref-type="bibr" rid="B69">69</xref>] and GEO [<xref ref-type="bibr" rid="B28">28</xref>] are readily comparable and, hence, can increase the tag count and sensitivity of the technique in discovering DETs between SAGE libraries. However, any meta-analyses involving various SAGE datasets are affected by experimental and biological variation; thus, a careful selection of matching libraries is crucial to limit systematic error or biases.</p><p>Our SAGE analysis robustly detected DETs with a low false positive rate (for example, &#x0003c;0.001% for comparison between left and right hemispheres of the adult cerebral cortex). Of all the identified DETs, approximately 8% were not mapped to either a single locus in the mouse genome or any unique annotation. This problem could be overcome by generating additional information from the 5' end of the transcript through alternative techniques such as PET sequencing [<xref ref-type="bibr" rid="B70">70</xref>], cap analysis gene expression (CAGE) [<xref ref-type="bibr" rid="B71">71</xref>] and 5' LongSAGE [<xref ref-type="bibr" rid="B72">72</xref>].</p><p>We have identified functional ontologies, molecular interactions and enriched canonical pathways that are distinct to the stage-specific gene clusters of validated DETs. The IPA network analysis generated connections between validated DETs across various developmental stages in relation to well-established proteins or molecules and neurological disorders. In the study, members of the Wnt/&#x003b2;-catenin signaling pathway were enriched in networks 1 and 2 (embryonic-specific gene clusters). In neural development, Wnt/&#x003b2;-catenin signaling plays an important role in regulating regional specification of the cortex along the rostro-caudal and dorso-ventral axes, and proliferation of cortical progenitors [<xref ref-type="bibr" rid="B73">73</xref>]. IPA highlighted three genes (<italic>Sox4</italic>, <italic>Sox11 </italic>and <italic>Sfrp1</italic>) associated with this pathway. In humans, the SFRP1 protein (secreted frizzled-related protein 1) stabilizes &#x003b2;-catenin and increases transcription from &#x003b2;-catenin-responsive promoters [<xref ref-type="bibr" rid="B74">74</xref>]. In &#x003b2;-catenin-deficient mouse mutants, expression of both <italic>Sox4 </italic>and <italic>Sox11 </italic>is downregulated [<xref ref-type="bibr" rid="B75">75</xref>,<xref ref-type="bibr" rid="B76">76</xref>]. Sox4 and Sox11 proteins play an important role in establishing neuronal properties, pan-neuronal gene expression and proper myelination of the central nervous system [<xref ref-type="bibr" rid="B65">65</xref>,<xref ref-type="bibr" rid="B66">66</xref>]. This suggests that the role of the Wnt/&#x003b2;-catenin signaling pathway in regulating neuronal development could be mediated, at least in part, by the Sox4 and Sox11 proteins.</p><p>The role of Wnt/&#x003b2;-catenin signaling in regulating DETs (<italic>Btg1</italic>, <italic>Cdk4</italic>, <italic>Cdkn1c</italic>, <italic>Csrp2</italic>, <italic>Ezh2</italic>, <italic>Neurod1</italic>, <italic>Pcna</italic>, and <italic>Rps4x</italic>) involved in cell cycle and proliferation remains unclear. Gain- and loss-of-function studies have established that Wnt/&#x003b2;-catenin signaling is essential to maintain the pool of precursors for proper development of the cerebral cortex [<xref ref-type="bibr" rid="B77">77</xref>,<xref ref-type="bibr" rid="B78">78</xref>]. To date, there is no direct evidence to show that <italic>Ezh2</italic>, <italic>Pcna</italic>, <italic>Rps4x </italic>and <italic>Btg1 </italic>are involved in cell cycle regulation during early embryonic neurogenesis. But their expression in the ventricular/subventricular zone of the E15.5 developing mouse cerebral cortex [<xref ref-type="bibr" rid="B33">33</xref>,<xref ref-type="bibr" rid="B35">35</xref>,<xref ref-type="bibr" rid="B36">36</xref>] suggests that they may be involved in regulating cell proliferation during neurogenesis. The role of these DETs and their association with the Wnt/&#x003b2;-catenin signaling pathway remains unclear and requires further experimentation.</p><p>Networks 3 and 4 from the adult gene cluster were associated with various canonical pathways, in particular, synaptic long term potentiation (LTP) and calcium signaling. LTP is a process of synapse enhancement, which is thought to underlie some forms of learning and memory [<xref ref-type="bibr" rid="B79">79</xref>]. This process depends on Ca<sup>2+ </sup>and calmodulin, which are major components of the calcium signaling pathway. We identified four DETs, <italic>Gria3</italic>, <italic>Itpr1</italic>, <italic>Ppp3ca </italic>and <italic>Camk2a</italic>, in both canonical pathways. In particular, the Camk2a enzyme is highly expressed in the brain and regulates mainly glutamatergic synapses during LTP [<xref ref-type="bibr" rid="B79">79</xref>]. DET products such as Nrgn and Camk2n1 can directly or indirectly regulate Camk2a or Ca<sup>2+</sup>/calmodulin and subsequently alter the outcome of the LTP pathway [<xref ref-type="bibr" rid="B80">80</xref>,<xref ref-type="bibr" rid="B81">81</xref>]. Therefore, they may serve as important candidate genes in the future analysis of the synaptic LTP pathway involving neurodegenerative diseases that cause the loss of cognitive function and memory.</p><p>Networks 5 and 6 are enriched for genes in the amyloid processing signaling pathway. <italic>App </italic>and <italic>Mapt </italic>are associated with this pathway. Under normal circumstances, the App protein is required for proper migration of neuronal precursors into the cortical plate in early embryonic corticogenesis [<xref ref-type="bibr" rid="B82">82</xref>]. The Mapt protein, on the other hand, plays an important role in maintaining the architecture of the neuronal cytoskeleton and intracellular trafficking. Overexpression of App protein and hyperphosphorylation of the Mapt protein have been implicated in the pathologies of Alzheimer's disease [<xref ref-type="bibr" rid="B83">83</xref>,<xref ref-type="bibr" rid="B84">84</xref>]. Interestingly, <italic>Ctsd</italic>, <italic>Atp7a</italic>, <italic>Clcn2 </italic>and <italic>Hprt1</italic>, the genes responsible for other human neurological disorders such as neuronal ceroid lipofuscinosis (<italic>Ctsd</italic>), Menkes disease (<italic>Atp7a</italic>), epilepsy (<italic>Clcn2</italic>), and Lesch-Nyhan syndrome (<italic>Hprt1</italic>), are associated with <italic>App </italic>and <italic>Mapt</italic>. These candidate genes are also involved in cell morphogenesis, assembly and organization and could be linked to deterioration of neurons during the pathologic progression of these disorders.</p><p>Pathway analysis of DETs classified into the N, G and B groups showed DETs in the neuron (N and B groups) are associated with Huntington's disease and schizophrenia, which were not previously identified in networks 3 to 6. Our analysis showed that both disorders share three common DETs, namely <italic>Rgs4</italic>, <italic>Ppp1r1b </italic>and <italic>Chgb</italic>, whose expression is downregulated in humans with Huntington's disease or schizophrenia [<xref ref-type="bibr" rid="B85">85</xref>-<xref ref-type="bibr" rid="B88">88</xref>]. A proportion of patients with Huntington's disease also develop schizophrenia [<xref ref-type="bibr" rid="B89">89</xref>,<xref ref-type="bibr" rid="B90">90</xref>]. Taken together, downregulation of <italic>Rgs4</italic>, <italic>Ppp1r1b </italic>and <italic>Chgb </italic>expression in neurons may contribute to the common symptoms in these disorders. Our findings imply that many DETs (including <italic>App</italic>, <italic>Hprt1 </italic>and <italic>Sncb</italic>) associated with both Huntington's disease and schizophrenia are also involved in neuronal/cell death processes [<xref ref-type="bibr" rid="B91">91</xref>-<xref ref-type="bibr" rid="B93">93</xref>]. Other DETs in the N group, not previously implicated in neuronal cell death, may serve as novel potential candidates during pathologic development in these disorders.</p><p>Regionalized development of the cerebral cortex involves the differential regulation of cell cycle exit, early migration and attainment of positional identity in neuronal fated cells. To date, only few genes have been associated with regionalized development of the cerebral cortex [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B94">94</xref>]. In the regionalization analysis, we identified the highest number of DETs in the comparison of the RL and CM libraries, which signifies that these two regions of the cerebral cortex are the most different. This finding supports the notion that the cerebral cortex is developed in a latero-medial axis followed by a rostro-caudal axis [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B8">8</xref>]. At E15.5, both <italic>Actb </italic>and <italic>Tmsb4x </italic>were expressed greater in the rostral cerebral cortex than in the caudal region. Both Actb and Tmsb4x proteins are involved in the actin cytoskeleton-signaling pathway [<xref ref-type="bibr" rid="B95">95</xref>]. In particular, the Tmsb4x protein has been shown to promote cardiomyocyte migration [<xref ref-type="bibr" rid="B96">96</xref>] and axonal tract growth in zebrafish [<xref ref-type="bibr" rid="B97">97</xref>]. Therefore, co-expression of <italic>Actb </italic>and <italic>Tmsb4x </italic>in the E15.5 mouse cortical plate suggests that they may have a synergistic role in early cortical cell development. Conversely, <italic>Blcap </italic>and <italic>Ankzf1 </italic>were expressed more highly in the caudal than in the rostral region of the E15.5 cerebral cortex. To date, the function of both <italic>Blcap </italic>and <italic>Ankzf1 </italic>in the cerebral cortex remains uncharacterized. This study provides the first comprehensive expression profile of <italic>Ankzf1 </italic>and suggests it could be an important transcription factor in cerebral corticogenesis.</p><p>At E15.5, <italic>Sox4 </italic>sense transcripts were expressed in a high-rostral and high-caudal manner with lesser expression within the intermediate region. By E17.5, <italic>Sox4 </italic>expression becomes obvious at the rostral cortical plate, which is similar to <italic>Rorb</italic>. But, we did not find that the regionalized expression of <italic>Sox4 </italic>sense transcripts resembles that of the restricted <italic>Rorb </italic>expression at E15.5 or in the postnatal brain [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B62">62</xref>]. This finding could be caused by the combined expression profiles of different <italic>Sox4 </italic>sense transcripts that are present across the rostro-caudal axis of the cortical plate. The regionalized expression of <italic>Sox4 </italic>sense transcripts occurs only between E15.5 and E17.5. Because the thalamic axon innervates the cortical plate after E17.5 [<xref ref-type="bibr" rid="B98">98</xref>], the regionalization of <italic>Sox4 </italic>sense transcripts in early cortical development could be an outcome of an intrinsic instead of an extrinsic mechanism that regulates early patterning of the cerebral cortex.</p><p>Genomic clustering of DETs identified the differentially regulated <italic>Sox4 </italic>and <italic>Sox11 </italic>gene loci. These genomic clusters imply that there are multiple overlapping sense and antisense transcripts surrounding the same gene locus that are co-transcribed simultaneously during cerebral cortex development. Both <italic>Sox4 </italic>and <italic>Sox11 </italic>are single exon genes and these transcript variants are therefore likely to be generated due to alternative polyadenylation. The 3' UTRs of both <italic>Sox4 </italic>and <italic>Sox11 </italic>have tandem terminal polyadenylation signals on both sense and antisense strands (data not shown), which supports the occurrence of multiple transcript forms or SAGE tags. Multiple mRNA forms with different 3' UTRs can lead to cell-specific regulation, different nuclear or cytoplasmic mRNA stability and translation rates [<xref ref-type="bibr" rid="B99">99</xref>,<xref ref-type="bibr" rid="B100">100</xref>]. The 3' UTR of <italic>Sox4 </italic>and <italic>Sox11 </italic>may contain AU-rich elements that play an important role in determining mRNA stability through deadenylation, decapping or 3' &#x02192; 5' decay [<xref ref-type="bibr" rid="B101">101</xref>]. Besides, different 3' UTR lengths may be targeted by different miRNAs, thus interfering with the translation process. Both <italic>Sox4 </italic>and <italic>Sox11 </italic>transcripts may be targeted by various miRNAs at different predicted positions across the 3' UTR (Tables S7 and S9 and Figures S15 and S18 in Additional data file 1). Therefore, 3' UTR lengths of <italic>Sox4 </italic>and <italic>Sox11 </italic>may be an important feature in the regulation of their protein expression during cerebral corticogenesis.</p><p>In the study, NATs were found at both the <italic>Sox4 </italic>and <italic>Sox11 </italic>gene loci overlapping the sense transcripts. Overlapping NATs may function as templates for the generation of pre-miRNA and mature miRNA with exceptional high sequence conservation that complement the overlapping sense protein-coding transcripts [<xref ref-type="bibr" rid="B102">102</xref>]. To date, no mature or pre-miRNAs have been predicted on the <italic>Sox4 </italic>and <italic>Sox11 </italic>sense and antisense strands (data not shown) or have been reported in miRBase [<xref ref-type="bibr" rid="B103">103</xref>]. In addition, NATs can self-complement to form double stranded RNA or pair with sense transcripts and function as templates for the generation of endogenous small interfering RNAs, which could subsequently interfere with translation or transcription of multiple protein-coding transcripts [<xref ref-type="bibr" rid="B104">104</xref>]. Because both Sox4 and Sox11 proteins are highly expressed in the cerebral cortex, the overlapping NATs do not seem to be involved in the regulation of Sox4 and Sox11 through miRNA- or small interfering RNA-mediated translation repression mechanisms, but rather through antisense-regulated sense transcription within the nucleus.</p><p>Our ISH analysis showed complementary cellular expression profiles of <italic>Sox4 </italic>sense and antisense transcripts at the piriform cortex, olfactory bulb and dentate gyrus. This finding implies that <italic>Sox4 </italic>antisense transcripts may be essential in intracellular and interlocus negative feedback loop regulation of the <italic>Sox4 </italic>sense transcripts. Similar expression profiles of <italic>Sox4 </italic>sense and antisense transcripts in multiple mouse organs and brain regions, however, suggest that these transcripts may be co-expressed. This observation is also supported by the temporal co-expression of <italic>Sox4 </italic>sense and antisense transcripts in the cortical plate or layers I to III of the cerebral cortex. Taken together, the sense and antisense transcripts of <italic>Sox4 </italic>are co-expressed in some cells and expressed complementarily in other cells, suggesting crucial cell-type-specific regulation.</p><p>Sox4 and Sox11 have been shown to have redundant roles during mouse development [<xref ref-type="bibr" rid="B105">105</xref>], and Sox11 may play a compensatory role in the absence of Sox4 during brain development [<xref ref-type="bibr" rid="B106">106</xref>]. We demonstrated that <italic>Sox4 </italic>and <italic>Sox11 </italic>sense and antisense transcripts have a similar expression in the brain, but not in other organs, suggesting a compensatory role for Sox11 only in the brain. <italic>Sox11 </italic>antisense transcripts were expressed in the brain, skin and stomach only, suggesting organ-specific regulation.</p><p>Our data show upregulation of <italic>Sox4 </italic>and <italic>Sox11 </italic>sense transcripts in differentiating P19 cells, consistent with the findings of others [<xref ref-type="bibr" rid="B107">107</xref>,<xref ref-type="bibr" rid="B108">108</xref>], and demonstrate upregulation of antisense transcripts as well. We also find both <italic>Sox4 </italic>and <italic>Sox11 </italic>sense transcripts expressed in the NSPCs cultured as neurospheres, which is in agreement with Dy <italic>et al</italic>. [<xref ref-type="bibr" rid="B109">109</xref>]. Furthermore, we identify upregulation of both <italic>Sox4 </italic>sense and antisense transcripts but downregulation of <italic>Sox11 </italic>sense transcripts in differentiating neurospheres. Taken together, our findings show that there are potentially common and distinct roles for <italic>Sox4 </italic>and <italic>Sox11 </italic>sense and antisense transcripts during neuronal and non-neuronal cell proliferation and differentiation. The underlying regulatory mechanism of these transcripts, particularly the antisense ones, remains unknown and requires further investigation.</p></sec><sec><title>Conclusions</title><p>This study provides avenues for future research focus in understanding the fundamental processes and development of neurological disorders related to the cerebral cortex. We confirm the regionalized expression of new candidate genes in the E15.5 cerebral cortex as well as differential regulation of multiple overlapping sense and novel antisense transcripts within <italic>Sox4 </italic>and <italic>Sox11 </italic>gene loci during cerebral corticogenesis. We also report for the first time the spatio-temporal regulation of <italic>Sox4 </italic>antisense transcripts in the brain as well as differential regulation of novel <italic>Sox4 </italic>and <italic>Sox11 </italic>antisense transcripts in various mouse organs and in proliferating and differentiating NSPCs and P19 cells. The finding provides an insight for future investigations into the role of antisense transcripts during cerebral corticogenesis and neuronal differentiation.</p></sec><sec sec-type="materials|methods"><title>Materials and methods</title><sec><title>Serial analysis of gene expression</title><sec><title>Handling of animals and dissection of the cerebral cortex</title><p>All experiments that involved animal breeding and handling were performed according to protocols approved by the Melbourne Health Animal Ethics Committee (Project numbers 2001.045 and 2004.041). All animals involved in the study were C57BL/6 mice unless specified otherwise. All mice were kept under conditions of a 12-h light/12-h dark cycle with unlimited access to food and water. All mice were culled by cervical dislocation prior to dissection. Cortical tissue was procured in the following fashion. For adult samples, after removal of the meninges, coronal cuts were used to excise the olfactory bulb from the rostral region, and the superior colliculus from the caudal region. A sagittal cut to separate the two cortical hemispheres was performed. The cortical pallium was dissected from the subpallial striatum and the septum. The neocortex was then dissected away from the cingulate cortex and the entorhinal cortex. For embryonic samples, the cortical tissue was dissected free from the underlying ganglionic eminences at the pallial-subpallial border. An orthogonal cut was made to remove the presumptive striatum and the overlying piriform cortex. On the medial aspect, the medial limbic cortex was included for analysis, but the adjacent hippocampal primordium, including the cortical hem, was excluded. For the E15.5 cerebral cortex, the resulting hemispheres containing cortical tissue only were placed on the bottom of the Petri dish and, using a fine scalpel, divided into four equal quadrants per hemisphere, namely RL, RM, CL and CM. Rostral and caudal quadrants from both hemispheres were pooled for SAGE library construction but separately tracked for RT-qPCR analysis. Procurement of other adult brain tissues and related mouse organs for <italic>Sox4 </italic>and <italic>Sox11 </italic>antisense transcript screening was carried out according to the standard mouse necropsy protocol accessible at the National Institute of Allergy and Infectious Diseases (NIAID) website [<xref ref-type="bibr" rid="B110">110</xref>].</p></sec><sec><title>SAGE libraries and analysis of tags</title><p>Ten SAGE libraries were constructed from the cerebral cortex of E15.5, E17.5 and 4- to 6-month-old (Ad) mice according to either one of the two methods described previously [<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B26">26</xref>], using I-SAGE&#x02122; or I-SAGE&#x02122; Long Kits (Invitrogen, Mulgrave, Victoria, Australia). Additional libraries from E15.5 and P1.5 of the cerebral cortex described previously [<xref ref-type="bibr" rid="B27">27</xref>] were also included in the analysis. These libraries contain a total of 26,436 traces. SAGE tags were preprocessed - that is, TAGs were extracted and corrected for sequencing errors, and artifacts like SAGE linkers, ribosomal RNA and duplicated ditags were removed using the 'sagenhaft' package, which is available from the Bioconductor website [<xref ref-type="bibr" rid="B111">111</xref>,<xref ref-type="bibr" rid="B112">112</xref>]. To compare libraries that contain long tags with those that contain short tags, all short tags were mapped to the existing long tags from the other libraries. A table for all libraries containing the unique long or short tags was generated and redundant tags were removed. Only tags with a total count &#x0003e;2 (across all libraries) were considered for subsequent comparisons. Each unique tag was mapped to the mouse genome using ESTgraph, which employs ESTs and their genomic position information. ESTgraph was created by Tim Beissbarth (unpublished) [<xref ref-type="bibr" rid="B113">113</xref>]. Identity was assigned to these tags and they were further grouped into the following categories: matching to a gene, a genomic sequence, or an EST, or ambiguous matches or no alignment at all. All annotations were based on the latest mouse assembly (mm9 released in July 2007) accessible from the UCSC Genome Bioinformatics website [<xref ref-type="bibr" rid="B63">63</xref>].</p></sec><sec><title>Identification of differentially expressed tags</title><p>Library comparisons were performed using two methods. Fisher's exact test was used to compare two individual SAGE libraries. In the analysis, multiple testing correction [<xref ref-type="bibr" rid="B114">114</xref>] was carried out to control for false-discovery rate and adjusted <italic>P</italic>-value cutoffs (Q-values) were used to select DETs. In cases where several libraries were combined to focus on a specific biological comparison (for example, different stages of development), a Bayesian model, as described previously [<xref ref-type="bibr" rid="B115">115</xref>], was used to integrate multiple libraries in pairwise comparisons involving biological replicates of libraries. The model accounts for within-class variability by means of mixture distributions. The resulting E-values were used to select DETs. A table of all relevant comparisons, the comparison method and Q- or E-value cutoffs is provided in Table S1 in Additional data file 1.</p></sec><sec><title>Hierarchical clustering of SAGE tags</title><p>To identify co-regulated genes, the clustering of DETs was performed based on the log2 of normalized counts. Each library was normalized to 100,000 tags per library to account for size differences. A pseudocount of 0.5 was added before taking the log2 of the normalized tag counts. The tag-wise mean was subtracted from the log2 tag intensities before computing the Euclidean distance of the individual tag profiles. Hierarchical clustering was performed on the tags using the 'hclust' function and complete linkage, which was implemented using the statistical computing environment of R [<xref ref-type="bibr" rid="B116">116</xref>].</p></sec><sec><title>Genomic clustering of SAGE tags</title><p>To assess whether there was any genomic clustering of tags, a method previously described [<xref ref-type="bibr" rid="B117">117</xref>] was adopted. In brief, first gene lists (based on all DETs in both pairwise and multiple library comparisons as well as gene lists from the hierarchical clustering analysis) were selected. The genomic clustering of either of these selections was compared to the total unique tag list (all 25,165 unique tags). The tags were mapped to the mouse genome. The number of selected tags in ten consecutive tag positions for each window of the chromosome was calculated. One thousand permutations were used to compute the null distribution of maximum tag counts per window. The method was implemented using the statistical computing environment of R [<xref ref-type="bibr" rid="B116">116</xref>].</p></sec></sec><sec><title>Functional classification and characterization of DETs</title><sec><title>Gene Ontology enrichment analysis</title><p>The DET lists generated from various comparisons were subjected to systematic functional annotation using the standardized Gene Ontology term analysis tools at the DAVID [<xref ref-type="bibr" rid="B30">30</xref>]. Functional clustering was performed using high stringency with a kappa similarity threshold of 0.85 and a minimum term overlap of 3. Classification was carried out using a multiple linkage threshold of 0.5 with both numbers of initial and final group members set to 3. A term was considered statistically significant when the computed <italic>P</italic>-value was &#x0003c; 0.05. All queries were performed in September 2009.</p></sec><sec><title>Molecular interactions and pathway analysis</title><p>Identification of molecular network interactions and pathway analysis of validated DETs or co-regulated genes was completed using the IPA [<xref ref-type="bibr" rid="B118">118</xref>] tools from Ingenuity Systems<sup>&#x000ae; </sup>(Redwood City, California, USA). Accession numbers for all genes with their corresponding fold changes or normalized counts were imported into the IPA software. No focus genes were set at the beginning of the analysis. To start building networks, the application queries the list of input genes and all other gene objects stored in the Ingenuity knowledge base. Networks with a maximum of 30 genes or proteins were constructed, and scores were computed based on the likelihood of the genes being connected together due to random chance. A score of 2 indicates that there is a 1/100 chance that these genes are connected in a network due to random chance. Therefore, any networks with a score of 2 or above are considered statistically significant (with &#x0003e;99% confidence). The most significant novel networks and their interactions with existing canonical pathways were investigated further.</p></sec></sec><sec><title>Quantitative RT-PCR</title><sec><title>Total RNA isolation and first strand cDNA synthesis</title><p>RT-qPCR was carried out to validate all selected candidate or co-regulated DETs. Biological triplicates from E15.5, E17.5, P1.5 and adult (5 to 6 months old) cerebral cortices were used. Genomic-free total RNA from independent mice was extracted using the RNeasy<sup>&#x000ae; </sup>Lipid Tissue Midi Kit (Qiagen, Doncaster, Victoria, Australia) according to the manufacturer's protocol (Section G in Additional data file 1). First strand cDNA was synthesized from high quality total RNA [<xref ref-type="bibr" rid="B119">119</xref>] using random hexamers (unless specified otherwise) and the SuperScript&#x02122; III Reverse Transcriptase Kit (Invitrogen, Mulgrave, Victoria, Australia), according to the manufacturer's protocol, under an RNAse-free environment.</p></sec><sec><title>Primer design and RT-qPCR</title><p>All primers were designed using ProbeFinder 2.35 at the Assay Design Center for Universal ProbeLibrary Assay provided by Roche Applied Science [<xref ref-type="bibr" rid="B120">120</xref>]. All RT-qPCR reactions were prepared in 10 &#x003bc;l volumes in a 384-well plate format consisting of LC480 Master Probe Mix (Roche Diagnostics, Castle Hill, New South Wales, Australia), Universal ProbeLibrary (Roche Diagnostics, Castle Hill, New South Wales, Australia) and forward and reverse primers (GeneWorks, Hindmarsh, South Australia, Australia or Bioneer Corporation, Daedeok-gu, Daejeon, Korea) according to the manufacturers' protocols. RT-qPCRs were performed using the LightCycler<sup>&#x000ae; </sup>480 System (Roche Diagnostics, Castle Hill, New South Wales, Australia) according to the manufacturer's protocol (Section G in Additional data file 1). A full list of primers and probes used in this study is included in Additional data file 8.</p></sec><sec><title>Relative quantification using a standard curve method</title><p>The crossing point (Cp) from each signal was calculated based on the Second Derivative Maximum method [<xref ref-type="bibr" rid="B121">121</xref>]. A set of serially diluted cDNAs was used to construct a four-data point standard curve for every PCR system in each run. A total of three reference genes (from <italic>Hprt1</italic>, <italic>Psmb2</italic>, phosphoglycerate kinase 1 gene (<italic>Pgk1</italic>) <italic>or Hmbs</italic>) were used as endogenous controls. An estimated starting amount of each target gene was calculated and intra-samples multiple reference genes normalization was performed (Section G in Additional data file 1). A linear model was fitted to the time course of expression values for each gene. Genes differentially expressed between the various stages of development or regions were selected using empirical Bayesian moderated t-statistics, which borrow information between genes [<xref ref-type="bibr" rid="B122">122</xref>]. Standard errors for the mean expression at various developmental stages were obtained from the linear model. For each comparison, <italic>P</italic>-values were adjusted using the Benjamini and Hochberg [<xref ref-type="bibr" rid="B114">114</xref>] method to control the false discovery rate. See Section H in Additional data file 1 for the R code used to execute the analysis.</p></sec></sec><sec><title>Validation of sense-antisense and multiple overlapping transcripts in genomic clusters</title><sec><title>Strand specific RT-PCR</title><p>All RNA was prepared as described above. Total RNA from all developmental stages (N = 3 per developmental stage) was equally pooled prior to cDNA synthesis. Four first strand cDNA synthesis reactions were prepared for each cluster as follows: with a primer complementary to the sense strand only; with a primer complementary to the antisense strand only; with oligo-d [T]<sub>15 </sub>as a positive control; and without any primers as a negative control. In all four reactions, both primers were added in subsequent PCRs (Section G in Additional data file 1). PCR amplifications were carried out using FastStart PCR High Fidelity System (Roche Diagnostics, Castle Hill, New South Wales, Australia) according to the manufacturer's protocol. More than one primer set was used in the sense-antisense strand specific RT-PCR (Additional data file 8).</p></sec><sec><title>RACE</title><p>First strand cDNA synthesis was carried out using pooled total RNA extracted from three biological replicates of rostral and caudal E15.5 and whole E15.5, E17.5, P1.5 and adult (5 to 6 months old) cerebral cortices. Oligo-d [T]<sub>15 </sub>with an adaptor sequence (5'-TACGACGTCTGCTAGGACTG-3') was used to prime the first strand cDNA synthesis. Second strand synthesis or PCR was then carried out using a strand-specific primer and the adaptor primers (Additional data file 8). All specific primers were designed to be complementary to the SAGE tags or their upstream sequences. PCR amplifications (Section G in Additional data file 1) were carried out using FastStart PCR High Fidelity System (Roche Diagnostics, Castle Hill, New South Wales, Australia) according to the manufacturer's protocol.</p></sec><sec><title>Southern blotting analysis</title><p>Amplified 3' RACE products were transferred to Hybond N<sup>+TM </sup>(GE Healthcare, Rydalmere, New South Wales, Australia) nylon membrane using the neutral transfer method. Prehybridization and hybridization steps were performed in Rapid-Hyb buffer (GE Healthcare, Rydalmere, New South Wales, Australia) according to the manufacturer's protocol. All oligonucleotides were designed to be complementary to sequence between the specific primer-priming site and the tag of interest. Synthetic oligonucleotides were 5' end-labeled using T4 polynucleotide kinase (Promega, Alexandria, New South Wales, Australia) and [&#x003b3;-<sup>32</sup>P]ATP (GE Healthcare, Rydalmere, New South Wales, Australia) with modifications to the manufacturer's protocol. After the hybridization step, the membrane was washed with 5&#x000d7; sodium chloride sodium citrate solution (with 0.1% v/v sodium dodecyl sulphate (SDS)) and 1&#x000d7; sodium chloride sodium citrate solution (with 0.1% w/v SDS) (Section G in Additional data file 1). See Additional data file 8 for primer sequences and oligonucleotides used for detection.</p></sec><sec><title>Northern blotting analysis</title><p>Independent preparations of total RNA from the cerebral cortex of seven mice at E15.5 and E17.5, and three adult mice were equally pooled to a final concentration of 20 &#x003bc;g per developmental stage. These pooled total RNAs were electrophoresed overnight and capillary transferred onto Hybond N<sup>+TM </sup>(GE Healthcare, Rydalmere, New South Wales, Australia) nylon membrane. Double-stranded DNA probes were radioactive-labeled using the Amersham Megaprime DNA Labeling System (GE Healthcare, Rydalmere, New South Wales, Australia) and [&#x003b2;-<sup>32</sup>P]CTP, according to the manufacturer's protocol. Hybridization was carried out overnight (approximately 18 h) at 65&#x000b0;C in aqueous buffer (7% w/v SDS with 0.5 M phosphate). After hybridization, blots were washed using 1% w/v SDS at 65&#x000b0;C for 5 to 6 times until the background signal was low.</p></sec><sec><title><italic>In situ </italic>RNA hybridization</title><p>ISH was carried out using paraffin sections (5 &#x003bc;m) of embryonic, postnatal and adult brains (E11.5, E13.5, E15.5, E17.5, P1.5 and P150) and a related [<sup>35</sup>S]UTP-labeled complementary RNA probe (Additional data file 8) as described previously (Section G in Additional data file 1) [<xref ref-type="bibr" rid="B123">123</xref>].</p></sec></sec><sec><title>Screening of <italic>Sox4 </italic>and <italic>Sox11 </italic>sense and antisense transcript expression in the adult mouse brain, organs and both the proliferating and differentiating P19 cells and neurospheres</title><sec><title>Strand-specific RT-qPCR</title><p>Total RNA was extracted from harvested organs using the TRIzol<sup>&#x000ae;</sup>'s reagent (Invitrogen, Mulgrave, Victoria, Australia) according to the manufacturer's protocol. To avoid genomic DNA contamination, all isolated total RNA was treated with the recombinant DNAse I enzyme provided by the DNA-<italic>free</italic>&#x02122; kit (Applied Biosystems, Scoresby, Victoria, Australia) according to the manufacturer's protocol. First strand cDNA synthesis was carried out using strand-specific primers followed by qPCR analysis as described above.</p></sec><sec><title>Embryonic neural stem cells grown as neurospheres</title><p>Mouse used for generation of neurospheres had a mixed genetic background including MF1, 129SvEv, C57BL/6 and CBA. Cerebral cortices from E14 embryos were dissected out into calcium-magnesium-free phosphate-buffered saline. The tissue was mechanically dissociated and centrifuged. The cells were plated in complete neuroculture medium (Section G in Additional data file 1) for 4 days followed by induction of neuronal differentiation. These cells were then plated on poly-D-lysine (catalogue number P6407, Sigma Aldrich, Castle Hill, New South Wales, Australia) and laminin (catalogue number 23017-015, Invitrogen, Mulgrave, Victoria, Australia) coated culture dishes in neuroculture medium with the presence of 2% (v/v) fetal bovine serum but not epidermal growth factor and basic fibroblast growth factor. The differentiation was allowed to proceed for 5 days. Total RNA was extracted from both proliferating and differentiating cells using TRIzol<sup>&#x000ae; </sup>reagent as described above.</p></sec><sec><title>P19 embryonal carcinoma cells</title><p>P19 mouse embryonal carcinoma cells were cultured and differentiated into neurons as described previously [<xref ref-type="bibr" rid="B124">124</xref>]. Briefly, P19 cell cultures were maintained in P19GM complete medium (Section G in Additional data file 1). For induction of neuronal differentiation, 1 &#x000d7; 10<sup>6 </sup>P19 cells were cultured in suspension form using bacteriological Petri dishes. The P19GM medium with additional supplementation of 5 &#x000d7; 10<sup>-7</sup>M all-trans retinoic acid (catalogue number R-2625; Sigma Aldrich, Castle Hill, New South Wales, Australia) was used for the induction. After 4 days, P19 cells formed embryoid body stages. Embryoid bodies were collected from suspension cultures and re-plated in adherent culture flasks in the P19GM medium with only 5% (v/v) fetal bovine serum and without retinoic acid supplementation. The cells were allowed to differentiate for 5 days. Total RNA was extracted from both proliferating and differentiating cells using TRIzol<sup>&#x000ae; </sup>reagent as described in above.</p></sec></sec></sec><sec><title>Abbreviations</title><p>CL: caudo-lateral; CM: caudo-medial; DAVID: Database for Annotation, Visualization and Integrated Discovery; DET: differentially expressed transcript/tag; E: embryonic day; EST: expressed sequence tag; GEO: Gene Expression Omnibus; IPA: Ingenuity Pathway Analysis; ISH: <italic>in situ </italic>hybridization; LTP: long term potentiation; miRNA: microRNA; NAT: natural antisense transcript; NSPC: neural stem/progenitor cell; OMIM: Online Mendelian Inheritance in Man; P: postnatal day; PET: paired-end diTag; RACE: rapid amplification of cDNA ends; RL: rostro-lateral; RM: rostro-medial; RT-qPCR: quantitative RT-PCR; SAGE: serial analysis of gene expression; SDS: sodium dodecyl sulphate; UCSC: University of California Santa Cruz; UTR: untranslated region.</p></sec><sec><title>Authors' contributions</title><p>KHL performed all the SAGE validation experiments. CAH, PZC and SST procured the mouse cerebral cortex and constructed the SAGE libraries. KHL, TB, LH and GKS designed, performed and supervised the SAGE, RT-qPCR and IPA analyses. KHL and TT performed all the ISH studies. KHL, KB, PSC, CNH and PQT carried out the expression studies on <italic>Sox4 </italic>and <italic>Sox11 </italic>transcripts. KHL, CAH and CNH drafted the manuscript. CAH, GKS, TT and HSS conceived of the study, and participated in its design and coordination. All authors read and approved the final manuscript.</p></sec><sec><title>Additional data files</title><p>The following additional data are available with the online version of this paper: analysis of SAGE, DETs, IPA, <italic>Sox4 </italic>and <italic>Sox11 </italic>genomic cluster analysis, and R script for implementing empirical Bayesian moderated <italic>t</italic>-test on multiple groups (Additional data file <xref ref-type="supplementary-material" rid="S1">1</xref>); SAGE tag information for 561 DETs (Additional data file <xref ref-type="supplementary-material" rid="S2">2</xref>); functional annotations clustering analysis using DAVID (Additional data file <xref ref-type="supplementary-material" rid="S3">3</xref>); RT-qPCR validation of DETs based on multiple comparisons between two developmental stages (E versus Ad, PN1.5 versus Ad and E15.5 versus PN1.5) (Additional data file <xref ref-type="supplementary-material" rid="S4">4</xref>); RT-qPCR validation of gene clusters based on hierarchical clustering analysis (Additional data file <xref ref-type="supplementary-material" rid="S5">5</xref>); RT-qPCR validation of DETs based on the rostral versus caudal E15.5 cerebral cortex comparison (Additional data file <xref ref-type="supplementary-material" rid="S6">6</xref>); statistically significant over-represented genomic loci based on genomic clustering of tags (Additional data file <xref ref-type="supplementary-material" rid="S7">7</xref>); list of primers, probes, clones and assays designed for RT-qPCR, RACE, Southern, Northern and ISH analysis (Additional data file <xref ref-type="supplementary-material" rid="S8">8</xref>).</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="S1"><caption><title>Additional data file 1</title><p>Analysis of SAGE, DETs, IPA, <italic>Sox4 </italic>and <italic>Sox11 </italic>genomic cluster analysis, and R script for implementing empirical Bayesian moderated <italic>t</italic>-test on multiple groups.</p></caption><media xlink:href="gb-2009-10-10-r104-S1.DOC" mimetype="text" mime-subtype="plain"><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="S2"><caption><title>Additional data file 2</title><p>SAGE tag information for 561 DETs.</p></caption><media xlink:href="gb-2009-10-10-r104-S2.XLS" mimetype="text" mime-subtype="plain"><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="S3"><caption><title>Additional data file 3</title><p>Functional annotations clustering analysis using DAVID.</p></caption><media xlink:href="gb-2009-10-10-r104-S3.XLS" mimetype="text" mime-subtype="plain"><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="S4"><caption><title>Additional data file 4</title><p>RT-qPCR validation of DETs based on multiple comparisons between two developmental stages (E versus Ad, PN1.5 versus Ad and E15.5 versus PN1.5).</p></caption><media xlink:href="gb-2009-10-10-r104-S4.XLS" mimetype="text" mime-subtype="plain"><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="S5"><caption><title>Additional data file 5</title><p>RT-qPCR validation of gene clusters based on hierarchical clustering analysis.</p></caption><media xlink:href="gb-2009-10-10-r104-S5.XLS" mimetype="text" mime-subtype="plain"><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="S6"><caption><title>Additional data file 6</title><p>RT-qPCR validation of DETs based on the rostral versus caudal E15.5 cerebral cortex comparison.</p></caption><media xlink:href="gb-2009-10-10-r104-S6.XLS" mimetype="text" mime-subtype="plain"><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="S7"><caption><title>Additional data file 7</title><p>Statistically significant over-represented genomic loci based on genomic clustering of tags.</p></caption><media xlink:href="gb-2009-10-10-r104-S7.XLS" mimetype="text" mime-subtype="plain"><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="S8"><caption><title>Additional data file 8</title><p>Primers, probes, clones and assays designed for RT-qPCR, RACE, Southern, Northern and ISH analysis.</p></caption><media xlink:href="gb-2009-10-10-r104-S8.XLS" mimetype="text" mime-subtype="plain"><caption><p>Click here for file</p></caption></media></supplementary-material></sec></body><back><sec><title>Acknowledgements</title><p>We thank Felix Ng, Sarah King and Caitlin Collins for technical assistance; Frank Weissenborn for assistance with tissue dissections; Ken Simpson and Keith Satterley for computational assistance. The P19 cell line was kindly provided by Dr K Jensen, School of Molecular and Biomedical Science, University of Adelaide, South Australia, Australia. This work was supported by a National Health and Medical Research Council fellowships (171601 and 461204 to HSS); National Health and Medical Research Council Grants 219176, 257501, 215201, and 257529 (to HSS, GKS, and S-ST), a fellowship from the Deutsche Forschungsgemeinschaft (to TB). PQT is a Pfizer Australia Research Fellow. K-HL was a recipient of the Melbourne International Fee Remission Scholarship (MIFRS) and Universiti Putra Malaysia Staff Training Scholarship (UPMSTS), and Adelaide International Fee Scholarship (AIFS) equivalent. The majority of DNA sequencing in production of SAGE libraries was performed by the Australian Genome Research Facility, which was established through the Commonwealth-funded Major National Research Facilities program.</p></sec><ref-list><ref id="B1"><mixed-citation publication-type="journal"><name><surname>Miyashita-Lin</surname><given-names>EM</given-names></name><name><surname>Hevner</surname><given-names>R</given-names></name><name><surname>Wassarman</surname><given-names>KM</given-names></name><name><surname>Martinez</surname><given-names>S</given-names></name><name><surname>Rubenstein</surname><given-names>JL</given-names></name><article-title>Early neocortical regionalization in the absence of thalamic innervation.</article-title><source>Science</source><year>1999</year><volume>285</volume><fpage>906</fpage><lpage>909</lpage><pub-id pub-id-type="pmid">10436162</pub-id><pub-id pub-id-type="doi">10.1126/science.285.5429.906</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><name><surname>Molyneaux</surname><given-names>BJ</given-names></name><name><surname>Arlotta</surname><given-names>P</given-names></name><name><surname>Menezes</surname><given-names>JR</given-names></name><name><surname>Macklis</surname><given-names>JD</given-names></name><article-title>Neuronal subtype specification in the cerebral cortex.</article-title><source>Nat Rev Neurosci</source><year>2007</year><volume>8</volume><fpage>427</fpage><lpage>437</lpage><pub-id pub-id-type="pmid">17514196</pub-id><pub-id pub-id-type="doi">10.1038/nrn2151</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><name><surname>O'Leary</surname><given-names>DD</given-names></name><name><surname>Chou</surname><given-names>SJ</given-names></name><name><surname>Sahara</surname><given-names>S</given-names></name><article-title>Area patterning of the mammalian cortex.</article-title><source>Neuron</source><year>2007</year><volume>56</volume><fpage>252</fpage><lpage>269</lpage><pub-id pub-id-type="pmid">17964244</pub-id><pub-id pub-id-type="doi">10.1016/j.neuron.2007.10.010</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><name><surname>Gupta</surname><given-names>A</given-names></name><name><surname>Tsai</surname><given-names>LH</given-names></name><name><surname>Wynshaw-Boris</surname><given-names>A</given-names></name><article-title>Life is a journey: a genetic look at neocortical development.</article-title><source>Nat Rev Genet</source><year>2002</year><volume>3</volume><fpage>342</fpage><lpage>355</lpage><pub-id pub-id-type="pmid">11988760</pub-id><pub-id pub-id-type="doi">10.1038/nrg799</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><name><surname>Marin</surname><given-names>O</given-names></name><name><surname>Rubenstein</surname><given-names>JL</given-names></name><article-title>A long, remarkable journey: tangential migration in the telencephalon.</article-title><source>Nat Rev Neurosci</source><year>2001</year><volume>2</volume><fpage>780</fpage><lpage>790</lpage><pub-id pub-id-type="pmid">11715055</pub-id><pub-id pub-id-type="doi">10.1038/35097509</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><name><surname>Nadarajah</surname><given-names>B</given-names></name><name><surname>Parnavelas</surname><given-names>JG</given-names></name><article-title>Modes of neuronal migration in the developing cerebral cortex.</article-title><source>Nat Rev Neurosci</source><year>2002</year><volume>3</volume><fpage>423</fpage><lpage>432</lpage><pub-id pub-id-type="pmid">12042877</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><name><surname>Smart</surname><given-names>IH</given-names></name><article-title>Histogenesis of the mesocortical area of the mouse telencephalon.</article-title><source>J Anat</source><year>1984</year><volume>138</volume><fpage>537</fpage><lpage>552</lpage><pub-id pub-id-type="pmid">6735915</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="book"><name><surname>Uylings</surname><given-names>HBM</given-names></name><name><surname>Van Eden</surname><given-names>CG</given-names></name><name><surname>Parnavelas</surname><given-names>JG</given-names></name><name><surname>Kalsbeek</surname><given-names>A</given-names></name><person-group person-group-type="editor">Kolb B, Tees RC</person-group><article-title>The prenatal and postnatal development of rat cerebral cortex.</article-title><source>The Cerebral Cortex of the Rat</source><year>1990</year><publisher-name>Cambridge, MA: MIT Press</publisher-name><fpage>36</fpage><lpage>76</lpage></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><name><surname>Bishop</surname><given-names>KM</given-names></name><name><surname>Goudreau</surname><given-names>G</given-names></name><name><surname>O'Leary</surname><given-names>DD</given-names></name><article-title>Regulation of area identity in the mammalian neocortex by Emx2 and Pax6.</article-title><source>Science</source><year>2000</year><volume>288</volume><fpage>344</fpage><lpage>349</lpage><pub-id pub-id-type="pmid">10764649</pub-id><pub-id pub-id-type="doi">10.1126/science.288.5464.344</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><name><surname>Mallamaci</surname><given-names>A</given-names></name><name><surname>Muzio</surname><given-names>L</given-names></name><name><surname>Chan</surname><given-names>CH</given-names></name><name><surname>Parnavelas</surname><given-names>J</given-names></name><name><surname>Boncinelli</surname><given-names>E</given-names></name><article-title>Area identity shifts in the early cerebral cortex of Emx2-/- mutant mice.</article-title><source>Nat Neurosci</source><year>2000</year><volume>3</volume><fpage>679</fpage><lpage>686</lpage><pub-id pub-id-type="pmid">10862700</pub-id><pub-id pub-id-type="doi">10.1038/76630</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><name><surname>Armentano</surname><given-names>M</given-names></name><name><surname>Chou</surname><given-names>SJ</given-names></name><name><surname>Tomassy</surname><given-names>GS</given-names></name><name><surname>Leingartner</surname><given-names>A</given-names></name><name><surname>O'Leary</surname><given-names>DD</given-names></name><name><surname>Studer</surname><given-names>M</given-names></name><article-title>COUP-TFI regulates the balance of cortical patterning between frontal/motor and sensory areas.</article-title><source>Nat Neurosci</source><year>2007</year><volume>10</volume><fpage>1277</fpage><lpage>1286</lpage><pub-id pub-id-type="pmid">17828260</pub-id><pub-id pub-id-type="doi">10.1038/nn1958</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><name><surname>Sahara</surname><given-names>S</given-names></name><name><surname>Kawakami</surname><given-names>Y</given-names></name><name><surname>Izpisua Belmonte</surname><given-names>JC</given-names></name><name><surname>O'Leary</surname><given-names>DD</given-names></name><article-title>Sp8 exhibits reciprocal induction with Fgf8 but has an opposing effect on anterior-posterior cortical area patterning.</article-title><source>Neural Dev</source><year>2007</year><volume>2</volume><fpage>10</fpage><pub-id pub-id-type="pmid">17509151</pub-id><pub-id pub-id-type="doi">10.1186/1749-8104-2-10</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><name><surname>Zembrzycki</surname><given-names>A</given-names></name><name><surname>Griesel</surname><given-names>G</given-names></name><name><surname>Stoykova</surname><given-names>A</given-names></name><name><surname>Mansouri</surname><given-names>A</given-names></name><article-title>Genetic interplay between the transcription factors Sp8 and Emx2 in the patterning of the forebrain.</article-title><source>Neural Dev</source><year>2007</year><volume>2</volume><fpage>8</fpage><pub-id pub-id-type="pmid">17470284</pub-id><pub-id pub-id-type="doi">10.1186/1749-8104-2-8</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><name><surname>Bulfone</surname><given-names>A</given-names></name><name><surname>Puelles</surname><given-names>L</given-names></name><name><surname>Porteus</surname><given-names>MH</given-names></name><name><surname>Frohman</surname><given-names>MA</given-names></name><name><surname>Martin</surname><given-names>GR</given-names></name><name><surname>Rubenstein</surname><given-names>JL</given-names></name><article-title>Spatially restricted expression of Dlx-1, Dlx-2 (Tes-1), Gbx-2, and Wnt-3 in the embryonic day 12.5 mouse forebrain defines potential transverse and longitudinal segmental boundaries.</article-title><source>J Neurosci</source><year>1993</year><volume>13</volume><fpage>3155</fpage><lpage>3172</lpage><pub-id pub-id-type="pmid">7687285</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><name><surname>Gaszner</surname><given-names>M</given-names></name><name><surname>Felsenfeld</surname><given-names>G</given-names></name><article-title>Insulators: exploiting transcriptional and epigenetic mechanisms.</article-title><source>Nat Rev Genet</source><year>2006</year><volume>7</volume><fpage>703</fpage><lpage>713</lpage><pub-id pub-id-type="pmid">16909129</pub-id><pub-id pub-id-type="doi">10.1038/nrg1925</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><name><surname>Kadonaga</surname><given-names>JT</given-names></name><article-title>Eukaryotic transcription: an interlaced network of transcription factors and chromatin-modifying machines.</article-title><source>Cell</source><year>1998</year><volume>92</volume><fpage>307</fpage><lpage>313</lpage><pub-id pub-id-type="pmid">9476891</pub-id><pub-id pub-id-type="doi">10.1016/S0092-8674(00)80924-1</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><name><surname>Ladd-Acosta</surname><given-names>C</given-names></name><name><surname>Pevsner</surname><given-names>J</given-names></name><name><surname>Sabunciyan</surname><given-names>S</given-names></name><name><surname>Yolken</surname><given-names>RH</given-names></name><name><surname>Webster</surname><given-names>MJ</given-names></name><name><surname>Dinkins</surname><given-names>T</given-names></name><name><surname>Callinan</surname><given-names>PA</given-names></name><name><surname>Fan</surname><given-names>JB</given-names></name><name><surname>Potash</surname><given-names>JB</given-names></name><name><surname>Feinberg</surname><given-names>AP</given-names></name><article-title>DNA methylation signatures within the human brain.</article-title><source>Am J Hum Genet</source><year>2007</year><volume>81</volume><fpage>1304</fpage><lpage>1315</lpage><pub-id pub-id-type="pmid">17999367</pub-id><pub-id pub-id-type="doi">10.1086/524110</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><name><surname>Fox</surname><given-names>AH</given-names></name><name><surname>Lam</surname><given-names>YW</given-names></name><name><surname>Leung</surname><given-names>AK</given-names></name><name><surname>Lyon</surname><given-names>CE</given-names></name><name><surname>Andersen</surname><given-names>J</given-names></name><name><surname>Mann</surname><given-names>M</given-names></name><name><surname>Lamond</surname><given-names>AI</given-names></name><article-title>Paraspeckles: a novel nuclear domain.</article-title><source>Curr Biol</source><year>2002</year><volume>12</volume><fpage>13</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">11790299</pub-id><pub-id pub-id-type="doi">10.1016/S0960-9822(01)00632-7</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><name><surname>Prasanth</surname><given-names>KV</given-names></name><name><surname>Prasanth</surname><given-names>SG</given-names></name><name><surname>Xuan</surname><given-names>Z</given-names></name><name><surname>Hearn</surname><given-names>S</given-names></name><name><surname>Freier</surname><given-names>SM</given-names></name><name><surname>Bennett</surname><given-names>CF</given-names></name><name><surname>Zhang</surname><given-names>MQ</given-names></name><name><surname>Spector</surname><given-names>DL</given-names></name><article-title>Regulating gene expression through RNA nuclear retention.</article-title><source>Cell</source><year>2005</year><volume>123</volume><fpage>249</fpage><lpage>263</lpage><pub-id pub-id-type="pmid">16239143</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2005.08.033</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><name><surname>Schratt</surname><given-names>GM</given-names></name><name><surname>Tuebing</surname><given-names>F</given-names></name><name><surname>Nigh</surname><given-names>EA</given-names></name><name><surname>Kane</surname><given-names>CG</given-names></name><name><surname>Sabatini</surname><given-names>ME</given-names></name><name><surname>Kiebler</surname><given-names>M</given-names></name><name><surname>Greenberg</surname><given-names>ME</given-names></name><article-title>A brain-specific microRNA regulates dendritic spine development.</article-title><source>Nature</source><year>2006</year><volume>439</volume><fpage>283</fpage><lpage>289</lpage><pub-id pub-id-type="pmid">16421561</pub-id><pub-id pub-id-type="doi">10.1038/nature04367</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><name><surname>Stark</surname><given-names>KL</given-names></name><name><surname>Xu</surname><given-names>B</given-names></name><name><surname>Bagchi</surname><given-names>A</given-names></name><name><surname>Lai</surname><given-names>WS</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Hsu</surname><given-names>R</given-names></name><name><surname>Wan</surname><given-names>X</given-names></name><name><surname>Pavlidis</surname><given-names>P</given-names></name><name><surname>Mills</surname><given-names>AA</given-names></name><name><surname>Karayiorgou</surname><given-names>M</given-names></name><name><surname>Gogos</surname><given-names>JA</given-names></name><article-title>Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model.</article-title><source>Nat Genet</source><year>2008</year><volume>40</volume><fpage>751</fpage><lpage>760</lpage><pub-id pub-id-type="pmid">18469815</pub-id><pub-id pub-id-type="doi">10.1038/ng.138</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><name><surname>Bak</surname><given-names>M</given-names></name><name><surname>Silahtaroglu</surname><given-names>A</given-names></name><name><surname>Moller</surname><given-names>M</given-names></name><name><surname>Christensen</surname><given-names>M</given-names></name><name><surname>Rath</surname><given-names>MF</given-names></name><name><surname>Skryabin</surname><given-names>B</given-names></name><name><surname>Tommerup</surname><given-names>N</given-names></name><name><surname>Kauppinen</surname><given-names>S</given-names></name><article-title>MicroRNA expression in the adult mouse central nervous system.</article-title><source>Rna</source><year>2008</year><volume>14</volume><fpage>432</fpage><lpage>444</lpage><pub-id pub-id-type="pmid">18230762</pub-id><pub-id pub-id-type="doi">10.1261/rna.783108</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><name><surname>Tochitani</surname><given-names>S</given-names></name><name><surname>Hayashizaki</surname><given-names>Y</given-names></name><article-title>Nkx2.2 antisense RNA overexpression enhanced oligodendrocytic differentiation.</article-title><source>Biochem Biophys Res Commun</source><year>2008</year><volume>372</volume><fpage>691</fpage><lpage>696</lpage><pub-id pub-id-type="pmid">18538132</pub-id><pub-id pub-id-type="doi">10.1016/j.bbrc.2008.05.127</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><name><surname>Smalheiser</surname><given-names>NR</given-names></name><name><surname>Lugli</surname><given-names>G</given-names></name><name><surname>Torvik</surname><given-names>VI</given-names></name><name><surname>Mise</surname><given-names>N</given-names></name><name><surname>Ikeda</surname><given-names>R</given-names></name><name><surname>Abe</surname><given-names>K</given-names></name><article-title>Natural antisense transcripts are co-expressed with sense mRNAs in synaptoneurosomes of adult mouse forebrain.</article-title><source>Neurosci Res</source><year>2008</year><volume>62</volume><fpage>236</fpage><lpage>239</lpage><pub-id pub-id-type="pmid">18812194</pub-id><pub-id pub-id-type="doi">10.1016/j.neures.2008.08.010</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><name><surname>Saha</surname><given-names>S</given-names></name><name><surname>Sparks</surname><given-names>AB</given-names></name><name><surname>Rago</surname><given-names>C</given-names></name><name><surname>Akmaev</surname><given-names>V</given-names></name><name><surname>Wang</surname><given-names>CJ</given-names></name><name><surname>Vogelstein</surname><given-names>B</given-names></name><name><surname>Kinzler</surname><given-names>KW</given-names></name><name><surname>Velculescu</surname><given-names>VE</given-names></name><article-title>Using the transcriptome to annotate the genome.</article-title><source>Nat Biotechnol</source><year>2002</year><volume>20</volume><fpage>508</fpage><lpage>512</lpage><pub-id pub-id-type="pmid">11981567</pub-id><pub-id pub-id-type="doi">10.1038/nbt0502-508</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><name><surname>Velculescu</surname><given-names>VE</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Vogelstein</surname><given-names>B</given-names></name><name><surname>Kinzler</surname><given-names>KW</given-names></name><article-title>Serial analysis of gene expression.</article-title><source>Science</source><year>1995</year><volume>270</volume><fpage>484</fpage><lpage>487</lpage><pub-id pub-id-type="pmid">7570003</pub-id><pub-id pub-id-type="doi">10.1126/science.270.5235.484</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><name><surname>Gunnersen</surname><given-names>JM</given-names></name><name><surname>Augustine</surname><given-names>C</given-names></name><name><surname>Spirkoska</surname><given-names>V</given-names></name><name><surname>Kim</surname><given-names>M</given-names></name><name><surname>Brown</surname><given-names>M</given-names></name><name><surname>Tan</surname><given-names>SS</given-names></name><article-title>Global analysis of gene expression patterns in developing mouse neocortex using serial analysis of gene expression.</article-title><source>Mol Cell Neurosci</source><year>2002</year><volume>19</volume><fpage>560</fpage><lpage>573</lpage><pub-id pub-id-type="pmid">11988023</pub-id><pub-id pub-id-type="doi">10.1006/mcne.2001.1098</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="other"><article-title>NCBI Gene Expression Omnibus.</article-title><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/geo/">http://www.ncbi.nlm.nih.gov/geo/</ext-link></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><name><surname>Boon</surname><given-names>WM</given-names></name><name><surname>Beissbarth</surname><given-names>T</given-names></name><name><surname>Hyde</surname><given-names>L</given-names></name><name><surname>Smyth</surname><given-names>G</given-names></name><name><surname>Gunnersen</surname><given-names>J</given-names></name><name><surname>Denton</surname><given-names>DA</given-names></name><name><surname>Scott</surname><given-names>H</given-names></name><name><surname>Tan</surname><given-names>SS</given-names></name><article-title>A comparative analysis of transcribed genes in the mouse hypothalamus and neocortex reveals chromosomal clustering.</article-title><source>Proc Natl Acad Sci USA</source><year>2004</year><volume>101</volume><fpage>14972</fpage><lpage>14977</lpage><pub-id pub-id-type="pmid">15466702</pub-id><pub-id pub-id-type="doi">10.1073/pnas.0406296101</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><name><surname>Dennis</surname><given-names>G</given-names><suffix>Jr</suffix></name><name><surname>Sherman</surname><given-names>BT</given-names></name><name><surname>Hosack</surname><given-names>DA</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Gao</surname><given-names>W</given-names></name><name><surname>Lane</surname><given-names>HC</given-names></name><name><surname>Lempicki</surname><given-names>RA</given-names></name><article-title>DAVID: Database for Annotation, Visualization, and Integrated Discovery.</article-title><source>Genome Biol</source><year>2003</year><volume>4</volume><fpage>P3</fpage><pub-id pub-id-type="pmid">12734009</pub-id><pub-id pub-id-type="doi">10.1186/gb-2003-4-5-p3</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><name><surname>Yuan</surname><given-names>X</given-names></name><name><surname>Chittajallu</surname><given-names>R</given-names></name><name><surname>Belachew</surname><given-names>S</given-names></name><name><surname>Anderson</surname><given-names>S</given-names></name><name><surname>McBain</surname><given-names>CJ</given-names></name><name><surname>Gallo</surname><given-names>V</given-names></name><article-title>Expression of the green fluorescent protein in the oligodendrocyte lineage: a transgenic mouse for developmental and physiological studies.</article-title><source>J Neurosci Res</source><year>2002</year><volume>70</volume><fpage>529</fpage><lpage>545</lpage><pub-id pub-id-type="pmid">12404507</pub-id><pub-id pub-id-type="doi">10.1002/jnr.10368</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="other"><article-title>Allen Institute for Brain Science.</article-title><ext-link ext-link-type="uri" xlink:href="http://mouse.brain-map.org/">http://mouse.brain-map.org/</ext-link></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="other"><article-title>Brain Gene Expression Map.</article-title><ext-link ext-link-type="uri" xlink:href="http://www.stjudebgem.org/">http://www.stjudebgem.org/</ext-link></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="other"><article-title>Gene Expression Nervous System Atlas.</article-title><ext-link ext-link-type="uri" xlink:href="http://www.gensat.org/">http://www.gensat.org/</ext-link></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="other"><article-title>GenePaint.org.</article-title><ext-link ext-link-type="uri" xlink:href="http://www.genepaint.org/">http://www.genepaint.org/</ext-link></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><name><surname>Ino</surname><given-names>H</given-names></name><name><surname>Chiba</surname><given-names>T</given-names></name><article-title>Expression of proliferating cell nuclear antigen (PCNA) in the adult and developing mouse nervous system.</article-title><source>Brain Res Mol Brain Res</source><year>2000</year><volume>78</volume><fpage>163</fpage><lpage>174</lpage><pub-id pub-id-type="pmid">10891596</pub-id><pub-id pub-id-type="doi">10.1016/S0169-328X(00)00092-9</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><name><surname>Lopez-Coviella</surname><given-names>I</given-names></name><name><surname>Follettie</surname><given-names>MT</given-names></name><name><surname>Mellott</surname><given-names>TJ</given-names></name><name><surname>Kovacheva</surname><given-names>VP</given-names></name><name><surname>Slack</surname><given-names>BE</given-names></name><name><surname>Diesl</surname><given-names>V</given-names></name><name><surname>Berse</surname><given-names>B</given-names></name><name><surname>Thies</surname><given-names>RS</given-names></name><name><surname>Blusztajn</surname><given-names>JK</given-names></name><article-title>Bone morphogenetic protein 9 induces the transcriptome of basal forebrain cholinergic neurons.</article-title><source>Proc Natl Acad Sci USA</source><year>2005</year><volume>102</volume><fpage>6984</fpage><lpage>6989</lpage><pub-id pub-id-type="pmid">15870197</pub-id><pub-id pub-id-type="doi">10.1073/pnas.0502097102</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><name><surname>Bhat</surname><given-names>NR</given-names></name><name><surname>Zhang</surname><given-names>P</given-names></name><name><surname>Bhat</surname><given-names>AN</given-names></name><article-title>The expression of myristoylated alanine-rich C-kinase substrate in oligodendrocytes is developmentally regulated.</article-title><source>Dev Neurosci</source><year>1995</year><volume>17</volume><fpage>256</fpage><lpage>263</lpage><pub-id pub-id-type="pmid">8575345</pub-id><pub-id pub-id-type="doi">10.1159/000111294</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><name><surname>Calabrese</surname><given-names>B</given-names></name><name><surname>Halpain</surname><given-names>S</given-names></name><article-title>Essential role for the PKC target MARCKS in maintaining dendritic spine morphology.</article-title><source>Neuron</source><year>2005</year><volume>48</volume><fpage>77</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">16202710</pub-id><pub-id pub-id-type="doi">10.1016/j.neuron.2005.08.027</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><name><surname>Lopez-Bendito</surname><given-names>G</given-names></name><name><surname>Flames</surname><given-names>N</given-names></name><name><surname>Ma</surname><given-names>L</given-names></name><name><surname>Fouquet</surname><given-names>C</given-names></name><name><surname>Di Meglio</surname><given-names>T</given-names></name><name><surname>Chedotal</surname><given-names>A</given-names></name><name><surname>Tessier-Lavigne</surname><given-names>M</given-names></name><name><surname>Marin</surname><given-names>O</given-names></name><article-title>Robo1 and Robo2 cooperate to control the guidance of major axonal tracts in the mammalian forebrain.</article-title><source>J Neurosci</source><year>2007</year><volume>27</volume><fpage>3395</fpage><lpage>3407</lpage><pub-id pub-id-type="pmid">17392456</pub-id><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4605-06.2007</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><name><surname>Sher</surname><given-names>F</given-names></name><name><surname>Rossler</surname><given-names>R</given-names></name><name><surname>Brouwer</surname><given-names>N</given-names></name><name><surname>Balasubramaniyan</surname><given-names>V</given-names></name><name><surname>Boddeke</surname><given-names>E</given-names></name><name><surname>Copray</surname><given-names>S</given-names></name><article-title>Differentiation of neural stem cells into oligodendrocytes: involvement of the polycomb group protein Ezh2.</article-title><source>Stem Cells</source><year>2008</year><volume>26</volume><fpage>2875</fpage><lpage>2883</lpage><pub-id pub-id-type="pmid">18687996</pub-id><pub-id pub-id-type="doi">10.1634/stemcells.2008-0121</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><name><surname>Mermelstein</surname><given-names>F</given-names></name><name><surname>Yeung</surname><given-names>K</given-names></name><name><surname>Cao</surname><given-names>J</given-names></name><name><surname>Inostroza</surname><given-names>JA</given-names></name><name><surname>Erdjument-Bromage</surname><given-names>H</given-names></name><name><surname>Eagelson</surname><given-names>K</given-names></name><name><surname>Landsman</surname><given-names>D</given-names></name><name><surname>Levitt</surname><given-names>P</given-names></name><name><surname>Tempst</surname><given-names>P</given-names></name><name><surname>Reinberg</surname><given-names>D</given-names></name><article-title>Requirement of a corepressor for Dr1-mediated repression of transcription.</article-title><source>Genes Dev</source><year>1996</year><volume>10</volume><fpage>1033</fpage><lpage>1048</lpage><pub-id pub-id-type="pmid">8608938</pub-id><pub-id pub-id-type="doi">10.1101/gad.10.8.1033</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal"><name><surname>Beiswanger</surname><given-names>CM</given-names></name><name><surname>Diegmann</surname><given-names>MH</given-names></name><name><surname>Novak</surname><given-names>RF</given-names></name><name><surname>Philbert</surname><given-names>MA</given-names></name><name><surname>Graessle</surname><given-names>TL</given-names></name><name><surname>Reuhl</surname><given-names>KR</given-names></name><name><surname>Lowndes</surname><given-names>HE</given-names></name><article-title>Developmental changes in the cellular distribution of glutathione and glutathione S-transferases in the murine nervous system.</article-title><source>Neurotoxicology</source><year>1995</year><volume>16</volume><fpage>425</fpage><lpage>440</lpage><pub-id pub-id-type="pmid">8584275</pub-id></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal"><name><surname>Saha</surname><given-names>S</given-names></name><name><surname>Datta</surname><given-names>K</given-names></name><name><surname>Rangarajan</surname><given-names>P</given-names></name><article-title>Characterization of mouse neuronal Ca2+/calmodulin kinase II inhibitor alpha.</article-title><source>Brain Res</source><year>2007</year><volume>1148</volume><fpage>38</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">17350603</pub-id><pub-id pub-id-type="doi">10.1016/j.brainres.2007.02.018</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><name><surname>Wilson</surname><given-names>CA</given-names></name><name><surname>Murphy</surname><given-names>DD</given-names></name><name><surname>Giasson</surname><given-names>BI</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Trojanowski</surname><given-names>JQ</given-names></name><name><surname>Lee</surname><given-names>VM</given-names></name><article-title>Degradative organelles containing mislocalized alpha-and beta-synuclein proliferate in presenilin-1 null neurons.</article-title><source>J Cell Biol</source><year>2004</year><volume>165</volume><fpage>335</fpage><lpage>346</lpage><pub-id pub-id-type="pmid">15123735</pub-id><pub-id pub-id-type="doi">10.1083/jcb.200403061</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal"><name><surname>Bachoo</surname><given-names>RM</given-names></name><name><surname>Kim</surname><given-names>RS</given-names></name><name><surname>Ligon</surname><given-names>KL</given-names></name><name><surname>Maher</surname><given-names>EA</given-names></name><name><surname>Brennan</surname><given-names>C</given-names></name><name><surname>Billings</surname><given-names>N</given-names></name><name><surname>Chan</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Rowitch</surname><given-names>DH</given-names></name><name><surname>Wong</surname><given-names>WH</given-names></name><name><surname>DePinho</surname><given-names>RA</given-names></name><article-title>Molecular diversity of astrocytes with implications for neurological disorders.</article-title><source>Proc Natl Acad Sci USA</source><year>2004</year><volume>101</volume><fpage>8384</fpage><lpage>8389</lpage><pub-id pub-id-type="pmid">15155908</pub-id><pub-id pub-id-type="doi">10.1073/pnas.0402140101</pub-id></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal"><name><surname>Lencesova</surname><given-names>L</given-names></name><name><surname>O'Neill</surname><given-names>A</given-names></name><name><surname>Resneck</surname><given-names>WG</given-names></name><name><surname>Bloch</surname><given-names>RJ</given-names></name><name><surname>Blaustein</surname><given-names>MP</given-names></name><article-title>Plasma membrane-cytoskeleton-endoplasmic reticulum complexes in neurons and astrocytes.</article-title><source>J Biol Chem</source><year>2004</year><volume>279</volume><fpage>2885</fpage><lpage>2893</lpage><pub-id pub-id-type="pmid">14593108</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M310365200</pub-id></mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal"><name><surname>Zeng</surname><given-names>H</given-names></name><name><surname>Chattarji</surname><given-names>S</given-names></name><name><surname>Barbarosie</surname><given-names>M</given-names></name><name><surname>Rondi-Reig</surname><given-names>L</given-names></name><name><surname>Philpot</surname><given-names>BD</given-names></name><name><surname>Miyakawa</surname><given-names>T</given-names></name><name><surname>Bear</surname><given-names>MF</given-names></name><name><surname>Tonegawa</surname><given-names>S</given-names></name><article-title>Forebrain-specific calcineurin knockout selectively impairs bidirectional synaptic plasticity and working/episodic-like memory.</article-title><source>Cell</source><year>2001</year><volume>107</volume><fpage>617</fpage><lpage>629</lpage><pub-id pub-id-type="pmid">11733061</pub-id><pub-id pub-id-type="doi">10.1016/S0092-8674(01)00585-2</pub-id></mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>PM</given-names></name><name><surname>Aizawa</surname><given-names>H</given-names></name><name><surname>Kim</surname><given-names>PS</given-names></name><name><surname>Huang</surname><given-names>AS</given-names></name><name><surname>Wickramasinghe</surname><given-names>SR</given-names></name><name><surname>Kashani</surname><given-names>AH</given-names></name><name><surname>Barrow</surname><given-names>RK</given-names></name><name><surname>Huganir</surname><given-names>RL</given-names></name><name><surname>Ghosh</surname><given-names>A</given-names></name><name><surname>Snyder</surname><given-names>SH</given-names></name><article-title>Serine racemase: activation by glutamate neurotransmission via glutamate receptor interacting protein and mediation of neuronal migration.</article-title><source>Proc Natl Acad Sci USA</source><year>2005</year><volume>102</volume><fpage>2105</fpage><lpage>2110</lpage><pub-id pub-id-type="pmid">15684087</pub-id><pub-id pub-id-type="doi">10.1073/pnas.0409723102</pub-id></mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal"><name><surname>Mandir</surname><given-names>AS</given-names></name><name><surname>Poitras</surname><given-names>MF</given-names></name><name><surname>Berliner</surname><given-names>AR</given-names></name><name><surname>Herring</surname><given-names>WJ</given-names></name><name><surname>Guastella</surname><given-names>DB</given-names></name><name><surname>Feldman</surname><given-names>A</given-names></name><name><surname>Poirier</surname><given-names>GG</given-names></name><name><surname>Wang</surname><given-names>ZQ</given-names></name><name><surname>Dawson</surname><given-names>TM</given-names></name><name><surname>Dawson</surname><given-names>VL</given-names></name><article-title>NMDA but not non-NMDA excitotoxicity is mediated by Poly(ADP-ribose) polymerase.</article-title><source>J Neurosci</source><year>2000</year><volume>20</volume><fpage>8005</fpage><lpage>8011</lpage><pub-id pub-id-type="pmid">11050121</pub-id></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal"><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Skoff</surname><given-names>RP</given-names></name><article-title>Proteolipid protein regulates the survival and differentiation of oligodendrocytes.</article-title><source>J Neurosci</source><year>1997</year><volume>17</volume><fpage>2056</fpage><lpage>2070</lpage><pub-id pub-id-type="pmid">9045733</pub-id></mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal"><name><surname>Southwood</surname><given-names>CM</given-names></name><name><surname>Peppi</surname><given-names>M</given-names></name><name><surname>Dryden</surname><given-names>S</given-names></name><name><surname>Tainsky</surname><given-names>MA</given-names></name><name><surname>Gow</surname><given-names>A</given-names></name><article-title>Microtubule deacetylases, SirT2 and HDAC6, in the nervous system.</article-title><source>Neurochem Res</source><year>2007</year><volume>32</volume><fpage>187</fpage><lpage>195</lpage><pub-id pub-id-type="pmid">16933150</pub-id><pub-id pub-id-type="doi">10.1007/s11064-006-9127-6</pub-id></mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal"><name><surname>Niciu</surname><given-names>MJ</given-names></name><name><surname>Ma</surname><given-names>XM</given-names></name><name><surname>El Meskini</surname><given-names>R</given-names></name><name><surname>Ronnett</surname><given-names>GV</given-names></name><name><surname>Mains</surname><given-names>RE</given-names></name><name><surname>Eipper</surname><given-names>BA</given-names></name><article-title>Developmental changes in the expression of ATP7A during a critical period in postnatal neurodevelopment.</article-title><source>Neuroscience</source><year>2006</year><volume>139</volume><fpage>947</fpage><lpage>964</lpage><pub-id pub-id-type="pmid">16549268</pub-id><pub-id pub-id-type="doi">10.1016/j.neuroscience.2006.01.044</pub-id></mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal"><name><surname>Sanosaka</surname><given-names>T</given-names></name><name><surname>Namihira</surname><given-names>M</given-names></name><name><surname>Asano</surname><given-names>H</given-names></name><name><surname>Kohyama</surname><given-names>J</given-names></name><name><surname>Aisaki</surname><given-names>K</given-names></name><name><surname>Igarashi</surname><given-names>K</given-names></name><name><surname>Kanno</surname><given-names>J</given-names></name><name><surname>Nakashima</surname><given-names>K</given-names></name><article-title>Identification of genes that restrict astrocyte differentiation of midgestational neural precursor cells.</article-title><source>Neuroscience</source><year>2008</year><volume>155</volume><fpage>780</fpage><lpage>788</lpage><pub-id pub-id-type="pmid">18640244</pub-id><pub-id pub-id-type="doi">10.1016/j.neuroscience.2008.06.039</pub-id></mixed-citation></ref><ref id="B55"><mixed-citation publication-type="journal"><name><surname>Mbebi</surname><given-names>C</given-names></name><name><surname>See</surname><given-names>V</given-names></name><name><surname>Mercken</surname><given-names>L</given-names></name><name><surname>Pradier</surname><given-names>L</given-names></name><name><surname>Muller</surname><given-names>U</given-names></name><name><surname>Loeffler</surname><given-names>JP</given-names></name><article-title>Amyloid precursor protein family-induced neuronal death is mediated by impairment of the neuroprotective calcium/calmodulin protein kinase IV-dependent signaling pathway.</article-title><source>J Biol Chem</source><year>2002</year><volume>277</volume><fpage>20979</fpage><lpage>20990</lpage><pub-id pub-id-type="pmid">11877414</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M107948200</pub-id></mixed-citation></ref><ref id="B56"><mixed-citation publication-type="journal"><name><surname>Jinnah</surname><given-names>HA</given-names></name><name><surname>Hess</surname><given-names>EJ</given-names></name><name><surname>Wilson</surname><given-names>MC</given-names></name><name><surname>Gage</surname><given-names>FH</given-names></name><name><surname>Friedmann</surname><given-names>T</given-names></name><article-title>Localization of hypoxanthine-guanine phosphoribosyltransferase messenger RNA in the mouse brain by <italic>in situ </italic>hybridization.</article-title><source>Mol Cell Neurosci</source><year>1992</year><volume>3</volume><fpage>64</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1016/1044-7431(92)90010-Y</pub-id></mixed-citation></ref><ref id="B57"><mixed-citation publication-type="journal"><name><surname>Poet</surname><given-names>M</given-names></name><name><surname>Kornak</surname><given-names>U</given-names></name><name><surname>Schweizer</surname><given-names>M</given-names></name><name><surname>Zdebik</surname><given-names>AA</given-names></name><name><surname>Scheel</surname><given-names>O</given-names></name><name><surname>Hoelter</surname><given-names>S</given-names></name><name><surname>Wurst</surname><given-names>W</given-names></name><name><surname>Schmitt</surname><given-names>A</given-names></name><name><surname>Fuhrmann</surname><given-names>JC</given-names></name><name><surname>Planells-Cases</surname><given-names>R</given-names></name><name><surname>Mole</surname><given-names>SE</given-names></name><name><surname>Hubner</surname><given-names>CA</given-names></name><name><surname>Jentsch</surname><given-names>TJ</given-names></name><article-title>Lysosomal storage disease upon disruption of the neuronal chloride transport protein ClC-6.</article-title><source>Proc Natl Acad Sci USA</source><year>2006</year><volume>103</volume><fpage>13854</fpage><lpage>13859</lpage><pub-id pub-id-type="pmid">16950870</pub-id><pub-id pub-id-type="doi">10.1073/pnas.0606137103</pub-id></mixed-citation></ref><ref id="B58"><mixed-citation publication-type="journal"><name><surname>Palfi</surname><given-names>A</given-names></name><name><surname>Kortvely</surname><given-names>E</given-names></name><name><surname>Fekete</surname><given-names>E</given-names></name><name><surname>Kovacs</surname><given-names>B</given-names></name><name><surname>Varszegi</surname><given-names>S</given-names></name><name><surname>Gulya</surname><given-names>K</given-names></name><article-title>Differential calmodulin gene expression in the rodent brain.</article-title><source>Life Sci</source><year>2002</year><volume>70</volume><fpage>2829</fpage><lpage>2855</lpage><pub-id pub-id-type="pmid">12269397</pub-id><pub-id pub-id-type="doi">10.1016/S0024-3205(02)01544-8</pub-id></mixed-citation></ref><ref id="B59"><mixed-citation publication-type="journal"><name><surname>Toyo-oka</surname><given-names>K</given-names></name><name><surname>Shionoya</surname><given-names>A</given-names></name><name><surname>Gambello</surname><given-names>MJ</given-names></name><name><surname>Cardoso</surname><given-names>C</given-names></name><name><surname>Leventer</surname><given-names>R</given-names></name><name><surname>Ward</surname><given-names>HL</given-names></name><name><surname>Ayala</surname><given-names>R</given-names></name><name><surname>Tsai</surname><given-names>LH</given-names></name><name><surname>Dobyns</surname><given-names>W</given-names></name><name><surname>Ledbetter</surname><given-names>D</given-names></name><name><surname>Hirotsune</surname><given-names>S</given-names></name><name><surname>Wynshaw-Boris</surname><given-names>A</given-names></name><article-title>14-3-3epsilon is important for neuronal migration by binding to NUDEL: a molecular explanation for Miller-Dieker syndrome.</article-title><source>Nat Genet</source><year>2003</year><volume>34</volume><fpage>274</fpage><lpage>285</lpage><pub-id pub-id-type="pmid">12796778</pub-id><pub-id pub-id-type="doi">10.1038/ng1169</pub-id></mixed-citation></ref><ref id="B60"><mixed-citation publication-type="journal"><name><surname>Kuo</surname><given-names>TY</given-names></name><name><surname>Hsueh</surname><given-names>YP</given-names></name><article-title>Expression of zinc finger transcription factor Bcl11A/Evi9/CTIP1 in rat brain.</article-title><source>J Neurosci Res</source><year>2007</year><volume>85</volume><fpage>1628</fpage><lpage>1636</lpage><pub-id pub-id-type="pmid">17455301</pub-id><pub-id pub-id-type="doi">10.1002/jnr.21300</pub-id></mixed-citation></ref><ref id="B61"><mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Lee</surname><given-names>JA</given-names></name><name><surname>Black</surname><given-names>DL</given-names></name><article-title>Neuronal regulation of alternative pre-mRNA splicing.</article-title><source>Nat Rev Neurosci</source><year>2007</year><volume>8</volume><fpage>819</fpage><lpage>831</lpage><pub-id pub-id-type="pmid">17895907</pub-id><pub-id pub-id-type="doi">10.1038/nrn2237</pub-id></mixed-citation></ref><ref id="B62"><mixed-citation publication-type="journal"><name><surname>Zhou</surname><given-names>C</given-names></name><name><surname>Tsai</surname><given-names>SY</given-names></name><name><surname>Tsai</surname><given-names>MJ</given-names></name><article-title>COUP-TFI: an intrinsic factor for early regionalization of the neocortex.</article-title><source>Genes Dev</source><year>2001</year><volume>15</volume><fpage>2054</fpage><lpage>2059</lpage><pub-id pub-id-type="pmid">11511537</pub-id><pub-id pub-id-type="doi">10.1101/gad.913601</pub-id></mixed-citation></ref><ref id="B63"><mixed-citation publication-type="other"><article-title>UCSC Genome Bioinformatics.</article-title><ext-link ext-link-type="uri" xlink:href="http://genome.ucsc.edu/">http://genome.ucsc.edu/</ext-link></mixed-citation></ref><ref id="B64"><mixed-citation publication-type="other"><article-title>Ensembl Genome Browser.</article-title><ext-link ext-link-type="uri" xlink:href="http://www.ensembl.org/">http://www.ensembl.org/</ext-link></mixed-citation></ref><ref id="B65"><mixed-citation publication-type="journal"><name><surname>Bergsland</surname><given-names>M</given-names></name><name><surname>Werme</surname><given-names>M</given-names></name><name><surname>Malewicz</surname><given-names>M</given-names></name><name><surname>Perlmann</surname><given-names>T</given-names></name><name><surname>Muhr</surname><given-names>J</given-names></name><article-title>The establishment of neuronal properties is controlled by Sox4 and Sox11.</article-title><source>Genes Dev</source><year>2006</year><volume>20</volume><fpage>3475</fpage><lpage>3486</lpage><pub-id pub-id-type="pmid">17182872</pub-id><pub-id pub-id-type="doi">10.1101/gad.403406</pub-id></mixed-citation></ref><ref id="B66"><mixed-citation publication-type="journal"><name><surname>Potzner</surname><given-names>MR</given-names></name><name><surname>Griffel</surname><given-names>C</given-names></name><name><surname>Lutjen-Drecoll</surname><given-names>E</given-names></name><name><surname>Bosl</surname><given-names>MR</given-names></name><name><surname>Wegner</surname><given-names>M</given-names></name><name><surname>Sock</surname><given-names>E</given-names></name><article-title>Prolonged Sox4 expression in oligodendrocytes interferes with normal myelination in the central nervous system.</article-title><source>Mol Cell Biol</source><year>2007</year><volume>27</volume><fpage>5316</fpage><lpage>5326</lpage><pub-id pub-id-type="pmid">17515609</pub-id><pub-id pub-id-type="doi">10.1128/MCB.00339-07</pub-id></mixed-citation></ref><ref id="B67"><mixed-citation publication-type="journal"><name><surname>Velculescu</surname><given-names>VE</given-names></name><name><surname>Madden</surname><given-names>SL</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Lash</surname><given-names>AE</given-names></name><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Rago</surname><given-names>C</given-names></name><name><surname>Lal</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>CJ</given-names></name><name><surname>Beaudry</surname><given-names>GA</given-names></name><name><surname>Ciriello</surname><given-names>KM</given-names></name><name><surname>Cook</surname><given-names>BP</given-names></name><name><surname>Dufault</surname><given-names>MR</given-names></name><name><surname>Ferguson</surname><given-names>AT</given-names></name><name><surname>Gao</surname><given-names>Y</given-names></name><name><surname>He</surname><given-names>TC</given-names></name><name><surname>Hermeking</surname><given-names>H</given-names></name><name><surname>Hiraldo</surname><given-names>SK</given-names></name><name><surname>Hwang</surname><given-names>PM</given-names></name><name><surname>Lopez</surname><given-names>MA</given-names></name><name><surname>Luderer</surname><given-names>HF</given-names></name><name><surname>Mathews</surname><given-names>B</given-names></name><name><surname>Petroziello</surname><given-names>JM</given-names></name><name><surname>Polyak</surname><given-names>K</given-names></name><name><surname>Zawel</surname><given-names>L</given-names></name><name><surname>Kinzler</surname><given-names>KW</given-names></name><article-title>Analysis of human transcriptomes.</article-title><source>Nat Genet</source><year>1999</year><volume>23</volume><fpage>387</fpage><lpage>388</lpage><pub-id pub-id-type="pmid">10581018</pub-id><pub-id pub-id-type="doi">10.1038/70487</pub-id></mixed-citation></ref><ref id="B68"><mixed-citation publication-type="journal"><name><surname>Brenner</surname><given-names>S</given-names></name><name><surname>Johnson</surname><given-names>M</given-names></name><name><surname>Bridgham</surname><given-names>J</given-names></name><name><surname>Golda</surname><given-names>G</given-names></name><name><surname>Lloyd</surname><given-names>DH</given-names></name><name><surname>Johnson</surname><given-names>D</given-names></name><name><surname>Luo</surname><given-names>S</given-names></name><name><surname>McCurdy</surname><given-names>S</given-names></name><name><surname>Foy</surname><given-names>M</given-names></name><name><surname>Ewan</surname><given-names>M</given-names></name><name><surname>Roth</surname><given-names>R</given-names></name><name><surname>George</surname><given-names>D</given-names></name><name><surname>Eletr</surname><given-names>S</given-names></name><name><surname>Albrecht</surname><given-names>G</given-names></name><name><surname>Vermaas</surname><given-names>E</given-names></name><name><surname>Williams</surname><given-names>SR</given-names></name><name><surname>Moon</surname><given-names>K</given-names></name><name><surname>Burcham</surname><given-names>T</given-names></name><name><surname>Pallas</surname><given-names>M</given-names></name><name><surname>DuBridge</surname><given-names>RB</given-names></name><name><surname>Kirchner</surname><given-names>J</given-names></name><name><surname>Fearon</surname><given-names>K</given-names></name><name><surname>Mao</surname><given-names>J</given-names></name><name><surname>Corcoran</surname><given-names>K</given-names></name><article-title>Gene expression analysis by massively parallel signature sequencing (MPSS) on microbead arrays.</article-title><source>Nat Biotechnol</source><year>2000</year><volume>18</volume><fpage>630</fpage><lpage>634</lpage><pub-id pub-id-type="pmid">10835600</pub-id><pub-id pub-id-type="doi">10.1038/76469</pub-id></mixed-citation></ref><ref id="B69"><mixed-citation publication-type="other"><article-title>The Cancer Genome Anatomy Project: SAGE Genie.</article-title><ext-link ext-link-type="uri" xlink:href="http://cgap.nci.nih.gov/SAGE">http://cgap.nci.nih.gov/SAGE</ext-link></mixed-citation></ref><ref id="B70"><mixed-citation publication-type="journal"><name><surname>Ng</surname><given-names>P</given-names></name><name><surname>Tan</surname><given-names>JJ</given-names></name><name><surname>Ooi</surname><given-names>HS</given-names></name><name><surname>Lee</surname><given-names>YL</given-names></name><name><surname>Chiu</surname><given-names>KP</given-names></name><name><surname>Fullwood</surname><given-names>MJ</given-names></name><name><surname>Srinivasan</surname><given-names>KG</given-names></name><name><surname>Perbost</surname><given-names>C</given-names></name><name><surname>Du</surname><given-names>L</given-names></name><name><surname>Sung</surname><given-names>WK</given-names></name><name><surname>Wei</surname><given-names>CL</given-names></name><name><surname>Ruan</surname><given-names>Y</given-names></name><article-title>Multiplex sequencing of paired-end ditags (MS-PET): a strategy for the ultra-high-throughput analysis of transcriptomes and genomes.</article-title><source>Nucleic Acids Res</source><year>2006</year><volume>34</volume><fpage>e84</fpage><pub-id pub-id-type="pmid">16840528</pub-id><pub-id pub-id-type="doi">10.1093/nar/gkl444</pub-id></mixed-citation></ref><ref id="B71"><mixed-citation publication-type="journal"><name><surname>Shiraki</surname><given-names>T</given-names></name><name><surname>Kondo</surname><given-names>S</given-names></name><name><surname>Katayama</surname><given-names>S</given-names></name><name><surname>Waki</surname><given-names>K</given-names></name><name><surname>Kasukawa</surname><given-names>T</given-names></name><name><surname>Kawaji</surname><given-names>H</given-names></name><name><surname>Kodzius</surname><given-names>R</given-names></name><name><surname>Watahiki</surname><given-names>A</given-names></name><name><surname>Nakamura</surname><given-names>M</given-names></name><name><surname>Arakawa</surname><given-names>T</given-names></name><name><surname>Fukuda</surname><given-names>S</given-names></name><name><surname>Sasaki</surname><given-names>D</given-names></name><name><surname>Podhajska</surname><given-names>A</given-names></name><name><surname>Harbers</surname><given-names>M</given-names></name><name><surname>Kawai</surname><given-names>J</given-names></name><name><surname>Carninci</surname><given-names>P</given-names></name><name><surname>Hayashizaki</surname><given-names>Y</given-names></name><article-title>Cap analysis gene expression for high-throughput analysis of transcriptional starting point and identification of promoter usage.</article-title><source>Proc Natl Acad Sci USA</source><year>2003</year><volume>100</volume><fpage>15776</fpage><lpage>15781</lpage><pub-id pub-id-type="pmid">14663149</pub-id><pub-id pub-id-type="doi">10.1073/pnas.2136655100</pub-id></mixed-citation></ref><ref id="B72"><mixed-citation publication-type="journal"><name><surname>Wei</surname><given-names>CL</given-names></name><name><surname>Ng</surname><given-names>P</given-names></name><name><surname>Chiu</surname><given-names>KP</given-names></name><name><surname>Wong</surname><given-names>CH</given-names></name><name><surname>Ang</surname><given-names>CC</given-names></name><name><surname>Lipovich</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>ET</given-names></name><name><surname>Ruan</surname><given-names>Y</given-names></name><article-title>5' Long serial analysis of gene expression (LongSAGE) and 3' LongSAGE for transcriptome characterization and genome annotation.</article-title><source>Proc Natl Acad Sci USA</source><year>2004</year><volume>101</volume><fpage>11701</fpage><lpage>11706</lpage><pub-id pub-id-type="pmid">15272081</pub-id><pub-id pub-id-type="doi">10.1073/pnas.0403514101</pub-id></mixed-citation></ref><ref id="B73"><mixed-citation publication-type="journal"><name><surname>Chenn</surname><given-names>A</given-names></name><article-title>Wnt/beta-catenin signaling in cerebral cortical development.</article-title><source>Organogenesis</source><year>2008</year><volume>4</volume><fpage>76</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">19279718</pub-id></mixed-citation></ref><ref id="B74"><mixed-citation publication-type="journal"><name><surname>Bafico</surname><given-names>A</given-names></name><name><surname>Gazit</surname><given-names>A</given-names></name><name><surname>Pramila</surname><given-names>T</given-names></name><name><surname>Finch</surname><given-names>PW</given-names></name><name><surname>Yaniv</surname><given-names>A</given-names></name><name><surname>Aaronson</surname><given-names>SA</given-names></name><article-title>Interaction of frizzled related protein (FRP) with Wnt ligands and the frizzled receptor suggests alternative mechanisms for FRP inhibition of Wnt signaling.</article-title><source>J Biol Chem</source><year>1999</year><volume>274</volume><fpage>16180</fpage><lpage>16187</lpage><pub-id pub-id-type="pmid">10347172</pub-id><pub-id pub-id-type="doi">10.1074/jbc.274.23.16180</pub-id></mixed-citation></ref><ref id="B75"><mixed-citation publication-type="journal"><name><surname>Morkel</surname><given-names>M</given-names></name><name><surname>Huelsken</surname><given-names>J</given-names></name><name><surname>Wakamiya</surname><given-names>M</given-names></name><name><surname>Ding</surname><given-names>J</given-names></name><name><surname>Wetering</surname><given-names>M van de</given-names></name><name><surname>Clevers</surname><given-names>H</given-names></name><name><surname>Taketo</surname><given-names>MM</given-names></name><name><surname>Behringer</surname><given-names>RR</given-names></name><name><surname>Shen</surname><given-names>MM</given-names></name><name><surname>Birchmeier</surname><given-names>W</given-names></name><article-title>Beta-catenin regulates Cripto- and Wnt3-dependent gene expression programs in mouse axis and mesoderm formation.</article-title><source>Development</source><year>2003</year><volume>130</volume><fpage>6283</fpage><lpage>6294</lpage><pub-id pub-id-type="pmid">14623818</pub-id><pub-id pub-id-type="doi">10.1242/dev.00859</pub-id></mixed-citation></ref><ref id="B76"><mixed-citation publication-type="journal"><name><surname>Fevr</surname><given-names>T</given-names></name><name><surname>Robine</surname><given-names>S</given-names></name><name><surname>Louvard</surname><given-names>D</given-names></name><name><surname>Huelsken</surname><given-names>J</given-names></name><article-title>Wnt/beta-catenin is essential for intestinal homeostasis and maintenance of intestinal stem cells.</article-title><source>Mol Cell Biol</source><year>2007</year><volume>27</volume><fpage>7551</fpage><lpage>7559</lpage><pub-id pub-id-type="pmid">17785439</pub-id><pub-id pub-id-type="doi">10.1128/MCB.01034-07</pub-id></mixed-citation></ref><ref id="B77"><mixed-citation publication-type="journal"><name><surname>Machon</surname><given-names>O</given-names></name><name><surname>Backman</surname><given-names>M</given-names></name><name><surname>Machonova</surname><given-names>O</given-names></name><name><surname>Kozmik</surname><given-names>Z</given-names></name><name><surname>Vacik</surname><given-names>T</given-names></name><name><surname>Andersen</surname><given-names>L</given-names></name><name><surname>Krauss</surname><given-names>S</given-names></name><article-title>A dynamic gradient of Wnt signaling controls initiation of neurogenesis in the mammalian cortex and cellular specification in the hippocampus.</article-title><source>Dev Biol</source><year>2007</year><volume>311</volume><fpage>223</fpage><lpage>237</lpage><pub-id pub-id-type="pmid">17916349</pub-id><pub-id pub-id-type="doi">10.1016/j.ydbio.2007.08.038</pub-id></mixed-citation></ref><ref id="B78"><mixed-citation publication-type="journal"><name><surname>Woodhead</surname><given-names>GJ</given-names></name><name><surname>Mutch</surname><given-names>CA</given-names></name><name><surname>Olson</surname><given-names>EC</given-names></name><name><surname>Chenn</surname><given-names>A</given-names></name><article-title>Cell-autonomous beta-catenin signaling regulates cortical precursor proliferation.</article-title><source>J Neurosci</source><year>2006</year><volume>26</volume><fpage>12620</fpage><lpage>12630</lpage><pub-id pub-id-type="pmid">17135424</pub-id><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3180-06.2006</pub-id></mixed-citation></ref><ref id="B79"><mixed-citation publication-type="journal"><name><surname>Lisman</surname><given-names>J</given-names></name><name><surname>Schulman</surname><given-names>H</given-names></name><name><surname>Cline</surname><given-names>H</given-names></name><article-title>The molecular basis of CaMKII function in synaptic and behavioural memory.</article-title><source>Nat Rev Neurosci</source><year>2002</year><volume>3</volume><fpage>175</fpage><lpage>190</lpage><pub-id pub-id-type="pmid">11994750</pub-id><pub-id pub-id-type="doi">10.1038/nrn753</pub-id></mixed-citation></ref><ref id="B80"><mixed-citation publication-type="journal"><name><surname>Pak</surname><given-names>JH</given-names></name><name><surname>Huang</surname><given-names>FL</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Balschun</surname><given-names>D</given-names></name><name><surname>Reymann</surname><given-names>KG</given-names></name><name><surname>Chiang</surname><given-names>C</given-names></name><name><surname>Westphal</surname><given-names>H</given-names></name><name><surname>Huang</surname><given-names>KP</given-names></name><article-title>Involvement of neurogranin in the modulation of calcium/calmodulin-dependent protein kinase II, synaptic plasticity, and spatial learning: a study with knockout mice.</article-title><source>Proc Natl Acad Sci USA</source><year>2000</year><volume>97</volume><fpage>11232</fpage><lpage>11237</lpage><pub-id pub-id-type="pmid">11016969</pub-id><pub-id pub-id-type="doi">10.1073/pnas.210184697</pub-id></mixed-citation></ref><ref id="B81"><mixed-citation publication-type="journal"><name><surname>Lepicard</surname><given-names>EM</given-names></name><name><surname>Mizuno</surname><given-names>K</given-names></name><name><surname>Antunes-Martins</surname><given-names>A</given-names></name><name><surname>von Hertzen</surname><given-names>LS</given-names></name><name><surname>Giese</surname><given-names>KP</given-names></name><article-title>An endogenous inhibitor of calcium/calmodulin-dependent kinase II is up-regulated during consolidation of fear memory.</article-title><source>Eur J Neurosci</source><year>2006</year><volume>23</volume><fpage>3063</fpage><lpage>3070</lpage><pub-id pub-id-type="pmid">16819996</pub-id><pub-id pub-id-type="doi">10.1111/j.1460-9568.2006.04830.x</pub-id></mixed-citation></ref><ref id="B82"><mixed-citation publication-type="journal"><name><surname>Young-Pearse</surname><given-names>TL</given-names></name><name><surname>Bai</surname><given-names>J</given-names></name><name><surname>Chang</surname><given-names>R</given-names></name><name><surname>Zheng</surname><given-names>JB</given-names></name><name><surname>LoTurco</surname><given-names>JJ</given-names></name><name><surname>Selkoe</surname><given-names>DJ</given-names></name><article-title>A critical function for beta-amyloid precursor protein in neuronal migration revealed by <italic>in utero </italic>RNA interference.</article-title><source>J Neurosci</source><year>2007</year><volume>27</volume><fpage>14459</fpage><lpage>14469</lpage><pub-id pub-id-type="pmid">18160654</pub-id><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4701-07.2007</pub-id></mixed-citation></ref><ref id="B83"><mixed-citation publication-type="journal"><name><surname>Alonso</surname><given-names>A</given-names></name><name><surname>Zaidi</surname><given-names>T</given-names></name><name><surname>Novak</surname><given-names>M</given-names></name><name><surname>Grundke-Iqbal</surname><given-names>I</given-names></name><name><surname>Iqbal</surname><given-names>K</given-names></name><article-title>Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments.</article-title><source>Proc Natl Acad Sci USA</source><year>2001</year><volume>98</volume><fpage>6923</fpage><lpage>6928</lpage><pub-id pub-id-type="pmid">11381127</pub-id><pub-id pub-id-type="doi">10.1073/pnas.121119298</pub-id></mixed-citation></ref><ref id="B84"><mixed-citation publication-type="journal"><name><surname>Rapoport</surname><given-names>M</given-names></name><name><surname>Dawson</surname><given-names>HN</given-names></name><name><surname>Binder</surname><given-names>LI</given-names></name><name><surname>Vitek</surname><given-names>MP</given-names></name><name><surname>Ferreira</surname><given-names>A</given-names></name><article-title>Tau is essential to beta-amyloid-induced neurotoxicity.</article-title><source>Proc Natl Acad Sci USA</source><year>2002</year><volume>99</volume><fpage>6364</fpage><lpage>6369</lpage><pub-id pub-id-type="pmid">11959919</pub-id><pub-id pub-id-type="doi">10.1073/pnas.092136199</pub-id></mixed-citation></ref><ref id="B85"><mixed-citation publication-type="journal"><name><surname>Carter</surname><given-names>CJ</given-names></name><article-title>eIF2B and oligodendrocyte survival: where nature and nurture meet in bipolar disorder and schizophrenia?</article-title><source>Schizophr Bull</source><year>2007</year><volume>33</volume><fpage>1343</fpage><lpage>1353</lpage><pub-id pub-id-type="pmid">17329232</pub-id><pub-id pub-id-type="doi">10.1093/schbul/sbm007</pub-id></mixed-citation></ref><ref id="B86"><mixed-citation publication-type="journal"><name><surname>Craddock</surname><given-names>N</given-names></name><name><surname>O'Donovan</surname><given-names>MC</given-names></name><name><surname>Owen</surname><given-names>MJ</given-names></name><article-title>The genetics of schizophrenia and bipolar disorder: dissecting psychosis.</article-title><source>J Med Genet</source><year>2005</year><volume>42</volume><fpage>193</fpage><lpage>204</lpage><pub-id pub-id-type="pmid">15744031</pub-id><pub-id pub-id-type="doi">10.1136/jmg.2005.030718</pub-id></mixed-citation></ref><ref id="B87"><mixed-citation publication-type="journal"><name><surname>Hodges</surname><given-names>A</given-names></name><name><surname>Strand</surname><given-names>AD</given-names></name><name><surname>Aragaki</surname><given-names>AK</given-names></name><name><surname>Kuhn</surname><given-names>A</given-names></name><name><surname>Sengstag</surname><given-names>T</given-names></name><name><surname>Hughes</surname><given-names>G</given-names></name><name><surname>Elliston</surname><given-names>LA</given-names></name><name><surname>Hartog</surname><given-names>C</given-names></name><name><surname>Goldstein</surname><given-names>DR</given-names></name><name><surname>Thu</surname><given-names>D</given-names></name><name><surname>Hollingsworth</surname><given-names>ZR</given-names></name><name><surname>Collin</surname><given-names>F</given-names></name><name><surname>Synek</surname><given-names>B</given-names></name><name><surname>Holmans</surname><given-names>PA</given-names></name><name><surname>Young</surname><given-names>AB</given-names></name><name><surname>Wexler</surname><given-names>NS</given-names></name><name><surname>Delorenzi</surname><given-names>M</given-names></name><name><surname>Kooperberg</surname><given-names>C</given-names></name><name><surname>Augood</surname><given-names>SJ</given-names></name><name><surname>Faull</surname><given-names>RL</given-names></name><name><surname>Olson</surname><given-names>JM</given-names></name><name><surname>Jones</surname><given-names>L</given-names></name><name><surname>Luthi-Carter</surname><given-names>R</given-names></name><article-title>Regional and cellular gene expression changes in human Huntington's disease brain.</article-title><source>Hum Mol Genet</source><year>2006</year><volume>15</volume><fpage>965</fpage><lpage>977</lpage><pub-id pub-id-type="pmid">16467349</pub-id><pub-id pub-id-type="doi">10.1093/hmg/ddl013</pub-id></mixed-citation></ref><ref id="B88"><mixed-citation publication-type="journal"><name><surname>Luthi-Carter</surname><given-names>R</given-names></name><name><surname>Strand</surname><given-names>A</given-names></name><name><surname>Peters</surname><given-names>NL</given-names></name><name><surname>Solano</surname><given-names>SM</given-names></name><name><surname>Hollingsworth</surname><given-names>ZR</given-names></name><name><surname>Menon</surname><given-names>AS</given-names></name><name><surname>Frey</surname><given-names>AS</given-names></name><name><surname>Spektor</surname><given-names>BS</given-names></name><name><surname>Penney</surname><given-names>EB</given-names></name><name><surname>Schilling</surname><given-names>G</given-names></name><name><surname>Ross</surname><given-names>CA</given-names></name><name><surname>Borchelt</surname><given-names>DR</given-names></name><name><surname>Tapscott</surname><given-names>SJ</given-names></name><name><surname>Young</surname><given-names>AB</given-names></name><name><surname>Cha</surname><given-names>JH</given-names></name><name><surname>Olson</surname><given-names>JM</given-names></name><article-title>Decreased expression of striatal signaling genes in a mouse model of Huntington's disease.</article-title><source>Hum Mol Genet</source><year>2000</year><volume>9</volume><fpage>1259</fpage><lpage>1271</lpage><pub-id pub-id-type="pmid">10814708</pub-id><pub-id pub-id-type="doi">10.1093/hmg/9.9.1259</pub-id></mixed-citation></ref><ref id="B89"><mixed-citation publication-type="journal"><name><surname>Lovestone</surname><given-names>S</given-names></name><name><surname>Hodgson</surname><given-names>S</given-names></name><name><surname>Sham</surname><given-names>P</given-names></name><name><surname>Differ</surname><given-names>AM</given-names></name><name><surname>Levy</surname><given-names>R</given-names></name><article-title>Familial psychiatric presentation of Huntington's disease.</article-title><source>J Med Genet</source><year>1996</year><volume>33</volume><fpage>128</fpage><lpage>131</lpage><pub-id pub-id-type="pmid">8929949</pub-id><pub-id pub-id-type="doi">10.1136/jmg.33.2.128</pub-id></mixed-citation></ref><ref id="B90"><mixed-citation publication-type="journal"><name><surname>Shiwach</surname><given-names>R</given-names></name><article-title>Psychopathology in Huntington's disease patients.</article-title><source>Acta Psychiatr Scand</source><year>1994</year><volume>90</volume><fpage>241</fpage><lpage>246</lpage><pub-id pub-id-type="pmid">7831992</pub-id><pub-id pub-id-type="doi">10.1111/j.1600-0447.1994.tb01587.x</pub-id></mixed-citation></ref><ref id="B91"><mixed-citation publication-type="journal"><name><surname>Chandra</surname><given-names>S</given-names></name><name><surname>Gallardo</surname><given-names>G</given-names></name><name><surname>Fernandez-Chacon</surname><given-names>R</given-names></name><name><surname>Schluter</surname><given-names>OM</given-names></name><name><surname>Sudhof</surname><given-names>TC</given-names></name><article-title>Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration.</article-title><source>Cell</source><year>2005</year><volume>123</volume><fpage>383</fpage><lpage>396</lpage><pub-id pub-id-type="pmid">16269331</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2005.09.028</pub-id></mixed-citation></ref><ref id="B92"><mixed-citation publication-type="journal"><name><surname>Evert</surname><given-names>BO</given-names></name><name><surname>Wullner</surname><given-names>U</given-names></name><name><surname>Klockgether</surname><given-names>T</given-names></name><article-title>Cell death in polyglutamine diseases.</article-title><source>Cell Tissue Res</source><year>2000</year><volume>301</volume><fpage>189</fpage><lpage>204</lpage><pub-id pub-id-type="pmid">10928291</pub-id><pub-id pub-id-type="doi">10.1007/s004410000228</pub-id></mixed-citation></ref><ref id="B93"><mixed-citation publication-type="journal"><name><surname>Morishima</surname><given-names>Y</given-names></name><name><surname>Gotoh</surname><given-names>Y</given-names></name><name><surname>Zieg</surname><given-names>J</given-names></name><name><surname>Barrett</surname><given-names>T</given-names></name><name><surname>Takano</surname><given-names>H</given-names></name><name><surname>Flavell</surname><given-names>R</given-names></name><name><surname>Davis</surname><given-names>RJ</given-names></name><name><surname>Shirasaki</surname><given-names>Y</given-names></name><name><surname>Greenberg</surname><given-names>ME</given-names></name><article-title>Beta-amyloid induces neuronal apoptosis via a mechanism that involves the c-Jun N-terminal kinase pathway and the induction of Fas ligand.</article-title><source>J Neurosci</source><year>2001</year><volume>21</volume><fpage>7551</fpage><lpage>7560</lpage><pub-id pub-id-type="pmid">11567045</pub-id></mixed-citation></ref><ref id="B94"><mixed-citation publication-type="journal"><name><surname>Mallamaci</surname><given-names>A</given-names></name><name><surname>Stoykova</surname><given-names>A</given-names></name><article-title>Gene networks controlling early cerebral cortex arealization.</article-title><source>Eur J Neurosci</source><year>2006</year><volume>23</volume><fpage>847</fpage><lpage>856</lpage><pub-id pub-id-type="pmid">16519650</pub-id><pub-id pub-id-type="doi">10.1111/j.1460-9568.2006.04634.x</pub-id></mixed-citation></ref><ref id="B95"><mixed-citation publication-type="journal"><name><surname>Philp</surname><given-names>D</given-names></name><name><surname>Huff</surname><given-names>T</given-names></name><name><surname>Gho</surname><given-names>YS</given-names></name><name><surname>Hannappel</surname><given-names>E</given-names></name><name><surname>Kleinman</surname><given-names>HK</given-names></name><article-title>The actin binding site on thymosin beta4 promotes angiogenesis.</article-title><source>Faseb J</source><year>2003</year><volume>17</volume><fpage>2103</fpage><lpage>2105</lpage><pub-id pub-id-type="pmid">14500546</pub-id></mixed-citation></ref><ref id="B96"><mixed-citation publication-type="journal"><name><surname>Bock-Marquette</surname><given-names>I</given-names></name><name><surname>Saxena</surname><given-names>A</given-names></name><name><surname>White</surname><given-names>MD</given-names></name><name><surname>Dimaio</surname><given-names>JM</given-names></name><name><surname>Srivastava</surname><given-names>D</given-names></name><article-title>Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair.</article-title><source>Nature</source><year>2004</year><volume>432</volume><fpage>466</fpage><lpage>472</lpage><pub-id pub-id-type="pmid">15565145</pub-id><pub-id pub-id-type="doi">10.1038/nature03000</pub-id></mixed-citation></ref><ref id="B97"><mixed-citation publication-type="journal"><name><surname>Roth</surname><given-names>LW</given-names></name><name><surname>Bormann</surname><given-names>P</given-names></name><name><surname>Bonnet</surname><given-names>A</given-names></name><name><surname>Reinhard</surname><given-names>E</given-names></name><article-title>beta-thymosin is required for axonal tract formation in developing zebrafish brain.</article-title><source>Development</source><year>1999</year><volume>126</volume><fpage>1365</fpage><lpage>1374</lpage><pub-id pub-id-type="pmid">10068630</pub-id></mixed-citation></ref><ref id="B98"><mixed-citation publication-type="journal"><name><surname>Lopez-Bendito</surname><given-names>G</given-names></name><name><surname>Molnar</surname><given-names>Z</given-names></name><article-title>Thalamocortical development: how are we going to get there?</article-title><source>Nat Rev Neurosci</source><year>2003</year><volume>4</volume><fpage>276</fpage><lpage>289</lpage><pub-id pub-id-type="pmid">12671644</pub-id><pub-id pub-id-type="doi">10.1038/nrn1075</pub-id></mixed-citation></ref><ref id="B99"><mixed-citation publication-type="journal"><name><surname>Winter</surname><given-names>J</given-names></name><name><surname>Kunath</surname><given-names>M</given-names></name><name><surname>Roepcke</surname><given-names>S</given-names></name><name><surname>Krause</surname><given-names>S</given-names></name><name><surname>Schneider</surname><given-names>R</given-names></name><name><surname>Schweiger</surname><given-names>S</given-names></name><article-title>Alternative polyadenylation signals and promoters act in concert to control tissue-specific expression of the Opitz Syndrome gene MID1.</article-title><source>BMC Mol Biol</source><year>2007</year><volume>8</volume><fpage>105</fpage><pub-id pub-id-type="pmid">18005432</pub-id><pub-id pub-id-type="doi">10.1186/1471-2199-8-105</pub-id></mixed-citation></ref><ref id="B100"><mixed-citation publication-type="journal"><name><surname>Abdel Wahab</surname><given-names>N</given-names></name><name><surname>Gibbs</surname><given-names>J</given-names></name><name><surname>Mason</surname><given-names>RM</given-names></name><article-title>Regulation of gene expression by alternative polyadenylation and mRNA instability in hyperglycaemic mesangial cells.</article-title><source>Biochem J</source><year>1998</year><volume>336</volume><fpage>405</fpage><lpage>411</lpage><pub-id pub-id-type="pmid">9820818</pub-id></mixed-citation></ref><ref id="B101"><mixed-citation publication-type="journal"><name><surname>Wilusz</surname><given-names>CJ</given-names></name><name><surname>Wilusz</surname><given-names>J</given-names></name><article-title>Bringing the role of mRNA decay in the control of gene expression into focus.</article-title><source>Trends Genet</source><year>2004</year><volume>20</volume><fpage>491</fpage><lpage>497</lpage><pub-id pub-id-type="pmid">15363903</pub-id><pub-id pub-id-type="doi">10.1016/j.tig.2004.07.011</pub-id></mixed-citation></ref><ref id="B102"><mixed-citation publication-type="journal"><name><surname>Lu</surname><given-names>C</given-names></name><name><surname>Jeong</surname><given-names>D-H</given-names></name><name><surname>Kulkarni</surname><given-names>K</given-names></name><name><surname>Pillay</surname><given-names>M</given-names></name><name><surname>Nobuta</surname><given-names>K</given-names></name><name><surname>German</surname><given-names>R</given-names></name><name><surname>Thatcher</surname><given-names>SR</given-names></name><name><surname>Maher</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Ware</surname><given-names>D</given-names></name><name><surname>Liu</surname><given-names>B</given-names></name><name><surname>Cao</surname><given-names>X</given-names></name><name><surname>Meyers</surname><given-names>BC</given-names></name><name><surname>Green</surname><given-names>PJ</given-names></name><article-title>Genome-wide analysis for discovery of rice microRNAs reveals natural antisense microRNAs (nat-miRNAs).</article-title><source>Proc Natl Acad Sci USA</source><year>2008</year><volume>105</volume><fpage>4951</fpage><lpage>4956</lpage><pub-id pub-id-type="pmid">18353984</pub-id><pub-id pub-id-type="doi">10.1073/pnas.0708743105</pub-id></mixed-citation></ref><ref id="B103"><mixed-citation publication-type="other"><article-title>miRBase.</article-title><ext-link ext-link-type="uri" xlink:href="http://microrna.sanger.ac.uk/">http://microrna.sanger.ac.uk/</ext-link></mixed-citation></ref><ref id="B104"><mixed-citation publication-type="journal"><name><surname>Watanabe</surname><given-names>T</given-names></name><name><surname>Totoki</surname><given-names>Y</given-names></name><name><surname>Toyoda</surname><given-names>A</given-names></name><name><surname>Kaneda</surname><given-names>M</given-names></name><name><surname>Kuramochi-Miyagawa</surname><given-names>S</given-names></name><name><surname>Obata</surname><given-names>Y</given-names></name><name><surname>Chiba</surname><given-names>H</given-names></name><name><surname>Kohara</surname><given-names>Y</given-names></name><name><surname>Kono</surname><given-names>T</given-names></name><name><surname>Nakano</surname><given-names>T</given-names></name><name><surname>Surani</surname><given-names>MA</given-names></name><name><surname>Sakaki</surname><given-names>Y</given-names></name><name><surname>Sasaki</surname><given-names>H</given-names></name><article-title>Endogenous siRNAs from naturally formed dsRNAs regulate transcripts in mouse oocytes.</article-title><source>Nature</source><year>2008</year><volume>453</volume><fpage>539</fpage><lpage>543</lpage><pub-id pub-id-type="pmid">18404146</pub-id><pub-id pub-id-type="doi">10.1038/nature06908</pub-id></mixed-citation></ref><ref id="B105"><mixed-citation publication-type="journal"><name><surname>Hoser</surname><given-names>M</given-names></name><name><surname>Potzner</surname><given-names>MR</given-names></name><name><surname>Koch</surname><given-names>JM</given-names></name><name><surname>Bosl</surname><given-names>MR</given-names></name><name><surname>Wegner</surname><given-names>M</given-names></name><name><surname>Sock</surname><given-names>E</given-names></name><article-title>Sox12 deletion in the mouse reveals nonreciprocal redundancy with the related Sox4 and Sox11 transcription factors.</article-title><source>Mol Cell Biol</source><year>2008</year><volume>28</volume><fpage>4675</fpage><lpage>4687</lpage><pub-id pub-id-type="pmid">18505825</pub-id><pub-id pub-id-type="doi">10.1128/MCB.00338-08</pub-id></mixed-citation></ref><ref id="B106"><mixed-citation publication-type="journal"><name><surname>Cheung</surname><given-names>M</given-names></name><name><surname>Abu-Elmagd</surname><given-names>M</given-names></name><name><surname>Clevers</surname><given-names>H</given-names></name><name><surname>Scotting</surname><given-names>PJ</given-names></name><article-title>Roles of Sox4 in central nervous system development.</article-title><source>Brain Res Mol Brain Res</source><year>2000</year><volume>79</volume><fpage>180</fpage><lpage>191</lpage><pub-id pub-id-type="pmid">10925158</pub-id><pub-id pub-id-type="doi">10.1016/S0169-328X(00)00109-1</pub-id></mixed-citation></ref><ref id="B107"><mixed-citation publication-type="journal"><name><surname>Jin</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Bian</surname><given-names>W</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>G</given-names></name><name><surname>Cheng</surname><given-names>L</given-names></name><name><surname>Jing</surname><given-names>N</given-names></name><article-title>Different transcription factors regulate nestin gene expression during P19 cell neural differentiation and central nervous system development.</article-title><source>J Biol Chem</source><year>2009</year><volume>284</volume><fpage>8160</fpage><lpage>8173</lpage><pub-id pub-id-type="pmid">19147497</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M805632200</pub-id></mixed-citation></ref><ref id="B108"><mixed-citation publication-type="journal"><name><surname>Lee</surname><given-names>MS</given-names></name><name><surname>Jun</surname><given-names>DH</given-names></name><name><surname>Hwang</surname><given-names>CI</given-names></name><name><surname>Park</surname><given-names>SS</given-names></name><name><surname>Kang</surname><given-names>JJ</given-names></name><name><surname>Park</surname><given-names>HS</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>JH</given-names></name><name><surname>Seo</surname><given-names>JS</given-names></name><name><surname>Park</surname><given-names>WY</given-names></name><article-title>Selection of neural differentiation-specific genes by comparing profiles of random differentiation.</article-title><source>Stem Cells</source><year>2006</year><volume>24</volume><fpage>1946</fpage><lpage>1955</lpage><pub-id pub-id-type="pmid">16627687</pub-id><pub-id pub-id-type="doi">10.1634/stemcells.2005-0325</pub-id></mixed-citation></ref><ref id="B109"><mixed-citation publication-type="journal"><name><surname>Dy</surname><given-names>P</given-names></name><name><surname>Penzo-Mendez</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Pedraza</surname><given-names>CE</given-names></name><name><surname>Macklin</surname><given-names>WB</given-names></name><name><surname>Lefebvre</surname><given-names>V</given-names></name><article-title>The three SoxC proteins - Sox4, Sox11 and Sox12 - exhibit overlapping expression patterns and molecular properties.</article-title><source>Nucleic Acids Res</source><year>2008</year><volume>36</volume><fpage>3101</fpage><lpage>3117</lpage><pub-id pub-id-type="pmid">18403418</pub-id><pub-id pub-id-type="doi">10.1093/nar/gkn162</pub-id></mixed-citation></ref><ref id="B110"><mixed-citation publication-type="other"><article-title>Virtual Mouse Necropsy.</article-title><ext-link ext-link-type="uri" xlink:href="http://www3.niaid.nih.gov/labs/aboutlabs/cmb/InfectiousDiseasePathogenesisSection/mouseNecropsy/">http://www3.niaid.nih.gov/labs/aboutlabs/cmb/InfectiousDiseasePathogenesisSection/mouseNecropsy/</ext-link></mixed-citation></ref><ref id="B111"><mixed-citation publication-type="journal"><name><surname>Beissbarth</surname><given-names>T</given-names></name><name><surname>Hyde</surname><given-names>L</given-names></name><name><surname>Smyth</surname><given-names>GK</given-names></name><name><surname>Job</surname><given-names>C</given-names></name><name><surname>Boon</surname><given-names>WM</given-names></name><name><surname>Tan</surname><given-names>SS</given-names></name><name><surname>Scott</surname><given-names>HS</given-names></name><name><surname>Speed</surname><given-names>TP</given-names></name><article-title>Statistical modeling of sequencing errors in SAGE libraries.</article-title><source>Bioinformatics</source><year>2004</year><volume>20</volume><issue>Suppl 1</issue><fpage>I31</fpage><lpage>I39</lpage><pub-id pub-id-type="pmid">15262778</pub-id><pub-id pub-id-type="doi">10.1093/bioinformatics/bth924</pub-id></mixed-citation></ref><ref id="B112"><mixed-citation publication-type="other"><article-title>Bioconductor.</article-title><ext-link ext-link-type="uri" xlink:href="http://www.bioconductor.org/">http://www.bioconductor.org/</ext-link></mixed-citation></ref><ref id="B113"><mixed-citation publication-type="other"><article-title>Mapping SAGE Tags to Genes Using EST and Genomic Information.</article-title><ext-link ext-link-type="uri" xlink:href="http://www.mbgproject.org/tagmapping/">http://www.mbgproject.org/tagmapping/</ext-link></mixed-citation></ref><ref id="B114"><mixed-citation publication-type="journal"><name><surname>Benjamini</surname><given-names>Y</given-names></name><name><surname>Hochberg</surname><given-names>Y</given-names></name><article-title>Controlling the false discovery rate: a practical and powerful approach to multiple testing.</article-title><source>J R Statist Soc</source><year>1995</year><volume>57</volume><fpage>289</fpage><lpage>300</lpage></mixed-citation></ref><ref id="B115"><mixed-citation publication-type="journal"><name><surname>Vencio</surname><given-names>RZ</given-names></name><name><surname>Brentani</surname><given-names>H</given-names></name><name><surname>Patrao</surname><given-names>DF</given-names></name><name><surname>Pereira</surname><given-names>CA</given-names></name><article-title>Bayesian model accounting for within-class biological variability in serial analysis of gene expression (SAGE).</article-title><source>BMC Bioinformatics</source><year>2004</year><volume>5</volume><fpage>119</fpage><pub-id pub-id-type="pmid">15339345</pub-id><pub-id pub-id-type="doi">10.1186/1471-2105-5-119</pub-id></mixed-citation></ref><ref id="B116"><mixed-citation publication-type="other"><article-title>The R Project for Statistical Computing.</article-title><ext-link ext-link-type="uri" xlink:href="http://www.r-project.org/">http://www.r-project.org/</ext-link></mixed-citation></ref><ref id="B117"><mixed-citation publication-type="journal"><name><surname>Gotter</surname><given-names>J</given-names></name><name><surname>Brors</surname><given-names>B</given-names></name><name><surname>Hergenhahn</surname><given-names>M</given-names></name><name><surname>Kyewski</surname><given-names>B</given-names></name><article-title>Medullary epithelial cells of the human thymus express a highly diverse selection of tissue-specific genes colocalized in chromosomal clusters.</article-title><source>J Exp Med</source><year>2004</year><volume>199</volume><fpage>155</fpage><lpage>166</lpage><pub-id pub-id-type="pmid">14734521</pub-id><pub-id pub-id-type="doi">10.1084/jem.20031677</pub-id></mixed-citation></ref><ref id="B118"><mixed-citation publication-type="other"><article-title>Ingenuity Pathway Analysis.</article-title><ext-link ext-link-type="uri" xlink:href="http://www.ingenuity.com">http://www.ingenuity.com</ext-link></mixed-citation></ref><ref id="B119"><mixed-citation publication-type="journal"><name><surname>Schroeder</surname><given-names>A</given-names></name><name><surname>Mueller</surname><given-names>O</given-names></name><name><surname>Stocker</surname><given-names>S</given-names></name><name><surname>Salowsky</surname><given-names>R</given-names></name><name><surname>Leiber</surname><given-names>M</given-names></name><name><surname>Gassmann</surname><given-names>M</given-names></name><name><surname>Lightfoot</surname><given-names>S</given-names></name><name><surname>Menzel</surname><given-names>W</given-names></name><name><surname>Granzow</surname><given-names>M</given-names></name><name><surname>Ragg</surname><given-names>T</given-names></name><article-title>The RIN: an RNA integrity number for assigning integrity values to RNA measurements.</article-title><source>BMC Mol Biol</source><year>2006</year><volume>7</volume><fpage>3</fpage><pub-id pub-id-type="pmid">16448564</pub-id><pub-id pub-id-type="doi">10.1186/1471-2199-7-3</pub-id></mixed-citation></ref><ref id="B120"><mixed-citation publication-type="other"><article-title>Assay Design Center for Universal ProbeLibrary Assay.</article-title><ext-link ext-link-type="uri" xlink:href="http://www.roche-applied-science.com/sis/rtpcr/upl/ezhome.html">http://www.roche-applied-science.com/sis/rtpcr/upl/ezhome.html</ext-link></mixed-citation></ref><ref id="B121"><mixed-citation publication-type="journal"><name><surname>Luu-The</surname><given-names>V</given-names></name><name><surname>Paquet</surname><given-names>N</given-names></name><name><surname>Calvo</surname><given-names>E</given-names></name><name><surname>Cumps</surname><given-names>J</given-names></name><article-title>Improved real-time RT-PCR method for high-throughput measurements using second derivative calculation and double correction.</article-title><source>Biotechniques</source><year>2005</year><volume>38</volume><fpage>287</fpage><lpage>293</lpage><pub-id pub-id-type="pmid">15727135</pub-id><pub-id pub-id-type="doi">10.2144/05382RR05</pub-id></mixed-citation></ref><ref id="B122"><mixed-citation publication-type="journal"><name><surname>Smyth</surname><given-names>GK</given-names></name><article-title>Linear models and empirical bayes methods for assessing differential expression in microarray experiments.</article-title><source>Stat Appl Genet Mol Biol</source><year>2004</year><volume>3</volume><comment>Article3</comment><pub-id pub-id-type="pmid">16646809</pub-id></mixed-citation></ref><ref id="B123"><mixed-citation publication-type="journal"><name><surname>Thomas</surname><given-names>T</given-names></name><name><surname>Voss</surname><given-names>AK</given-names></name><name><surname>Chowdhury</surname><given-names>K</given-names></name><name><surname>Gruss</surname><given-names>P</given-names></name><article-title>Querkopf, a MYST family histone acetyltransferase, is required for normal cerebral cortex development.</article-title><source>Development</source><year>2000</year><volume>127</volume><fpage>2537</fpage><lpage>2548</lpage><pub-id pub-id-type="pmid">10821753</pub-id></mixed-citation></ref><ref id="B124"><mixed-citation publication-type="book"><name><surname>Rudnicki</surname><given-names>MA</given-names></name><name><surname>McBurney</surname><given-names>MW</given-names></name><person-group person-group-type="editor">Robertson EJ</person-group><article-title>Cell culture methods and induction of differentiation of embryonal carcinoma cell lines.</article-title><source>Teratocarcinomas and Embryonic Stem Cells: A Practical Approach</source><year>1987</year><publisher-name>Oxford: IRL Press</publisher-name><fpage>19</fpage><lpage>49</lpage></mixed-citation></ref></ref-list></back></article>